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Summary 
This work is a study of the syntheses of HPLC chiral stationary phases (CSPs) 
derived from perfunctionalized b-cyclodextrins (b-CDs), namely mono-(6-azido-6-
deoxy)-perfunctionalized-b-CDs (2.3a-h), heptakis-(6-azido-6-deoxy-2,3-di-O-
perfunctionalized)-b-CDs (3.3) and partial-6-(5-pent-1-enylated)-perfunctionalized-b-
CDs (4.2). Mono-(6-azido-6-deoxy)-perfunctionalized-b-CD-based CSPs (2.4) and 
heptakis-(6-azido-6-deoxy-2,3-di-O-perfunctionalized)-b-CD-based CSPs (3.4) were 
prepared by immobilizations of b-CD derivatives onto amino-functionalized silica gel 
via single and multiple urea linkage(s), respectively, using the application of 
Staudinger reaction. The CSPs (4.4) derived from partial-6-(5-pent-1-enylated)-b-CDs 
were produced by hydrosilylation and immobilization via ether linkages to silica gel. 















2.3/4a, g, h R= phenyl carbamate 
2.3/4b  R= naphthyl carbamate 
2.3/4c  R= acetyll 
2.3/4d  R= methyl 
2.3/4e  R= benzoyl 
2.3/4f  R= benzyl 
5.1  R= phenyl carbamate 
Mono-(6-azido-6-deoxy)-perfunctionalized-b-CDs can be synthesized in two 
steps: first, monotosylated-cyclodextrin was converted into mono-azido-b-cyclodextrin 
by the SN2 reaction, followed by perfunctionalization by reaction with phenyl 
isocyanate, naphthyl isocyanate, acetic anhydride, benzyl bromide and benzoyl 
chloride respectively.  
 vi 
Heptakis-azido-b-cyclodextrin was firstly produced by reaction with iodine with 
the help of PPh3, followed by the substitution by azido groups. After the 
functionalization, the b-CD derivatives were converted to CSPs via multiple urea 
linkages to silica gel. In syntheses of above two series of CSPs, the immobilization of 
b-CD derivatives were effected in presence of PPh3 and CO2 via an application of the 
Staudinger reaction.  





a: R= phenyl carbamate 






















Partial-6-(5-pent-1-enylated) b-CD was prepared by reacting with the 1-pentene 
bromide in the presence of sodium hydride. After functionalization, the b-CD 
derivatives were hydrosilylated by triethoxylsilane followed by the immobilization 
onto the surface of silica gel via stable ether covalent linkers. 
Structures of partial- (5-pent-1-enylated)-perfunctionalized b-cyclodextrin and CSPs 






a: R= phenyl carbamate 
b: R= naphthyl carbamate 









The enantioseparation abilities of these CSPs were evaluated using a wide 
variety of racemic compounds and pharmaceutical drugs/intermediates including (1-
aryl)ethanols, b-blockers, amines, tropines and pyrimidines. Results indicated that 
2.4a-c, 2.4g-h, 3.4, 4.4 and 5.1 exhibited good enantioseparation abilities under both 
normal and/or reversed phases conditions.  
2.4g-h and 5.1 were prepared by immobilization of 2.3a onto silica gels with 
different particle sizes of 5mm, 3mm and 15-35 mm, respectively. The enantioseparation 
results indicated that particle sizes and surface properties of silica gels play an 
important role in their chromatographic properties. When applied in preparative scale, 
5.1 proved to be effective in collecting the optical pure isomers of atropine, 
propranolol, isoproterenol, alprenolol, bendroflumethiazide and O-acetyl propranolol 
under reversed phases. 
Thermodynamic studies showed that all the CSPs were effective within the 
temperature ranges of 0 to 40°C. Enantioselectivity was enthalpy dominated where 
there is no conformational transition of CSPs during this temperature range. In 
reversed phase, the most suitable polar organic solvent is MeOH. The best pH value of 
the buffer comprising triethylamine and acetic acid applied under the reversed phases 
fall in range of 4.65-5.65. The optimized conditions of several isomers in terms of 
resolution (Rs) were also obtained.  
 viii 
Abbreviations and Symbols 
a Selectivity  
b-CD Beta-Cyclodextrin 
[a]D Optical rotation 
AA Acetic acid 
CD Cyclodextrin 
CE Capillary Electrophoresis  
CH3CN Acetonitrile  
CSP Chiral stationary phase 
DMF Dimethyl formamide 
FT-IR Fourier Transform Infrared Spectroscopy 
GC Gas Chromatography 
HPLC High performance liquid chromatography 
IPA Isopropanol, (or 2-propanol) 
k’ Capacity ratio 
L Column length 
MeOH Methanol 
Neff Column efficiency: effective plate number 
NMR Nuclear Magnetic Resonance 
NP Normal phase 
RP Reverse phase 
Rs Resolution  
t0 Dead time (retention time of unretained solute) 
TEA Triethylamine 
TEAA Triethylammonium acetate  
TEAP Triethylammonium phosphate 
THF Tetrahydrofuran 
tR Retention time of solute 
 
 ix 
Name of derivatives of b-cyclodextrin: 




































Names of Chiral Stationary Phases (CSPs). 
SINU-PC Mono-(6-azido-6-deoxy)-perphenylcarbamoylated-b-cyclodextrin 
immobilized on Hypersil 5mm silica gel 
SINU-NC Mono-(6-azido-6-deoxy)-pernaphthylcarbamoylated-b-cyclodextrin 
immobilized on Hypersil 5mm silica gel  
SINU-AC Mono-(6-azido-6-deoxy)-peracetylated-b-cyclodextrin immobilized 
on Hypersil 5mm silica gel  
SINU-ME Mono-(6-azido-6-deoxy)-permethylated-b-cyclodextrin 
immobilized on Hypersil 5mm silica gel  
SINU-BN Mono-(6-azido-6-deoxy)-perbenzoylated-b-cyclodextrin 
immobilized on Hypersil 5mm silica gel  
SINU-BY Mono-(6-azido-6-deoxy)-perbenzylated-b-cyclodextrin 
immobilized on Hypersil 5mm silica gel  
SINU-PC-BDS5 Mono-(6-azido-6-deoxy)-perphenylcarbamoylated-b-cyclodextrin 
immobilized on Hypersil BDS-5mm silica gel 
SINU-PC-BDS3 Mono-(6-azido-6-deoxy)-perphenylcarbamoylated-b-cyclodextrin 
immobilized on Hypersil BDS-3mm silica gel 
PREP-SINU-PC Mono-(6-azido-6-deoxy)-perphenylcarbamoylated-b-cyclodextrin 
immobilized on Kieselgel 100 silica gel 
HEPT-PC Heptakis-(6-azido-6-deoxy-2,3-di-O-perphenylcarbamoylated)-b-
cyclodextrin immobilized on Hypersil 5 mm silica gel 
HEPT-NC Heptakis-(6-azido-6-deoxy-2,3-di-O-pernaphthylcarbamoylated)-b-
cyclodextrin immobilized on Hypersil 5 mm silica gel 
ETHR-PC Partial-6-(5-pent-1-enylated)-perphenylcarbamoylated-b-
cyclodextrin immobilized on Hypersil 5 mm silica gel 
ETHR-NC Partial-6-(5-pent-1-enylated)-pernaphthylcarbamoylated-b-




Figure 1.1 Stereochemical structures of one pair of enantiomers........................................2 
Figure 1.2a) Structure of Pioglitazone ...............................................................................3 
Figure 1.2b) Structure of troglitazone (Rezulin)..................................................................4 
Figure 1.3 Stereochemical structure of thalidomide ..........................................................4 
Figure 1.4 Structure of Pirkle-type CSP........................................................................10 
Figure 1.5 Basic unit of cellulose type phase.................................................................12 
Figure 1.6 Ligand exchange type phases.......................................................................15 
Figure 1.7 Diagram of human alpha-acid glycoprotein ...................................................16 
Figure 1.8a) Structure of b-cyclodextrin molecule ............................................................23 
Figure 1.8b) Diagrammatic representation of b-cyclodextrin molecule ................................23 
Figure 1.9 Post-immobilization derivatization of cyclodextrin .........................................27 
Figure 1.10 Three-point interaction model of CSPs in HPLC ............................................30 
Figure 1.11 Formation of reversible inclusion complex ....................................................31 
Figure 2.1 Formation of stable urea linkage through Staudinger reaction...........................42 
Figure 2.2 Possible mechanism of the immobilization ....................................................43 
Figure 2.3 FT-IR spectra of the CSPs. ..........................................................................46 
Figure 2.4 Substituted (1-aryl)ethanols with different substituents at the para position 
of aromatic ring .........................................................................................57 
Figure 2.5 Typical structure of b-blockers ....................................................................60 
Figure 2.6 Chromatogram of alprenolol on SINU-PC. ....................................................63 
Figure 2.7 Chromatograms of labetalol and nadolol on SINU-PC-BDS3 and SINU-PC-
BDS5. ......................................................................................................65 
Figure 2.8 Enantioseparations of propranolol on SINU-PC-BDS3 and SINU-PC-
BDS5. ......................................................................................................66 
Figure 2.9 Typical structures for atropines and scopolamines ..........................................68 
Figure 2.10 Chromatograms for enantioseparation of TCPA, TCPG, NCPA and NCPG 
on HEPT-PC. ............................................................................................70 
Figure 2.11 Structural transforming of benzoin in acidic media .........................................74 
Figure 2.12 Chromatogram of bendroflumethiazide. ........................................................75 
Figure 2.13 Diagrammatic difference in SINU-NC and CYCLOBOND I 2000 SN ..............77 
Figure 3.1 MALDI-MS spectra of heptakis-(6-azido-6-deoxy-2,3-di-O-
phenylcarbamoylated)-b-CD. (C140H133O42N35, M = 2977.80 Da).....................88 
Figure 3.2 Chromatograms for 1-(4-chlorophenyl)- and 1-(4-bromophenyl)ethanol 
under both NP and RP ................................................................................91 
Figure 3.3 Enantioseparation of propranolol under both NP and RP on HEPT-PC..............94 
Figure 3.4 Enantioseparation of bendroflumethiazide under both NP and RP.....................95 
Figure 3.5 Representative chromatogram of enantioseparation of atropine. .......................97 
Figure 3.6 Chromatograms for enantioseparations of TCPP and NCPA on HEPT-PC. ........97 
 xii 
Figure 4.1 Chromatograms of labetolol and nadolol on ETHR-NC. ................................ 111 
Figure 4.2 Chromatogram of 2-(phenyl-phenylamino-methyl)-cyclopentanone................ 112 
Figure 4.3 Basic structure of chiral phenyl dihydrotriazines. ......................................... 114 
Figure 5.1 General strategy for preparative enantioseparation........................................ 119 
Figure 5.2 Chromatograms of atropine using the different injection amounts on PREP-
SINU-PC. ............................................................................................... 127 
Figure 5.3 Effects of the loading amount on k¢, a and Rs on PREP-SINU-PC.................. 128 
Figure 6.1 Effect of temperature on k’ and a of 1-(3-hydroxyphenyl)ethanol................... 135 
Figure 6.2 Van’t Hoff curves for k’ and a of 1-(3-hydroxyphenyl)ethanol on SINU-
PC.......................................................................................................... 137 
Figure 6.3 Van’t Hoff plots for k’ and a of brompheniramine on SINU-NC. ................... 137 
Figure 6.4 Enthalpy-entropy compensation for brompheniramine on SINU-PC with n-
hexane/IPA as the mobile phase. ................................................................ 138 
Figure 6.5 Effect of temperature on k’ and a of 1-(4-bromophenyl)ethanol on ETHR-
PC.......................................................................................................... 139 
Figure 6.6 Van’t Hoff curves for k’ and a of 1-(4-bromophenyl)ethanol on ETHR-PC. .... 139 
Figure 6.7 Enthalpy-entropy compensation for 1-(4-bromophenyl)ethanol on ETHR-
PC with n-hexane/IPA as the mobile phase. ................................................. 140 
Figure 7.1 Interaction sites in  mono-(6-azido-6-deoxy)-pernaphthylcarbamoylated-b-
CD ......................................................................................................... 145 
Figure 7.2 Retentions of aromatic compounds on SINU-NC.......................................... 147 
Figure 7.3 Enantioseparations of M-NT in MeOH (or CH3CN)/ buffer on ETHR-NC....... 153 
Figure 7.4a-b)  Influence of the IPA proportion on k’ and a  for each enantiomer on SINU-
PC.......................................................................................................... 154 
Figure 7.4c-d)  Influence of CH3CN proportion in RP on k’ and a   for each enantiomer on 
SINU-PC. ............................................................................................... 154 
Figure 7.5a) Effects of2-propanol content on k¢, a  and Rs for metoprolol in NP. ................ 157 
Figure 7.5b) Effects of IPA content on k¢, a and Rs for 1-(4-bromophenyl)ethanol in NP .... 157 
Figure 7.5c) Effects of CH3CN content on k¢, a and Rs for bendroflumethiazide in RP ....... 159 
Figure 7.5d) Effects of CH3CN content on k¢, a and Rs for M-NT in RP ........................... 159 
Figure 7.6 Effects of bufferusing M-NT as analyte....................................................... 161 
Figure 7.7a) Effect of pH on k’, a and Rs for O-Br......................................................... 162 
Figure 7.7b) Effect of pH on k’, a and Rs for M-NT. ...................................................... 163 
Figure 7.8 Effect of concentration of TEAA on k', a and Rs of P-OM. ........................... 164 
Figure 7.9 Influence of flow rate on retentions, selectivity and resolutions of O-Br .......... 165 
Figure 7.10a) SEMs for Ggel silica gel with irregular shapes. (Particle size is 5mm.) ............ 168 
Figure 7.10b) SEMs for Hypersil silica gel with spherical shapes. (Particle size is 5mm.)....... 168 




Table 1.1 Examples of pharmaceutical products and food additives which show the 
effect of chirality..........................................................................................5 
Table 1.2 Classification of chiral stationary phases .........................................................9 
Table 1.3 Recent developed Pirkle-type CSPs..............................................................11 
Table 1.4 Four series of columns developed by Daicel Chemical Industries, Ltd...............13 
Table 1.5 The types, structures and applications of cellulose and amylose-based 
Daicel columns ..........................................................................................13 
Table 1.6 Structures and applications of Ticoplanin and Vancomycin .............................18 
Table 1.7 Physical properties of a, b and g-cyclodextrin ................................................22 
Table 2.1  Mono-(6-azido-6-deoxy)-perfunctionalised cyclodextrins................................45 
Table 2.2 Mono-(6-decanyl-6-deoxy)- or mono- (6-(10’-undecenylcarbamido)-6-
deoxy)-perfunctionalised cyclodextrins .........................................................45 
Table 2.3 Elemental analyses and surface concentrations of the CSPs .............................47 
Table 2.4 Column efficiencies, theoretical heights of plates and surface 
concentrations for HPLC columns ................................................................49 
Table 2.5 Enantioseparations of substituted (1-aryl)ethanols on SINU-PC and SINU-
NC ...........................................................................................................52 
Table 2.6 Enantioseparations of substituted (1-aryl)ethanols on SINU-ME. .....................53 
Table 2.7 Enantioseparations of (1-aryl)ethanols on SINU-PC-BDS3 and SINU-PC-
BDS5. ......................................................................................................55 
Table 2.8 Enantioseparations of 1-(4-bromophenyl)ethanol and 1-(4-
chlorophenyl)ethanol on SINU-PC-BDS3 and SINU-PC-BDS5. ......................58 
Table 2.9 Enantioseparations of b-blocking agents on SINU-PC, SINU-NC and 
SINU-ME .................................................................................................61 
Table 2.10 Enantioseparations of pindolol, propranolol and O-acetyl propranolol on 
SINU-PC and SINU-NC .............................................................................62 
Table 2.11 Enantioseparations of b-adrenergic blocking agents in RP  on SINU-PC-
BDS3 and BDS5 ........................................................................................62 
Table 2.12 Chromatograms of Atropine. .......................................................................69 
Table 2.13 Separation results of atropine, homatropine and eight tropinyl and 
piperidinyl esters on SINU-ME. ...................................................................69 
Table 2.14 Enantioseparations of amines.......................................................................73 
Table 2.15 Enantioseparations of weak acids .................................................................75 
Table 2.16 Enantioseparations for other drugs in the RP mode. ........................................76 
Table 2.17 Enantioseparations on CYCLOBOND I 2000 SN. ..........................................79 
Table 2.18 Enantioseparations of drugs onCYCLOBOND and SINU-NC..........................80 
Table 3.1 Physical properties of the b-CD derivatives ...................................................87 
Table 3.2 Elemental analysis of the b-CD derivatives, amino-silica gel and CSPs.............89 
Table 3.3 Enantioseparations of substituted (1-aryl)ethanols ..........................................91 
 xiv 
Table 3.4 Enantioseparations of amines.......................................................................92 
Table 3.5 Enantioseparations of b-blocking agents .......................................................93 
Table 3.6 Enantioseparations of nonprotolytic drugs and weak acids...............................95 
Table 3.7 Enantioseparations of other drugs on HEPT-PC. ............................................96 
Table 3.8 Enantioseparations of atropine and its derivatives on HEPT-PC. ......................96 
Table 4.1 Physical properties of partial-6-(5-pent-1-enylated)-functionalized b-CDs ....... 103 
Table 4.2 FT-IR data for partial-6-(5-pent-1-enylated)-perfunctionalised b-CD .............. 104 
Table 4.3 Elemental analyses for ETHR-PC and ETHR-NC. ........................................ 104 
Table 4.4 Enantioseparations of (1-aryl)ethanols on ETHR-PC and ETHR-NC............... 106 
Table 4.5 Enantioseparations of 1-(4-chlorophenyl)ethanol and 1-(4-
bromophenyl)ethanol on ETHR-PC under different mobile conditions ............ 107 
Table 4.6 Enantioseparations of substituted pheniramine ............................................. 109 
Table 4.7 Enantioseparations on ETHR-PC and ETHR-NC under reversed-phase. .......... 110 
Table 4.8 Chromatographic data of nadolol and labetalol on ETHR-PC and ETHR-
NC. ........................................................................................................ 111 
Table 4.9 Enantioseparations of PAPM and PPMC..................................................... 112 
Table 4.10 Enantioseparations of (4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(substituted 
phenyl)-s-triazines) .................................................................................. 115 
Table 4.11 Trends with substituted groups in enantioseparations on analytes (In terms 
of Rs)..................................................................................................... 116 
Table 5.1 Amounts of reagents and intermediates in preparation of perphenyl-
carbamoylated-b-CD onto silica gel in preparative scale................................ 123 
Table 5.1 Chromatographic data for preparative scale separation. ................................. 126 
Table 5.2 Loading amounts and recovered yield of drugs............................................. 129 
Table 5.3 Optical rotations of propranolol, isoproterenol and atropine. .......................... 129 
Table 6.1 Influence of the mobile phase concentration on 
0HDD  and 
0SDD ................ 138 
Table 6.2 Influence of the mobile phase concentration on 0HDD  and 0SDD ................ 140 
Table 7.1 Enantiomers resolved on our CSPs............................................................. 151 
Table 7.2 Column efficiencies for CSPs on divergent silica gel. ................................... 167 
Table 7.3 Elemental analyses of the amino-functionalized silica gel and 







1.1 General background 
Chiral molecules refer to those which have identical structures but differ in the 
relative spatial arrangement of component parts. A chiral molecule and its non-
superimposable mirror image are special types of stereoisomers called enantiomers. 
Enantiomers can only be distinguished by their optical activities --the direction in 
which they rotate plane polarized light when passed through them. A mixture of 
enantiomers (I) and (II) present in equal amounts is known as a racemic mixture. 










( I )                             ( II ) 
R1 ¹ R2 ¹ R3 ¹ R4 
Figure 1.1 Stereochemical structures of one pair of enantiomers 
Chirality is of immense importance in nature. Particularly many key building 
blocks of life such as proteins, nucleic acids and polysaccharides are chiral. Thus, 
chirality plays major role in biosyntheses and metabolisms in living organisms. 
Consequently, it is not surprising that chiral molecules have been extensively studied 
and investigated.  
Most of the compounds currently developed in the pharmaceutical pipeline are 
chiral. These compounds play a significant part in the global pharmaceutical market. 
Sales of chiral drugs in 1999 was estimated at US$337 billion with a growth rate of 
11% and set to break through the US$506 billion mark in year 2004.  
To date, many drugs are still marketed as racemic mixtures. A report from 
Technological Catalyst International (TCI) showed that in 1997 among the top 500 
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drugs sold worldwide, 269 are single enantiomers with sales accounting for 52 % 
(US$71.1 billion) of a total $135.9 billion.1 
Another example of a chiral drug named pioglitazone (Actos), shown in Figure 
1.2a has been developed to treat diabetes. It is chiral but marketed (by Takeda 








Figure 1.2a) Structure of Pioglitazone 
Enantiomers of the same compound / drug may have substantially different 
biological activities in metabolism, potency, toxicity, pharmacological action and urine 
excretion kinetics. Severe problems are sometimes encountered due to the different 
toxicochemical effects of the enantiomers. Thus, one enantiomer may interact 
specifically with a cell receptor, responsible for a given pharmacological activity, 
while the other may be less active, inactive or even has undesirable side effects 
through other interactions. The difference of the enantiomers in the pharmacokinetic 
and pharmocodynamic properties demonstrated by Giacomini2 depicted the way of 
how the racemic mixtures work. For example, in the case of a drug, penicillamine, the 
d-isomer is therapeutic with anti-arthritic effect, while the l- isomer is highly toxic.  
Another example is troglitazone (Figure 1.2b), which has 2 chiral centers and 
was marketed by Parke-Davis Company as mixture of the 4 isomers. However, it can 
cause severe side effects, which include potential lung damage found in a small 











Figure 1.2b) Structure of troglitazone (Rezulin) 
Another highly publicized example in 1960’s is thalidomide. (Figure 1.3) The 
d- form of this drug is a safe sedative, easing or alleviating the nausea of women 



























Figure 1.3 Stereochemical structure of thalidomide 
Similar phenomenon also exists in the food and drink industry where the 
property of the flavor and fragrance products is highly dependent upon their chiral 
purity. Some examples of pharmaceutical products and food additives which show 
different effects depending on the respective enantiomer are summarized in Table 1.1.  
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Table 1.1 Examples of pharmaceutical products and food additives which show the effect of 
chirality 6 
Compounds Isomer Effects 
Warfarin S 
R 
A racemic compound is administrated but S-isomer is 
5 times more potent as a blood anti-coagulant than R-
isomer. 
Quinidine / Quinine 
(+) 
(-) 
Cardiac suppressant  













A racemic compound is administrated but only S(-) 







On the basis of the reasons stated above, the US Food & Drug Administration 
(FDA) and the European Committee for Proprietary Medicinal Products have required 
manufacturers to research and characterize each enantiomer in all drugs proposed to be 
marketed as a racemic mixture.7 
1.2 Methods available for chiral discrimination 
In both research and industry, much efforts were devoted in developing 
methods for chiral discrimination on both analytical and preparative scales.  
The history of enantioseparation can be traced back to the pioneering work of 
Louis Pasteur using mechanical means (i.e. hands and eyes) to separate enantiomers.8 
In 1858 he used bacteria to discriminate between enantiomers, while in 1860 he 
introduced the methodology of resolution via diastereoisomer (i.e. salt) formation 
followed by fractional crystallization. 
Schlenk brought the inclusion compounds formed between urea and a wide 
range of straight-chain aliphatic compounds into the field of enantioseparation.9 The 
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urea was designed in either a left-hand or right-hand screw along the lattice formed by 
the host molecules, which allowed only one of the enantiomers to enter the cavity thus 
achieving separation. 
Silica gel was first used in a separation technique called 'surface-imprinting' by 
Dickey.10 Enantiomers with similar structures can be separated partially using the 
footprints left by organic molecules.  
However, all the methods mentioned above are not problem-free and typically 
require tedious steps with low efficiency. A key milestone in the area of 
enantioseparation was brought forth in 1939, when Henderson and Rule demonstrated 
the separation of derivatives of camphor on d-lactose and successfully accomplished 
chiral resolution.11 Thereafter, many reports on the enantioseparation of amino acids 
on cellulose as a chiral support appeared in the literature.12-15 
1950s to 1960s was the golden era for enantioseparation using Gas 
Chromatography (GC) after the first chiral resolution accomplished by Gil-Av16 on a 
GC chiral stationary phase (CSP). In 1966, Gil-Av and his co-workers demonstrated 
the first direct enantioseparation and suggested that strong interactions such as p-p 
interaction, coordinate / covalent bonds and hydrogen bonds etc between the solution 
and analytes may contribute much to the enantioseparation.17 As a simple model, 
derivatized amino acid was chosen to carry out the experiment, which was designed to 
prove the above theory.18 
Gas liquid chromatography (GLC) with chiral stationary phases, followed by 
achiral GLC or thin- layer chromatography (TLC)19 with the help of chiral reagents was 
also developed to carry out enantioseparation. In the 1960s liquid chromatography 
(LC) was used for enantioseparation,20-25while in the 1980s high-performance liquid 
chromatography (HPLC) with chiral stationary phases (CSPs)26such as the ones 
developed by Pirkle became available.27 
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Modern methods for separation and /or determination of enantiomers involve 
several different approaches (e.g. enzymatic resolution and asymmetric syntheses). 
Analytical methods include chiral reagents, NMR,28-36 enantiomeric specific 
immunoassays,37 chromatographic methods and so on. 
In the research area, analytical methods capable of discriminating enantiomers 
are employed in many fields. Some examples are investigating products, monitoring 
asymmetric synthesis, determining enantiomeric drugs in body fluids for 
pharmacokinetic studies, in-vitro metabolism studies and fate-testing of agrochemicals 
in the environment, etc.  
 
1.3 Chromatographic methods for chiral discrimination  
As a direct method for achieving enantioseparation, chromatography has 
attracted tremendous attentions since the first racemic mixture was resolved using 
chiral GC.  
Nowadays chromatographic methods for enantioseparation have been extended 
to other chromatographic techniques including HPLC, TLC, Supercritical Fluid 
Chromatography (SFC), Capillary Electrophoresis (CE), and Capillary 
Electrochromatograpy (CEC). In comparison, GC has the advantages of high 
efficiency and sensitivity, but also has the limitation of the small range of operating 
conditions and analytes. As a relatively new technique in enantioseparation, CE has the 
highest column efficiency and has been widely used in the separation of amino acids. 
However, it is applied mostly using aqueous phase eluent, which makes the choice of 
analytes very limited. Moreover, the results are somewhat non-reproducible on account 
of the obscurity of the separation mechanism.  
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TLC is generally less efficient with reduced sensitivity, while the relatively new 
technique of SFC has yet to make an impact to fully commensurate with its promise. A 
major advantage of SFC compared to the rest of techniques is that it can be easily 
scaled up to provide optical pure enantiomers in microgram to gram scale range for 
biological evaluation or for application in stereospecific synthesis.  
Generally, HPLC is the separation technique of choice since it offers a 
combination of an impressive range of selectivity, ease of use, high sensitivity, good 
efficiency, availability and robustness unrivalled by other chromatographic techniques.  
Enantioseparation by HPLC includes two major parts: chiral stationary phases 
(CSPs) and chiral mobile phase additives (CMPAs). 
 
1.3.1 Chiral stationary phases (CSPs) 
Chiral HPLC columns are generally prepared by immobilizing or coating chiral 
selectors onto inert supports, which are then packed into stainless steel columns. 
The type of column used for separating a class of enantiomers is often very 
specific. Combined with the high cost of these chiral columns, choosing the right 
column seems at first bewildering. Fortunately, taking time to study the structures of 
CSPs and visualizing the potential interactions with the analytes can narrow down the 
choices significantly.  
Enantiomeric separation using CSPs is a state-of-art technique for separating 
pharmaceutical compounds and other organic racemates.38-41 At present, more than 45 
chiral HPLC columns for direct enantioseparation and resolution of a wide range of 
racemic drugs / compounds are commercially available. They are derivatives of 
cyclodextrin (CD), cellulose, amylose and polymer etc and are supplied by companies 
such as Astec, Daicel, Merck, Hypersil, and Kromosil, etc. These chiral HPLC 
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columns usually have the advantages of high efficiency, wide applicability and good 
reproducibility. Some of these CSPs can also be applied on a preparative scale. For 
example, CSPs developed by physical coating of cellulose triacetate onto silica gels 
with the particle size of 10, 15-25 and 25-40 mm can be applied generally in 
preparative scale enantioseparations. A great advantage of cellulose triacetate based 
CSP is the availability of all particle sizes from one batch, which makes it easy to scale 
up a separation from analytical via semi-preparative to preparative scale.  
Most HPLC-CSPs have quite specific structural requirements for successful 
enantiomer separation and thus they can be applied only to a limited range of 
compounds. Several authors have classified columns into groups and have attempted to 
describe the mechanism of separation and therefore the structural requirements on the 
analytes.42-45Accordingly, the CSPs were classified into five general types depending 
on the manner in which the analyte-CSP complexes are formed and how the separation 
is ultimately achieved.(Table 1.2) Using this classification, it is possible to select the 
appropriate CSP for resolving a specific enantiomer pair.  
Table 1.2 Classification of chiral stationary phases 
Classification Interactions 
Type I Attractive interactions, H-bonding, p-p interactions and dipole 
interactions 
Type II Both attractive interactions and inclusion complex formations 
Type III Retention via formation of inclusion complexes within chiral cavities 
Type IV Ligand exchange mechanisms with metal complexes 
Type V Hydrophobic and polar interactions with bound protein phases 
 
I. Type I  Donor-acceptor -Brush type (Pirkle) type phases 
This type of CSPs is the most widely researched and encompasses the largest 
range commercially available products. 
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The columns within this group are mainly the research results of Pirkle and his 
co-workers.46-48 The first commercially available CSP for HPLC was reported as R-N-
(3,5-dinitrobenzoyl)-phenylglycine bound ionically to aminopropyl silica, which was 
developed by Regis Chemical Company in 1980.25 The structure of this phase is shown 
in Figure 1.4.  
 
Figure 1.4 Structure of Pirkle -type CSP 
There are two main types of CSPs, p-acceptor and p-donor phases. The most 
common p-acceptor phase is N-(3,5-dinitrobenzoyl)-phenylglycine bonded to n-
propylamino silica. The p-accepting dinitrobenzoyl group can interact with p-donor 
groups such as aromatic rings or alkyl groups, which make these columns capable of 
separating a large range of compounds with a p-donor group introduced by 
derivatization with naphthyl chloride or other appropriate reagents. 
Conversely, p-donor phases (typically naphthyl-amino-acid derivatives 
covalently bonded to silica) require the analyte to contain a p-acceptor group such as 
the dinitrobenzoyl group. The dinitrobenzoyl group can easily be introduced to a wide 
range of compounds such as alcohols, amines, carboxylic acids and so on using 
dinitrobenzoyl chloride, isocyanate or dinitroanaline. 
The main advantage of these CSPs is that they can be easily synthesized and 
thus become commercially available at reasonable costs. Pirkle columns can give good 
selectivities with high loading factors. The disadvantages are that such columns only 
work with aromatic compounds and that derivatization may be necessary to aid the 
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separation. Furthermore, the desired mobile phases are restricted to relatively non-
polar organic solvents, which may limit their applicabilities.  
Table 1.3 Recent developed Pirkle-type CSPs 








85:10:5 with the help of 10 
mM ammonium acetate  
Beta-blockers 49 
SS BLAMO II 
Both a p-donor and 
a p-acceptor region 




Both pi-acid and pi-
basic groups are 
present 







More recently developed CSPs in this field have been listed in Table 1.3.  
In particular, CSP SS BLAMO II has a high coverage of chiral selector of 1.8 x 
10-4 moles/gram, which makes it well suited to preparative chromatography. SS 
WHELK-O1 phase also has high loading capacity thus has been used in SFC where 
some exceptional loadings such as 50 mg have been achieved to trans-stilbene oxide 
on an analytical column. All these developments make such columns of wide 
applicability in various fields.  
 
II Type II  Cellulose derivatives 
Another class of CSPs derived from cellulose derivatives such as cellulose 
esters. (Figure 1.5) In these CSPs, the derivatives of cellulose and more recently those 
of amylose are frequently physically coated or chemically bonded onto silica supports. 
Mechanistically it is believed that the [solute-CSP] complexes are formed by attractive 
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interactions and through the inclusion of the solute in a chiral cavity or ravine on the 






Figure 1.5 Basic unit of cellulose type phase 
Commercially available columns include microcrystalline triacetate- (MCTA), 
tribenzoate-, trisphenyl-carbamate- and tris(3,5-dimethylphenylcarbamate)-cellulose. 
Each unit of the cellulose phases displays a propeller-type shape and is thus believed to 
form helical polymeric structures which combine polar and p-p  interactions with 
inclusion complexion. Different substituents are believed to be responsible for 
changing hydrogen bond formation, as well as the size and the shape of the chiral 
cavity.50 More recently, columns with complimentary enantioseparation results have 
been made using amylose (starch). These columns showed different selectivity 
compared to cellulose columns but were however less robust.  
A Japanese company, Daicel Chemical Industries, Ltd, is the main 
manufacturer of these columns. Their CSPs are mainly divided into 4 series including 
cellulose and its derivatives, amylose and its derivatives, crown ethers and 
polymethylmethacrylate. (Table 1.4) Among the four series, the first three were used 
on HPLC while the fourth was used in ligand chromatography. In particular, the CSPs 
for series I and II which were prepared by physical coating of polysaccharides and 
their derivatives onto the surface of silica gel attracted many attentions and have been 
widely applied. Their types, structures and applications are shown in the Table 1.5.  
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Table 1.4 Four series of columns developed by Daicel Chemical Industries, Ltd 
Cellulose derivatives Amylose derivatives Crown ether Polymethylmethacrylate 
CHIRALCEL® ODTM CHIRALPAK® ADTM CROWNPAK® CRTM CHIRALPAK® OP(+)TM 
CHIRALCEL® OJTM CHIRALPAK® ASTM CROWNPAK® CRTM (+) CHIRALPAK® OT(+)TM 
CHIRALCEL® OKTM  CROWNPAK® CRTM (-)  
 
Table 1.5 The types, structures and applications of cellulose and amylose-based Daicel 
columns 














Aryl methyl esters,  















Alkaloids, tropines,  


















Alkaloids, tropines,  










Alkaloids, tropines, amines  
 
These CSPs are mostly used in normal phase separation with low polarity 
mobile phases; typically alcohol/ n-hexane mixtures. Chlorinated solvents must be 
avoided since they may strip the cellulose from the silica support. Suitable modifiers 
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such as 0.1% of N, N-diethylamine for basic samples or trifluoroacetic acid in the case 
of acidic samples were used to improve enantioseparation. Moreover, since starch is 
water-soluble, in such columns the mobile phases must have a zero water content to 
ensure column durability.  
These CSPs were widely used and reported to separate a variety of alkaloids 
and pharmaceutical compounds. Under suitable conditions, over 300 chiral organic 
compounds and drugs have been enantioseparated.51-52 However, these columns are 
relatively expensive and are also subject to pressure limitations. 
 
III Type III  Chiral cavity phases 
Type III CSPs rely on the primary mechanism of the formation of inclusion 
complexes. This group of CSPs encompasses carbohydrate polymers, cyclodextrins, 
microcrystalline cellulose triacetates and tribenzoates,53-54 together with crown ethers 
and synthetic polymers.  
The classic inclusion complex column is CD-typed CSPs, which are mainly 
developed by Armstrong55 and supplied by Astec.(Advanced Separation Technologies 
Inc.) Some CSPs use native cyclodextrin (with structure and properties shown in 
Figure 1.8) as the starting materials followed by their functionalization and chemical 
bonding onto the surface of silica gel through a spacer. This chemical bonding makes 
the column much more stable in the aqueous phases. These CSPs are commercially 
available and widely used56-57 to separate a variety of drugs and amino acids. The 
separation is relatively good under both normal phase and reversed-phase.  
Other CSPs in this class are helical polymers such as poly (phenylmethacrylate) 




IV Type IV  Ligand exchange columns  
Chiral Ligand Exchange Chromatography (CLEC) has been used for 
enantioseparation for many years and now is commercially available. The CSPs in 
CLEC were prepared by attaching an amino acid, more commonly proline, 
hydroxyproline or valine, to silica or polymeric support via a spacer, followed by 
treatment with copper salts.  
The separation mechanism involves the formation of diastereomeric metal 
complexes.62 In order to achieve enantioseparation, the analyte molecules must form a 
reversible complex with the copper ion.63-64 (Figure 1.6) Therefore, the analyte 
molecules must have two polar functional groups on (or adjacent to) the asymmetric 
carbon atom.  
Other transition metals such as nickel, cobalt, zinc or cadmium ions have been 
used in CLEC, with copper having the widest application. The complexation process is 
a comparatively slow one, which may be helped by running at elevated temperatures, 









Figure 1.6 Ligand exchange type phases. 
The use of CLEC is ideal to a-amino acids and amino alcohols, but they are not 
applicable for other compounds. They should be used in aqueous mobile phases where 
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water is believed to stabilize the complex by coordinating in an axial position. Steric 
factors then determine which of the two complexes is more stable.   
The loading capacity of CLEC columns is reasonable, however, the presence of 
copper in the mobile phase is not convenient for the recovery of pure isomers. Copper 
should be removed using an iminodiacetic-acid based resin column. Currently loose 
"Chiralsolve" polyacrylamide polymer LEC material is available in kilogram scale and 
has been used to separate multi-gram amounts of simple amino acid derivatives on 2.5 
x 50 cm columns. 
 
V Type V  Protein phases 
Protein CSPs are defined as Type V CSPs where separations mainly rely on a 
combination of hydrophobic and polar interactions.  
Several types of proteins have been used as CSPs. Currently available phases 
are Human a-Acid Glycoprotein (AGP),65-67 Human Serum Albumin (HSA),68-75 
Bovine Serum Albumin (BSA) 76-78  and Ovomucoid protein (OV).79 
AGP (Figure 1.7) is a polypeptide with 181 amino acid residues and 40 sialic 
acid residues with an isoelectric point of 2.7. It is a very stable protein with two 
disulphide bridges and may be covalently bonded to silica to produce a reversed-phase 
column.  
 
Figure 1.7 Diagram of human alpha-acid glycoprotein 
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BSA is a globular hydrophobic protein consisting of a single amino acid chain 
with 17 disulphide bridges forming nine double loops with a molecular weight of 
66,000 and an isoelectric point of 4.7. A wide range of compounds have been 
separated on BSA and AGP columns56, 59 with the help of small amounts of organic 
modifiers.  
HSA is a polypeptide with a molecular weight of 69,000 and an isoelectric 
point of 4.8. Two major drug-binding sites, the warfarin-azapropazone site and the 
benzodiazapine-indole binding site are believed to exist in the protein. The column has 
proved particularly useful in separating benzodiazepine enantiomers using octanoic 
acid in the mobile phase. Warfarin and oxazepam may be separated using sodium 
phosphate (100 mM, pH7.0)/ CH3CN/2-propanol = 84/10/6 (v/v). 
Protein columns probably have the broadest application among all the chiral 
columns but do not always offer the most efficient separations. They can produce good 
enantioseparations although the chromatographic efficiency is poor. Typical mobile 
phases are phosphate buffer pH 4-7 with a low percentage of organic modifiers such as 
2-propanol, CH3CN, ethanol, MeOH or tetrahydrofuran. Retention and 
stereoselectivity can be altered by pH value, ionic strength of the buffer or the content 
of organic modifiers such as propanol, diethyloctylamine or ion-pair reagents. The 
shortcoming of these columns is that the loading capacity is so low at 20ul (injecting 
volume) of 0.02mg/ml (sample concentration) that there is no potential to be used for 
preparative work. 
 
VI Macrocyclic Antibiotics 
Recently macrocyclic antibiotics (eg Rifamycin, Vancomycin and Ticoplanin) 
have been immobilized on silica to form a new class of chiral columns.80 Rifamycin 
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has been more successful in the CE field as a mobile phase additive. Columns from the 
other two antibiotics, glycopeptides vancomycin and ticoplanin are robust enough to be 
used as multi-modal columns in HPLC. The separation on these columns relies on p-p 
interactions, H-bonding, inclusion complex, ionic interactions and peptide binding. 
Their structures and applications are shown in Table 1.6. More significantly, the 
vancomycin columns have exceptional loading capacity and are very suited to 
preparative applications. 
Table 1.6 Structures and applications of Ticoplanin and Vancomycin  
 Structures Application modes Analytes 
Teicoplanin Has a molecular weight of 
1885 has 20 chiral centers 
three sugar groups and 
four fused rings.  
Reversed-phases. 
Polar organic mode, 
normal phases  
All amino acids, 
Amino acid 
derivatives such as 
methyl esters and 
peptides 
Vancomycin Has a molecular weight of 
1449, 18 chiral centers and 
three fused rings.  
Reverse, Polar and 
Normal phase mode 
Amines, amides 
neutrals and esters 
 
 
1.3.2 Chiral mobile phase additives (CMPA) 
When an optically pure additive interacts with a mixture of enantiomers to 
produce diastereoisomers, the products can be separated using achiral stationary phases 
such as reversed-phase or ion exchange HPLC columns.81-82 
CMPAs have the following advantages and drawbacks over CSPs:  
Advantages Drawbacks 
i. Can use standard (cheap) columns  
ii.  High loading capacities are possible  
iii.  Solute character may be modified 
(i.e. ion pairing)  
iv. Wide Range of additives available.  
i. The difficulty in removal of the 
chiral selector after chromatography 
ii.  Separations are difficult to develop  
iii.  May be expensive on a large scale 
without recycling of additives.  
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CMPAs are of several types: ion pair, inclusion complexes, ligand exchange 
and protein interactions.  
I Ion Pair additives 
The mechanism of separation is complicated because many factors may have 
different effects on retention and resolution, which makes the interpretation difficult. 
Once a chiral counterion is dissolved in the mobile phase, it can be used to separate 
enantiomers of acids or amines by formation of diastereomeric ion-pairs. For example, 
propranolol has been separated in this way using tartaric acid as the counter ion. Other 
amino alcohols have been separated using quinine, N-benzoxycarbonyl-glycyl-L-
proline and (+)-10-camphorsulphonic acid.83-85A major disadvantage of this type of 
columns is the low loading capacity of ion pair separations. 
 
II Inclusion complexes 
Inclusion complexes may be formed by adding CD to an aqueous mobile phase. 
Pure acid / base extractions and solid phase extractions on a C18 column are typically 
the two options for the removal of CDs after chromatography to obtain the pure 
isomers. 
A reasonable scale separation of a few milligrams has been achieved using 
CDs. One advantage is that scaling up of a separation is not limited to the availability 
of a specialist column. 
 
III Ligand exchange 
Ligand chromatography can be carried out by using chiral selectors such as N-
alkyl-L-hydroxyproline with copper acetate added to the mobile phase on a C18 
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column. The chiral selector is strongly adsorbed onto the C18 surface effectively thus 
forming a CSP where separation takes place.   
Large amounts of separations have been achieved on ligand exchange 
stationary phases. In principle similar separations should be possible using mobile 
phase additives. 
 
IV Protein additives. 
Both BSA and a-acid glycoprotein have been used as mobile phase additives. 
BSA may be added to aqueous mobile phases at a concentration of around 3 g/l on 
C18, CN or diol columns. However, BSA has the disadvantage of showing a UV cutoff 
at 340 nm, which limits its use. On the contrary, a-acid glycoprotein has the advantage 
of being UV transparent; however being a human blood product it is exceptionally 
expensive. As those protein stationary phases, both BSA and a-acid glycoprotein have 
low preparative capacity. 
 
1.4 Cyclodextrin and its applications 
Cyclodextrins (CDs) have attracted much attention in a wide variety of areas 
such as enzyme models, drug and food formulations, separations and many other 
applications.  
Cyclodextrins also known as Schardinger dextrins, cycloamyloses and 
cycloglucoamyloses, are cyclic oligosaccharides comprised of glucopyranose units. It 
was first reported by Villiers86 in 1891 and called as cellulosine as it resembled 
cellulose. In 1908 Schardinger87-88 was the first to characterize CD as an 
oligosaccharide and to give a detailed description of its preparation and isolation. 
Freudenberg89 first reported the CD as a natural product composed of glucose units 
 21
bonded through a-(1, 4) linkages. He also recognized the ability of CD to form 
inclusion complexes and gave a general procedure of purifying CD.  90-91 
CDs have been used as chiral shift and solvating agents in optical purity 
determination or chiral recognition probes due to the discrete and concentration-
independent NMR signals of the CD complexed enantiomers. Applications included 
natural, permethylated68, 77-81, 92-95 or benzoylated a- / b-CD.96 The chiral recognition or 
purity determination was carried basically on the variation of chemical shift or other 
spectral parameters of the samples due to the formation of a transient diastereoisomeric 
species with the added CD.  
These "chiral additives" were usually applied in aqueous81 or organic phases.82 
Therefore, similar to the CSP, there are also several requirements for chiral recognition 
proposed for these chiral additives, such as H-bonding, capability of forming inclusion 
complexes and so on. Whether the solute fits tightly or not seems to be essential for 
achieving high enantioselectivity, depending upon the samples’ steric hindrance and 
rigidity as well as the flexibility of the chiral additive.  
 
1.4.1 Structure and physical properties of cyclodextrins 
Cyclodextrins are cyclic oligosaccharides containing six to twelve D(+) 
glucopyranose units bonded through a-(1,4) linkages. They are produced by the action 
of Bacillus macerans amylase or the enzyme CD transglycosylase (CTG) on starch.97-
98 Currently three naturally occurring CDs, alpha, beta & gamma corresponding to 6, 7 
and 8 glucopyranose units, respectively, are commercially available.  
The CD molecules are toroidal, cyclic oligosaccharides. The whole molecule 
forms a truncated cone with the diameter depending on the number of glucopyranose 
units. Table 1.7 shows the internal diameter of a-CD as 4.5-6.0Å, which is appropriate 
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for complexing a single five- or six-membered aromatic ring. The internal diameter of 
b-CD varies from 6.0-8.0 Å and can easily accommodate molecules that are the size of 
biphenyl or naphthalene rings. The internal diameter of g-CD varies from 
approximately 8-10Å, which can accommodate molecules as large as substituted 
pyrenes.  
Table 1.7 Physical properties of a, b and g-cyclodextrin 99 














a 6 972 13.7 5.7 7.8 12.33 0.114 30 
b 7 1135 15.3 7.8 7.8 12.20 0.016 35 
g 8 1297 16.9 9.5 7.8 12.08 0.179 40 
 
Figure1.8 shows the structure of b-CD. The CD molecule has secondary 2- and 
3- hydroxyl groups lining at the mouth of the cavity and primary 6-hydroxyl groups at 
the rear end of the molecule (Figure 1.8b).  
The number of glucose units determines the dimension and size of the cavity. 
(Table 1.7) The interior cavity of CD is lined with glucosidic oxygen linkages, while 
the nonbonding electron pairs of the glycosidic oxygen bridges are directed toward the 
inside of the cavity, producing a high electron density and lending it some Lewis base 
character. As a result of this special arrangement of the functional groups in the CD 
molecules, the cavity itself is relatively hydrophobic and permits inclusion of 
hydrophobic portions of solute molecules. Meanwhile, the C-H forms two rings at the 
outer rims of the cyclodextrin, which is rather hydrophilic.100-101 In cyclodextrin 
molecules, a ring of hydrogen bonds is also formed intramolecularly between the 2- 
and 3-hydroxyl groups of adjacent glucose units, which gives the CD a remarkably 
rigid structure.102-106 The CDs are, therefore, chiral structures. For example, b-CD has 
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35 stereogenic centers, which serve as the foundation of their applications in 
enantioseparation of chiral compounds. 
 
 











Figure 1.8b) Diagrammatic representation of b-cyclodextrin molecule 
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As a consequence of these special structural features, CDs exhibit some unique 
physical and chemical properties.  
Cyclodextrins are water-soluble oligosaccharides with solubilities of 0.114, 
0.016 and 0.179 M for a-, b- and g-CD respectively. They can also be dissolved in 
DMF and DMSO. Under normal experimental conditions, (pH higher than 3.5, and 
temperature lower than 60°C), CDs are fairly stable.  
The most characteristic property of CDs is their remarkable ability to form 
inclusion complexes with a wide variety of guest molecules ranging from organic / 
inorganic compounds of neutral / ionic nature to noble gases. The only requirement for 
the formation of inclusion complexes with the guest molecules is that it must fit into 
the cavity, even if only partially.  
Complex formation in solution is a dynamic equilibrium process, which can be 
depicted by the following equation: 
GCDGCD -«+  1-1 
Where, CD is cyclodextrin, G is the guest molecule and GCD -  is the 
inclusion complex. The stability of the inclusion complex can be described in terms of 
the formation constant (Kf) or the dissociation constant (Kd) as defined in equation 1-2 
and 1-3. 
[ ]
















  1-3 
It has been generally accepted that the binding forces involved in the complex 
formation are: hydrophobic interaction between the hydrophobic moiety of the guest 
molecules and the CD cavity; H-bonding between the polar functional groups of guest 
molecules and the hydroxyl groups of the CD; Van der Waals interactions; release of 
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high-energy water molecules from the cavity in the complex formation process and 
release of strain energy in the ring frame system of CD. In most cases, a combination 
of these factors is operative; however, the first two seem to be most dominant.  
Regardless of what kind of stabilizing forces are involved, the geometric 
capability and the polarity of the guest molecules, the medium and the temperature are 
the most important factors for determining the stability of the inclusion complex. Of 
which, geometric rather than the chemical factors are decisive in determining what 
kind of guest molecules can penetrate into the cavity. 
 
1.4.2 Cyclodextrin-based chiral stationary phases (CD-CSPs) 
In 1965, Solms and Egli107 reported the first preparation of insoluble CD 
polymers-epichlorohydrin resins and their selectivity in binding various substances. 
Enantioseparations of various natural products, perfumes, aromatic acids, o-, p-
nitrophenols, substituted chlorobenzoic acids, nucleic acids etc. had been achieved on 
these CD-polymer CSPs.82 Thereafter, several other CD-containing resins e.g. CD-
polyurea and CD-poly(vinyl alcohol) were also developed and applied in 
chromatographic separation of natural amino acids108-109 and alkaloids.110 Successful 
separations of optical isomers108, 110-114 were also reported on copolymerised CD cross-
linked on silica gel. However, the obvious disadvantages of these CSPs such as poor 
anti-pressure ability, long equilibrium time within the particle instead of on the surface, 
limited choice of mobile phases, together with poor mechanical strength and low 
efficiency made them unsuitable for HPLC application. Therefore, with increased 
interest in using CDs in separations, it is necessary to prepare CD-bonded stationary 
phases with necessary mechanical strength for HPLC use.  
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In the mid-1980s, the first case of immobilized CD-CSPs on silica gel through 
specific non-hydrolytic silane linkages was reported by Armstrong.57, 115 Early attempts 
to develop such stationary phases included bonding the CD to silica gel via nitrogen 
linkage arms.116-117 Meanwhile, other research groups attempted to attach different CD 
derivatives to silica gel via propylamine, ethylene diamine and other related 
linkages.118-120 However, these CD-CSPs have serious limitations due to the 
hydrolytical instability of the amine and amide linkages and low loading amount of CD 
on the surface of silica gel. Meanwhile, the amine groups were suspected to affect the 
selectivity of these CSPs.  
In the past twenty years, chemically bonded CD-silica stationary phases have 
been developed.121-123 Now high-efficiency columns are prepared by attaching CD to 
silica gel via the primary hydroxyl groups.124 For example, Armstrong had developed 
CD-bonded CSPs with ether linkages instead of nitrogen- linkages. Since then, series of 
native125-126 and functionalized-CD bonded CSPs were introduced into LC for 
enantioseparation.127-135 More recently, CD derivatives produced by modifying some 
of the secondary hydroxyl groups 136 have been prepared to alter the chiral specificity. 
These novel series of CD-CSPs were hydrolytically stable under reversed-phase 
conditions thus exhibited excellent enantioseparation under both normal and reversed-
phase conditions.  
In order to increase their enantioselectivities for racemates, CD-CSPs are 
usually derivatized to vary their solubility behaviors, to extend their separation 
capabilities and to modify their complex properties. Of all the hydroxyl groups, the 
primaries are easily modified, while the secondary hydroxyl groups can be derivatized 
selectively. Generally the ones at position 2 are more reactive than those at position 3. 
After derivatization, CD-CSPs exhibit relatively good enantioseparation abilities under 
 27
normal phases.137, 138 Currently, a variety of derivatized CD-based CSPs are now 
commercially available. 
Despite the fact that these CD-CSPs were successfully and widely used in the 
area of enantioseparation of pharmaceutical drugs / amino acids, they are not without 
limitations. First, the predominant methods of synthesizing these phases involve 
immobilizing the CD onto silica substrate followed by the derivatization of the bonded 
CD ligand.139 (Figure 1.9) Advantage of this method is that excessive derivatizing 
agents can be readily removed from the bonded sorbent. However, as the 
functionalization procedures involve heterogeneous solid- liquid phases reaction, partial 
derivatization of the hydroxyl groups of the CD usually resulted in large, sterically 
encumbered substituents and consistently, with a lower extent of derivatization. In 
addition, these methods did not give good reproducible or uniform products largely 
because that separation of enantiomers may vary from batch to batch of CD-based 















Figure 1.9 Post-immobilization derivatization of cyclodextrin  
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Moreover, this approach provides no information regarding the sites of the 
substitution. The importance of the substitution site on chiral recognition has been 
recently addressed in a capillary zone electrophoresis studied by Gahm and Stalcup.139 
Examples of derivatizing agents used to functionalize previously immobilized CD 
include acetic anhydride, 3,5-dimethylphenyl isocyanate, 2,6-dimethylphenyl 
isocyanate, p-toluoyl chloride, and (R)- or (S)-1-(1-napthyl) ethyl isocyanate.140-141 
 
1.4.3 Mechanism of separation 
1.4.3.1 Multiple-interaction (multi-model) chiral bonded phases 
In the field of chiral liquid chromatography there is a large and important class 
of CSPs, which may be termed synthetic multiple- interaction (multi-model) bonded 
phases. This class of CSPs has arisen during the past ten years or so, nurtured by an 
eminently sensible idea: the greater the number of specific, discrete, simultaneous 
interactions between chiral solute molecules and a chiral locus on the stationary phase, 
then the greater the likelihood of effective chiral discrimination, and thus that of 
chromatographic resolution of enantiomeric solutes.  
Starting from this premise, practitioners in this area have designed, constructed 
and bound to silica a variety of chiral organic molecules; these molecules, with 
relatively simple and well-defined structure, contain at least one each of three types of 
functional groups, each in proximity to the chiral center: 
· p-Acidic or p-basic aromatic groups, capable of donor-acceptor interaction 
(charge-transfer complexation) 
· Polar hydrogen-bond and/or dipole-stacking sites 
· Bulky non-polar groups, providing steric repulsion, van der Waals 
interaction, and/or conformational control. 
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CSPs bearing these three types of groups are highly effective in resolving 
enantiomeric compounds which contain similar but complementary groups.  
 
1.4.3.2 Enantioseparation mechanism 
Of more importance in HPLC technology is the chiral selection mechanism. It 
is well accepted that the resolution of enantiomers relies on the formation of transient 
diastereomeric complexes between the enantiomeric solute molecules and the chiral 
selectors in the columns that have different physical properties, which often can be 
easily separated. The compound which forms more stable diastereoisomer will be more 
retained, whereas the opposite enantiomer will form a less stable diastereoisomer and 
will elute first. The difference between the physical properties or the stability of the 
diastereomers decides the enantioseparation magnitude of a, the selectivity. Therefore, 
there must be sufficient differences in the free energy transfer of the two species 
between the mobile phase and stationary phase. 
According to Pirkle’s point of view, for chiral resolution to take place, there 
must be at least three simultaneous interactions between a CSP and a solute 
enantiomer. Whereby, one or more of the interactions must be stereochemically 
dependent. On this basis, Delgleish142 represented a "three-point" mechanism (Figure 
1.10) in which the CSP is assumed to have four possible points of interaction with the 
analyte molecules, while at least three are necessary for enantioseparation to occur. 
Typical intermolecular interactions involved in the chiral recognition process are p-p 
interactions, H-bonding, dipole-dipole, hydrophobic and steric interactions. The forces 
that lead to these interactions are very weak and require careful optimization by 
adjusting the mobile phase and the temperature to maximize selectivity.  
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Delgleish also pointed out that the conformation rigidity is important and 
chromatography is a multi-step method where the separation is a combined result of 
the above interactions, which can be augmented by the formation of inclusion 
complexes and binding to specific sites such as peptide or receptor sites in complex 
phases. Each site of interaction ensures the analytes to adopt the most accessible face 
of the chiral selector. For the more retained enantiomer, the complimentary sites are 
arrayed more favorably for the interaction than that for the less retained enantiomer. 
Typically a free energy of interaction difference of only 0.03 kJ/mol between the 













Figure 1.10 Three-point interaction model of CSPs in HPLC 
However, it must be emphasized that even though intense interest in CSPs has 
been evoked in the past few decades as evidenced by the number of reviews and papers 
on the subject which has been developed empirically, the mechanism of the separation 
and the mode of the action are still uncertain and barely understood.143-146 Further 
studies should be carried out by means of molecular modeling and simulations at the 
supramolecular level to shed more light on the mechanism.  
The concept of multi-model chiral stationary phases refers to those CSPs which 
can be effectively used under both normal and reversed-phases towards different sets 
of enantiomers. However, the main forces that affect the enantioseparation under 
normal phase and reversed-phases are different.  
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1) Reversed-phase (RP) 
The term “reverse-phase (RP)” is used to describe a chromatographic system 
where the stationary phase is nonpolar and the mobile phase is polar. In a chiral RP 
mode, the primary mechanism is believed to depend on the formation of an inclusion 
complex between the hydrophobic moiety of the analyte and the relatively non-polar 
interior of the CD cavity.  
For chiral recognition, the first important consideration for proper retention and 
chiral recognition is the proper fit of the molecules to the CD cavity. This fit is a 
function of both size and shape of the analyte relative to the cyclodextrin cavity, i.e., 
there must be a relatively tight fit between the guest molecules and the CD cavity.147, 
148 Further, the guest needs to interact with the 2- or 3-hydroxy groups of the CD 











Figure 1.11 Formation of reversible inclusion complex 
For chiral resolution to occur, a portion of the molecule must enter the 
hydrophobic cavity and a hydrogen-bonding region of the molecule must interact with 
the mouth of the cavity. b-CD has been found to have the widest application because 
recent structural information has shown that it has a pronounced kink in its structure, 
whereas the a and g forms are more planar. It is essential, therefore, that the analyte 
must have at least one aromatic ring if an enantioseparation is attempted in the 
reversed-phase.  
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As stated previously, geometric rather than chemical factors is decisive in 
determining the kind of guest molecules that can penetrate the cavity. If the guest is too 
small, it will easily pass in and out the cavity with little or no interaction at all and thus 
no enantioseparation will be obtained. 
The stability of a complex is proportional to the hydrophobic character of the 
guest molecules. Therefore, highly hydrophilic molecules turn the complex much 
weaker or even drive it to non-existing at all. 
 
2) Normal phase (NP) 
The term “normal phase” (NP) refers to a chromatographic system that utilizes 
a polar stationary phase and a nonpolar mobile phase. In the chiral NP mode, however, 
the CD cavity is more likely to be occupied by non-polar component of the mobile 
phase. Therefore, the retention mechanism is dependent upon H-bonding, p-p 
interaction, steric hindrance and so on.  
 
3) Polar organic phase 
Polar organic phase is akin to non-aqueous RP (NARP) chromatography. The 
typical mobile phase consists of CH3CN with maximum of 10% MeOH plus 0.5% 
acetic acid (AA) and/or 0.5% triethylamine (TEA). In this mode, CH3CN occupies the 
hydrophobic CD cavity and the enantioseparation occurs at the mouth of the cavity by 
means of H-bonding provided by the hydroxyl groups. A typical polar organic phase 
may be CH3CN/MeOH/AA/TEA= 95:5:0.2:0.3(v/v/v/v). The enantioseparation is 
significantly affected by adding amounts of TEA and AA. Varying their concentrations 
may control the ionization of the analyte to achieve a better enantioseparation. To 
achieve a "polar organic" separation it is necessary for the analyte to have an aromatic 
ring and 2 groups providing H-bonding interactions with CSPs, with one adjacent to 
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the aromatic ring and the other anywhere in the rest of the molecule. By forming these 
interactions, polar organic phase always exhibits different enantioselectivity towards 
some of the racemates from that of aqueous RPs.  
In polar organic mode, molecule structure of analytes is important. Analytes 
that have two hydrogen donor sites or one hydrogen donor and one hydrogen acceptor 
site on a side chain containing the stereogenic center are more preferable to achieve the 
enantioseparation.  
Many CD derivatives offer high steroselectivity in the NP mode. Phenyl and 
naphthyl carbamates, for example, utilize the p  basic naphthyl ring structure to interact 
with any p  acidic analyte to create molecular orientation of a stereogenic center in a 
side chain to offer the hydrogen donor / acceptor sites of the carbamate structure for 
stereoselectivity interaction.  
 
1.5 Scope of project work 
Based on the previous works reported by many researchers, this research 
project aims to: 
i) Prepare novel CSPs derived from functionalized-b-CDs chemically bonded to 
silica gel; 
a Synthesize series of fully functionalized-b-CDs with different 
substituents and reactive groups for further immobilization onto silica gel.  
b Vary the immobilization of these chiral selectors onto silica with different 
surface properties, pore sizes, particle sizes and functional groups.  
c Characterize the functionalized-b-CDs, especially those with well-defined 
structures and their corresponding CSPs using structural techniques such 
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as Fourier Transform Infrared Spectroscopy (FT-IR), Nuclear Magnetic 
Resonance Spectroscopy (NMR), Elemental Analysis (EA) etc. 
ii) Inspect the enantioseparation abilities of these CSPs towards a variety of 
racemic compounds / drugs under both NP and RP using HPLC.   
iii)  Study the chromatographic properties of these CSPs and optimize the 
enantioseparation conditions.  
iv) Explore the potential of using the preparative techniques to collect pure 
isomers after their separation.  






Chiral Stationary Phases Derived from Mono-(6-
Azido-6-Deoxy)-Perfunctionalized-b-Cyclodextrins via 




Arising from the work from the research groups of Okamoto and Armstrong, 
poly and oligosaccharides (such as cyclodextrin (CD)) have been successfully 
introduced into the chiral chromatographic field depicting unique enantioseparation 
abilities.50-52, 55-56, 125-127 Comparatively, functionalized CD-bonded columns exhibited 
better enantioseparation abilities and wider applicable ranges than the original / native 
CD-bonded columns towards most enantiomers by forming the multi-model mode, and 
consequently have been attracting burgeoning interests.  
It was reported that chromatographic properties and chiral recognition abilities 
of functionalized CD-chiral stationary phases (CSPs) varied, depending upon the 
functional groups on the cyclodextrin residues.124, 126, 150-152 The variations are mainly 
attributed to selective interactions (e.g. hydrogen bonding (H-bonding), dipole-dipole, 
p-p  interactions or steric effects) introduced by the substituents to affect 
enantioseparation behaviors of these CSPs.  
However, previous research efforts were directed mainly on chemically 
anchoring CD onto solid matrices116-117, 147 before the functionalizaion had been 
accomplished. As described in Chapter 1, (page 27), in these approaches, a complex 
mixture of multi-anchored CD instead of one with well-defined chemical structure 
were obtained, with partial substitution of CD residues and uncontrollable batch-to-
batch reproducibility on account of the heterogeneous solid- liquid phase reactions. 
These factors, in part, may have contributed to the high cost and poor availability of 
such CD-CSPs.  
On this basis, we report herein novel and facile methodologies for the 
preparations of three series of fully functionalized b-CDs.153-156  These three series are 
as follows: 
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Series I Mono-(6-azido-6-deoxy)-perfunctionalized-b-CDs. (Scheme 2.2) 
Series II Mono-(6-decenylcarbamido-6-deoxy)-perfunctionalized-b-CDs. 
(Scheme 2.3) 
Series III Mono-(6-(10’-undecenylcarbamido-6-deoxy)-perfunctionalized-b-
CDs. (Scheme 2.3) 
The preparation of compounds for mono-(6-azido-6-deoxy)-perfunctionalized-
b-CDs (series I) proved to be an effective methodology into regional-defined b-CD 
precursors for the synthetic generation of CSPs. Unlike the CSPs reported previously, 
these compounds were fully functionalized, purified and characterized, followed by 
further immobilized onto the surface of amino-functionalized silica gel via single 
stable urea linkage.91-92 
The purpose for obtaining compounds of series II was to investigate the 
optimized conditions for the Staudinger reaction which was involved in syntheses / 
immobilization for series III and I, respectively. Meanwhile, compounds with w-
alkenyl pendants for series III are anticipated to afford themselves to further reactive 
transformations into other useful functionalities.  
The key step for b-CD derivatives in series II, III and CSPs derived from series 
I utilized an extended application of Staudinger reaction,157 which was widely applied 
in the preparation of sugar phosphinimines.158-159 This involves the reaction of azido 
groups and amine to form stable urea linkages in the presence of carbon dioxide. 
(Scheme 2.3 and 2.5) 
For the compounds of series I, after immobilization onto silica supports, the 
resulting CSPs were evaluated in detail towards enantioseparations of a wide range of 
structurally divergent racemates under various conditions. As a result, it was found that 
these CSPs exhibited excellent enantioseparation abilities under both normal (NP) 
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and/or reverse-phase (RP). In addition, a comparative study of enantioselectivities on a 
commercially available CD-based column and a “homemade” naphthylcarbamoylated-
CSP was also carried out. The Results demonstrated that our CSP exhibited 
exceptional enantioseparation ability mainly to basic samples, while the commercial 
column was effective mainly for acidic racemates.   
 
2.2 Syntheses 
2.2.1 General overview 
The synthetic route for the preparations of the above-mentioned b-CD 














(     )6
TsCl/ Pyridine
25 °C, 12 hrs 95 °C, 4 hrs
 
 
The mono-(6-(p-tosylsulfonyl)-6-deoxy)-b-CD 2.1 was prepared by the 
reaction of b-CD with p-toluenesulfonyl chloride in dry pyridine.160-168  Transformation 
to mono-(6-azido-6-deoxy)-b-CD 2.2 can be readily effected by SN2 reaction with 
excess sodium in dry N,N-dimethylformamide (DMF).169 (Scheme 2.1)  
Mono-(6-(p-tosylsulphonyl)-6-deoxy)-b-CD 2.1 is by far, one of the few mono-
substituted-b-CDs with well-defined chemical structure. Its ease of preparation makes 
it a very attractive precursor for syntheses, thus making it the key intermediate in the 
synthesis of other CD derivatives. In this work, the sulphonate group was readily 
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replaced by nucleophilic substitution with a nucleophile of azido group in high yield 
under a relatively mild condition.  
In the process of a standard nucleophilic displacement reaction, solvolysis of 
the mono-tosylated-CD competes with the desired nucleophilic substitution when the 
reaction is carried out in water, giving rise to cyclohexaamylose. Despite the azido 
anion being a relatively strong nucleophile, solvolysis nevertheless still afforded some 
cyclohexaamylose (ca 5%) by TLC analysis.169 Hence, in order to avoid the formation 
of any cyclohexaamylose, the preparation of monoazido-CD should be carried out in 
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a: R= phenylcarbamate; 
b: R= naphthylcarbamate 
c: R= acetyl; 
d: R= methyl 
e: R= benzoyl; 
f: R= benzyl 
Reagents and conditions: 
i: a-b:  Phenyl isocyanate or naphthyl isocyanate / pyridine, 95°C, 15 hrs,  
c:  (AcO)2O/pyridine at 40 °C, 15 hrs,  
d:  CH3I / DMF / NaH, 25 °C, 12 hrs,  
e :  benzoyl chloride / pyridine, 30°C, 12 hrs.  
f:  benzyl bromide/ NaH / DMF, 30°C, 12 hrs. 
 
The remaining 6-,  2- and 3-hydroxyl groups at b-CD residues can be fully 
functionalized by reaction with alkyl or aryl halides, isocyanates or acid chlorides. 
(Scheme 2.2) Thereafter, the reactive azido groups can be used to complete the 
preparations for the compounds of series II and III, or immobilization of series I onto 
surface of amino-functionalized silica gel.  
2.3a, c, d reacted with the w-alkenyl / w-alkyl amine to form the w-alkenyl / w-
alkyl pendants at the side chain of b-CD via single urea linkage. (Scheme 2.3) When 
w-alkenyl amine is used, the reactive terminal C=C group can be introduced, which 
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may then readily hydrosilylized and anchored onto polysiloxane backbone for GC,170-







2.4a; R= phenylcarbamate                  
2.4b; R= phenylcarbamate   
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2.4e; R= methyl
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The attachment of the alkyl/alkenyl pendants to the azido moiety was readily 
accomplished by constant bubbling of CO2 in anhydrous THF solution of n-
decanylamine / w-undecenylamine and mono azido-perfunctionalised-b-CD, followed 
by addition of PPh3. This experiment was carried out under mild condition. 
2.3a-f may also react with amino groups on the surface of amino-functionalized 
silica gel (prepared according to Scheme 2.4) to afford chemically anchored CSPs 




















The silica gel was aminized using 3-aminopropyltriethoxysilane in anhydrous 
toluene.175-176 It is recommended to carry out this reaction in the absence of water to 
reduce the possibility of deactivazation of aminopropyltriethoxysilane in water. 
Meanwhile, vigorous stirring of the reaction mixture has to be avoided to prevent the 
cracking of silica gel.  
In this chapter, three different types of spherical silica gel: Hypersil (classical), 
Hypersil-BDS5 and Hypersil-BDS3 were applied in order to determine the effects of 
properties of silica gel on enantioseparations. All sources of the silica gel have the 
same surface areas of 170 m2/g. However, their surface properties are different in that 
Hypersil has untreated surface, while the other two have base-deactivated surfaces 
(BDS). Meanwhile, the particle size for Hypersil-BDS3 is 3 mm, while that for the 
other two is 5 mm. The results from detailed studies on the effects of shape, particle 
and pore sizes as well as surface property of the silica gels on the enantioseparation 
















a: R= phenylcarbamate; 
b: R= naphthylcarbamate 
c: R= acetyl; 
d: R= methyl 
e: R= benzoyl; 
f: R= benzyl 
 
 
Immobilization of b-CD derivatives onto the silica gel was carried out 
according to scheme 2.5. In this step, Staudinger reaction of the b-CD derivatives was 
also initiated by CO2 / PPh3 into a THF suspension of the aminized silica gel. It is the 
most crucial step in the whole process, because it will directly affect the formation of 
chemical bonds between the silica gel and b-CD derivatives, the loading amount of 
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chiral selectors on the support surface, and column efficiencies and thus the 
enantioseparation behaviors of resulting CSPs.  
The current approach was proved straightforward and facile thus ensuring good 
reproducibility. All the CSPs prepared by the present method possess well-defined 
chemical structures compared to commercially available CD based CSPs.177 
 
2.2.2 Staudinger reaction 
Staudinger reaction93-94, 158-159 was generally applied to prepare sugar 
phosphinimines, which are further converted by carbon dioxide into cyclic carbamates 
of amino sugars from various azido sugars by reaction with PPh3 at room temperature 
(ca. 25 °C) in quantitative yield.  
In this thesis, azido groups in b-CD derivatives react with amino groups in 
silica gel to form the stable urea linkages after the elimination of N2 and Ph3P=O. 
(Figure 2.1) The reaction was initiated by PPh3 and carried out by bubbling CO2 in 
mixture of the reactants in THF an ambient temperature (ca 25°C). 
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Figure 2.2 Possible mechanism of the immobilization 
In general outline, the mechanism of the Staudinger reaction is known.178 It 
seems to proceed without either free radicals or nitrene participation179 and possibly, 
with retention of phosphorus stereoconfiguration.180  
As proposed in Figure 2.2, a phosphazide (III) was formed after addition of 
mono-(6-azido-6-deoxy)-perfunctionalized-b-CD and PPh3. (Step i in Figure 2.2) In 
this step, the primary electrophilic attack of an azide molecule on phosphorus is 
accelerated by acceptor groups in the azide and donor radicals in the trivalent 
phosphorus compound. The phosphazide further decomposed to give the 
corresponding phosphazo compound by the intramolecular mechanism via the 4-
membered ring transition state (IV),179, 181 and the reaction was preceded by the 
elimination of N2 to give phosphimine (V).  
In the presence of CO2, this phosphinimine might have formed another active 
intermedia te (VI), which was then transform to b-CD-isocyanate (VII) 182-186 after the 
elimination of Ph3P=O. VII further formed the stable urea linkage with amino groups 
on the surface of silica gel.  
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2.2.3 Preparations of HPLC columns 
Packing the resulting CSPs 2.6a-f into the stainless steel columns, (4.6 ´ 250 
mm, i.d ´ l) the HPLC columns namely SINU-PC, SINU-NC, SINU-AC, SINU-ME, 
SINU-BL and SINU-BN were obtained. Meanwhile, the CSPs derived from 2.6a on 




b-CD derivatives and resulting CSPs were thoroughly purified and their 
proposed structures were confirmed by high resolution NMR, elemental analyses (EA) 
and IR spectra.   
1 Physical Properties 
The physical properties of b-CD derivatives exhibited differences in the 
melting points, optical rotations, solubility etc on account of different substituents at 
the b-CD residues. Compared to pristine b-CD, the most obvious improvement was the 
solubility. Pristine b-CD has poor solubility where it is only soluble in pyridine, DMF, 
DMSO and hot water. However, after functionalized, solubility is markedly improved. 
For example, acetylated and methylated b-CDs are water-soluble and also soluble in 
most organic solvents such as chloroform and MeOH. The derivatives with aromatic 
substituents are less soluble in aqueous and non-polar solvents, while exhibiting good 
solubility in highly polar organic solvents such as MeOH. This improvement in the 
solubility gives a great advantage in enlarging their areas of applications.  
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Tables 2.1 and 2.2 summarize some physical properties of b-CD derivatives.  
Table 2.1  Mono-(6-azido-6-deoxy)-perfunctionalised-b-cyclodextrins 2.3  
Compounds Substituents Yields 
(%) 
Mp (°C) 25][ Da  (c 0.01, 
CHCl3) 
2.2 H 98 >220°C, decomposed +109 (in water) 
2.3a Phenyl carbamate 57 220-227 +33.40 
2.3b Naphthyl carbamate 55 192-199 +89.56 
2.3c Acetyl 82 133-135 +120.92 
2.3d Methyl 82 95-99 +157.00 
2.3e  Benzoyl 66 96-99 +24.65 
2.3f Benzyl 68 39-42 +45.20 
 
After functionalization, a decrease in the melting points of b-CD derivatives is 
observed compared to pristine b-CD. For example, to methylated-, benzylated- and 
benzoylated-b-CDs, their melting points are lower than 100 °C. However, to those b-
CD derivatives that have substituents comprising aromatic rings, urea or ester linkages 
such as acetyl and phenyl carbamate groups, high melting points ranging from 133 to 
220°C are observed. 
Similar trends in the melting points can be observed for mono-(6-
decenylcarbamido-6-deoxy)- and mono-(6-(10’-undecenylcarbamido)-6-deoxy)-
perfunctionalized-b-CDs. (Table 2.2).  
Table 2.2 Mono-(6-decanylcarbamido-6-deoxy)- or mono-(6-(10’-undecenylcarbamido)-6-
deoxy)-perfunctionalised cyclodextrins 2.4  
Compounds R R’ Yields (%) Mp (°C) 
25][ Da  (c 1.0, 
CHCl3) 
2.4a Phenyl carbamate 10’-undecenyl 97 198-200 +8.5 
2.4b Phenyl carbamate n-decanyl 96 206-209 +5.6 
2.4c Acetyl 10’-undecenyl 97 115-117 +106.1 
2.4d Acetyl n-decanyl 98 127-129 +107.7 
2.4e  Methyl 10’-undecenyl 95 72-74 +132.9 
2.4f Methyl n-decanyl 96 78-80 +126.0 
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2 FT-IR spectra of functionalized-b-CDs and CSPs.  
The IR spectra of the b-CD derivatives showed different vibrational bands 
attributable to different functionalizations at b-CD residues.  
From the IR spectra, the characteristic azide stretches are easily identified in the 
vibrational bands at 2100 cm-1 in mono-(6-azido-6-deoxy)-b-CD and its derivatives 
throughout the whole synthetic procedure, which demonstrate that this group is very 
stable in various synthetic conditions.  
Different functionalized-b-CDs also give the characteristic vibrational bands 
for the substituents. For example, perbenzoylated b-CD gives the characteristic C=O 
stretches around 1734 cm-1. Perphenyl and pernaphthylcarbamoylated b-CDs show 
characteristic N-H stretches in the regions of 3304-3393 cm-1.  
The FT-IR spectra of respective CSPs are depicted in Figure 2.3. Successful 
immobilizations of the b-CD derivatives are corroborated by the weak but 
characteristic vibrational bands particularly in the 1800-1400 cm-1 region reminiscent 
of those present in the precursor compounds.  
 
 
(A) Aminized silica gel 




(1) SINU-NC-CSP  
 
 
Figure 2.3 FT-IR spectra of the CSPs. 
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3 Elemental analyses and MS spectra 
Data obtained from elemental analyses and MS spectra for the b-CD 
derivatives further prove their proposed structures. (Detailed data please refer to 
chapter 8)  
To the CSPs, their higher carbon contents obtained from elemental analyses on 
the silica gel further corroborate the success of the immobilization approach. The 
increases in the organic constituents are summarized in Table 2.3. 
Table 2.3 Elemental analyses and surface concentrations of the CSPs 
Materials Substituents C % H % N % 
2.5a Hypersil (classical) Amino groups 3.42 0.95 1.11 
2.5b Hypersil-BDS5 Amino groups 2.85 1.03 1.03 
Amino-
functionalize
d silica gel 
2.5c Hypersil-BDS3 Amino groups 2.85 0.81 1.04 
2.6a SINU-PC Phenyl carbamate  17.42 2.15 2.56 
2.6b SINU-NC Naphthyl carbamate 16.17 2.07 2.45 
2.6c SINU-AC Acetyl  16.70 2.98 1.56 
2.6d SINU-ME Methyl 15.49 3.07 1.52 
2.6e  SINU-BN Benzyl  4.95 0.97 0.94 
2.6f SINU-BL Benzoyl  17.25 2.40 1.43 
2.6g SINU-PC-BDS5 Phenyl carbamate  9.03 1.32 1.74 
CSPs 
2.6h SINU-PC-BDS3 Phenyl carbamate  9.01 1.42 1.86 
 
It is noted from Table 2.3 that aminized-Hypersil (classical) obtains the highest 
carbon content as 3.42%, while that for BDS5 and BDS3 are relatively low as 2.85 and 
2.85%, respectively. This difference may be explained by the inert based-deactivated 
surface for BDS5/BDS3. Similarly, the SINU-PC obtains higher carbon content in 
comparison with SINU-PC-BDS5 and SINU-PC-BDS3.  
We also note from the Table that SINU-BN affords lowest carbon content. This 
indicates that the immobilization for this CSP was not very successful.  
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2.4 Enantioseparation abilities of the CSPs 
According to the procedure described in section 8.3.3, 3.2 g of each CSP was 
packed into stainless steel HPLC columns to give the HPLC columns namely SINU-
PC, SINU-NC, SINU-AC, SINU-ME, SINU-BN, SINU-BL, SINU-PC-BDS5 and 
SINU-PC-BDS3, respectively. Chromatographic properties such as column 
efficiencies and surface concentrations were obtained, (Table 2.4) followed by the 
enantioseparation abilities of the columns investigated towards a wide variety of 
racemates.  
 
2.4.1 Column efficiencies, theoretical heights of plates and surface 
concentrations  
Biphenyl was used as test probe for column efficiency because hexane was 
applied, as the slurry solvent for packing the HPLC columns. Thus, the column 
efficiencies (Neff) and corresponding theoretical heights of plate (H) of these chiral 
HPLC columns are summarized in Table 2.4. According to the formula 8-8, the surface 
concentrations relating to the units of b-CD derivatives anchored to the silica gel were 
calculated based on EA results of CSPs and are given in Table 2.4 too.  
Of these HPLC columns, it is obvious that CSPs on BDS silica gel afford 
highest column efficiencies, while that on Hypersil (classical) silica gel give fair 
column efficiencies. The effects of the Neff and silica gel surface to the 
enantioseparation abilities of HPLC columns are discussed in detail in Chapter 7. 
 49
Table 2.4 Column efficiencies, theoretical heights of plates and surface concentrations for 
HPLC columns 
 Column names CSPs in the column Neff (plates/m) 
H 
(mm) S (mmol m
-2) 
2.6a SINU-PC SINU-PC-CSP 28,000 0.036 0.32 
2.6b SINU-NC SINU-NC-CSP 32,000 0.031 0.20 
2.6c SINU-AC SINU-AC-CSP 25,000 0.040 0.67 
2.6d SINU-ME SINU-ME-CSP 32,000 0.032 0.80 
2.6e  SINU-BN SINU-BN-CSP 18,000 0.056 0.04 
2.6f SINU-BL SINU-BL-CSP 15,000 0.067 0.32 
2.6g SINU-PC-BDS5 SINU-PC-BDS5-CSP 38,000 0.026 0.17 
2.6h SINU-PC-BDS3 SINU-PC-BDS3-CSP 60,000 0.017 0.15 
 
 
2.4.2 Enantioseparation abilities of the HPLC columns 
Of the six columns namely SINU-PC, SINU-NC, SINU-ME, SINU-AC, SINU-
BN and SINU-BL, the first three exhibited excellent enantioseparation abilities, while 
the latter three did not demonstrate enantioseparation abilities within the ranges of 
racemates. The enantioseparation data are summarized in Tables 2.5-2.16. 
In general, under NP conditions employing mixtures of hexane/2-propanol 
(IPA) in different composition as mobile phases without any additive, SINU-PC and 
SINU-NC afforded enantioseparations to various racemates, including simple racemic 
compounds and some b-adrenergic blocking agents (e.g. propranolol and metoprolol).  
Under polar organic phase and RP, SINU-PC, SINU-NC and SINU-ME 
exhibited excellent enantioseparation abilities towards a variety of racemic compounds 
/ drugs including (1-aryl)ethanols, amines, weak acids, b-blockers etc. The mobile 
phases used were generally acetonitrile (CH3CN), methanol (MeOH) or a mixture of 
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the above two solvents with/without the help of aqueous buffers with different 
concentrations and various pH values. 
In summary, our experimental results indicate that SINU-PC and SINU-NC 
exhibited good enantioseparation abilities under both NP and RP, while SINU-ME was 
only effective to several samples under RP conditions.   
These results may be due to the structurally difference of CSPs, which were 
derived from the different substituents at b-CD residues.  
A. Simple racemic compounds 
Fourteen (1-aryl)ethanols were chosen for the purpose of investigating the 
enantioseparation abilities of these CSPs in NP/ RP. The mobile phase applied herein 
were mixtures of hexane/IPA and CH3CN/ water.  
The results are summarized in Tables 2.5 and 2.6. Results show that most 
enantioseparations were obtained in mixture of hexane/IPA, while only a few examples 
were enantioseparated in the mobile phase of CH3CN / water.  
 
1) SINU-PC and SINU-NC 
Among the fourteen racemic samples, thirteen were separated on SINU-PC 
while only five were separated on SINU-NC. (Table 2.5) Meanwhile, three samples 
were separated using CH3CN/water mixtures on SINU-PC while SINU-NC did not 
show enantioseparation ability towards this series of racemates under this condition.  
The above results indicate that SINU-PC appears to be effective CSP in NP for 
(1-aryl)ethanols. Eleven of the thirteen samples gave resolution (Rs) above 1.0, while 
nine of them such as compounds S/n 2, 9 and 10 in Table 2.5 afforded baseline 
resolutions. Particularly, three compounds S/n 6, 9 and 10 could also be separated in 
RP applying the mixture of CH3CN/ water as mobile phase on SINU-PC.  
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Compared to SINU-PC, SINU-NC showed poorer enantioseparation ability 
under both NP and RP. In particular, it did not show any enantioseparation ability 
towards this series of racemates under RP. Meanwhile, with the same samples, SINU-
PC afforded better results than SINU-NC in terms of selectivities (a) and resolutions 
(Rs). Considering 1-(4-bromophenyl)ethanol (S/n 10) as an example, it achieved a of 
2.0 and 1.16, with Rs of 6.55 and 0.94, respectively, on SINU-PC and SINU-NC. 
Similar trends could also be observed in case of 1-(4-chlorophenyl)ethanol (S/n 9). 
These results indicate that under NP, SINU-PC is much more effective than SINU-NC. 
It is interesting to note that for a certain sample, capacity factor of the first 
componet, k1’, which represents the retention time of the first eluted enantiomer, is 
higher on SINU-NC than that on SINU-PC under the same conditions. This indicates 
that the retention of samples on the former is longer than on the latter.  
The above results can be easily explained by the structural differences in the 
CSPs. Since SINU-NC has bigger substituents at the rim of the b-CD cone in 
comparison with SINU-PC, this may result in a bigger extended b-CD cavity with the 
naphthyl carbamate groups. This may have two positive influences on the 
enantioseparation of the CSP. One is the bigger cavity that allows the bulky analytes 
deeper into the cavity thus forming a more stable transient state between the CSP and 
analytes, the other is the stronger p-p  interactions with analytes brought about by 
naphthyl groups. The combination of these two factors explains the stronger retention 
of samples on SINU-NC than that on SINU-PC. 
Based on the above results, it is evident therefore that of these two CSPs, 
SINU-NC prefers RP conditions where inclusion complex is the domain factor to the 
enantioseparation, while SINU-PC is effective in both NP and RP under the combined 
effects of both the H-bonding and p-p  interaction. 
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Table 2.5 Enantioseparations of substituted (1-aryl)ethanols on SINU-PC and SINU-NC 
S/n Analytes k1’ a Rs Conditions CSPs 
0.37 1.11 1.07 Hexane/IPA=90/10 SINU-PC 
1 
O
 0.47 1.75 3.54 Hexane/IPA=90/10 SINU-NC 
2 
OH 
0.82 1.20 1.52 Hexane/IPA=90/10 SINU-PC 
3 
OH  
0.71 1.11 1.33 Hexane/IPA=90/10 SINU-PC 
4 
OH 
1.54 1.09 0.70 Hexane/IPA=90/10 SINU-PC 
5 
OH 
0.73 1.13 1.53 Hexane/IPA=90/10 SINU-PC 
6 OH
HO  





2.0 1.10 1.11 Hexane/IPA=90/10 SINU-PC 
1.82 1.09 0.91 Hexane/IPA=90/10 SINU-PC 
8 OH
H3CO  
1.94 1.05 0.47 Hexane/IPA=90/10 SINU-NC 
1.29 1.72 6.02 Hexane/IPA=90/10 SINU-PC 
1.88 1.5 3.30 H2O/CH3CN =70/30 SINU-PC 9 
OH
Cl
 2.48 1.23 0.83 Hexane/IPA=90/10 SINU-NC 
1.38 2.00 6.55 Hexane/IPA=90/10 SINU-PC 
2.26 1.73 3.78 H2O/CH3CN =70/30 SINU-PC 10 
OH
Br

















0.33 Hexane/IPA=90/10 SINU-PC 
14 S
O 




Table 2.6 summarizes the enantioseparation results obtained on SINU-ME 
under various conditions. From the table we may conclude that of the fourteen 
samples, only nine were enantioseparated with relatively low selectivities and 
resolutions than that on SINU-PC.  
Table 2.6 Enantioseparations of substituted (1-aryl) ethanols on SINU-ME.  
S/n Analytes k1’ k2’ a Rs Conditions 
0.64 0.70 1.08 0.27 Hexane/IPA=90/10 
0.05 0.42 8.12 0.26 CH3CN 
2.52 2.74 1.09 0.61 H2O / CH3CN =75/25 
1.  
OH 
1.79 1.93 1.08 0.53 H2O / CH3CN =70/30 
0.50 1.61 3.22 3.45 Hexane/IPA=90/10 
7.00 7.45 1.06 0.67 H2O / CH3CN =75/25 2.  
OH 3.34 4.69 1.07 0.71 H2O / CH3CN = 70/30 
3.  OH
H3CO  
1.20 1.31 1.09 0.70 H2O / CH3CN =70/30 
1.02 1.14 1.12 0.67 Hexane/IPA=90/10 
0.15 0.57 3.68 0.60 CH3CN 4.  
OH
Cl
 5.26 5.70 1.08 0.89 H2O / CH3CN =75/25 
0.84 0.91 1.09 0.58 Hexane/IPA=90/10 
0.22 0.67 3.06 0.69 CH3CN 5.  
OH
Br
 7.28 7.68 1.06 0.60 H2O / CH3CN =75/25 
0.95 1.65 1.74 0.27 CH3CN 6.  OH
HO  




1.89 2.05 1.09 0.69 H2O / CH3CN =75/25 
8.  
OH  
0.16 0.53 3.41 0.20 CH3CN 











In details, only five samples were separated in NP conditions, while five and 
seven were resolved in CH3CN and mixture of CH3CN/water, respectively, on SINU-
ME. These results demonstrate that SINU-ME afforded better enantioseparation 
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abilities in RP than in NP, despite the fact that the highest a and Rs for S/n 2 was 
obtained in NP. 
This can be easily explained by the small methyl groups in SINU-ME, so that 
extending of the CD cavity will not be accomplished effectively. Meanwhile, there are 
less active interactions such as H-bonding, p-p interaction etc in methyl groups, thus 
making it less effective in NP. The above two reasons explain the weaker 
enantioseparation abilities and shorter retention times of samples for SINU-ME 
compared to SINU-PC and SINU-NC.  
 
3) SINU-PC-BDS5 and SINU-PC-BDS3 
Enantioseparations of the (1-aryl) ethanols on SINU-PC-BDS3 and SINU-PC-
BDS5 (with abbreviation as BDS3 and BDS5 in table, respectively) are summarized in 
Table 2.7. From the table we may know that out of twelve racemates, all were 
enantioseparated on BDS3, while ten were resolved on BDS5.  
It is interesting to note that good enantioresolution occurred when the analyte 
has a chiral carbon adjacent to the aromatic ring. It can be demonstrated by 1-phenyl-
propan-2-ol (S/n 4), which has a chiral carbon at the b-position of the aromatic ring, 
was unable to be resolved in NP. However, it could be separated in RP. It can be easily 
understood that in RP, since the aromatic ring is so small compared to the cavity of the 
CD, it may be able to rotate freely in it where H-bonding may be weak. Furthermore, 
the chiral carbon also can rotate freely along the a-carbon, making the molecule more 
flexible with minimum energy states, thus resulting the energy difference between the 
[(R-solute)-CSP], and [(S-solute)-CSP] complexes being not high enough to cause an 
effective enantioseparation. Nevertheless, on the other hand, the OH group at the b-
position of sample S/n 4 may be more accessible to the carbamate group to form 
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stronger H-bonds. This helps to limit the free rotation of the molecule in the cavity, 
resulting in the formation of a relatively ‘tight complex’, which explains the reason of 
its separation in RP.  
Table 2.7 Enantioseparations of (1-aryl) ethanols on SINU-PC-BDS3 and SINU-PC-BDS5.  
S/n Analytes k1’ k2’ a Rs Condition CSPs 




 1.37 1.61 1.18 1.78 Hexane/ IPA=95/5 BDS3 




 2.79 3.03 1.09 1.10 Hexane/ IPA =  98 / 2 BDS3 
3.33 3.67 1.10 1.29 Hexane/ IPA= 99.5/0.5 BDS5 
3.  





5.80 6.64 1.14 1.08 H2O/MeOH=60/40 BDS3 
7.67 8.40 1.10 1.17 Hexane/ IPA= 99.5/0.5 BDS5 
5.  
OH 2.18 2.34 1.07 0.63 Hexane/ IPA = 95 / 5 BDS3 




 4.58 5.00 1.09 1.11 Hexane/ IPA= 99.5/0.5 BDS3 
7.  OH
H3CO  
2.52 2.68 1.06 0.65 Hexane/ IPA = 95 / 5 BDS3 
1.25 1.45 1.16 1.53 Hexane/ IPA= 95/5 BDS5 
8.  OH
Br  1.36 1.60 1.18 1.56 Hexane/ IPA = 95 / 5 BDS3 




 1.36 1.61 1.18 2.00 Hexane/ IPA = 95 / 5 BDS3 




 2.90 3.38 1.17 1.22 Hexane/ IPA =  98 / 2 BDS3 
1.28 1.47 1.15 1.30 Hexane/ IPA= 95/5 BDS5 
11.  
OH  








Furthermore, the positions of substituent groups in analytes will also affect their 
enantioseparation. There are two different positional substituents, with one adjacent to 
chiral center, while the other at the aromatic moiety. Further discussions are depicted 
as follows.  
 
a) Adjacent to chiral center. 
From the enantioseparations of compounds S/n 2 and 3 in Table 2.5, 2 afforded 
higher Rs and a than 3. This may be a result of the ethyl group in compound 3. Since 
the bigger ethyl group will “shield” the –OH group adjacent to chiral carbon, it will 
also weaken the H-bonding, thus leads to the poorer enantioseparation.  
However, compound 12 in Table 2.5 is an exception that it afforded higher Rs 
than S/n 2 and 3, which can be explained by the strong p-p  interaction with CSP 
brought about by the triple bond, thus resulting in a longer retention and better 
enantioseparation. Similar trend can also be observed to the compounds 1, 3 and 10 in 
Table 2.7.  
These results indicate that substituents adjacent to the chiral center in the 
racemates also play an important role in the enantioseparation by providing the strong 
interaction sites and steric hindrance. 
 
b) At the aromatic moiety 
Figure 2.4 gives five structurally divergent (1-aryl) ethanols, with different 
substituents at the para (p-) position of aromatic ring to chiral center in their 
molecules. From the data in Table 2.5, it is apparent that a and Rs increased when the 
para substituent on the aromatic ring is changed from methoxy through methyl to H to 
Cl/Br. This trend is similar to that of the data obtained from SINU-PC-BDS3 and 
SINU-PC-BDS5 in Table 2.7.  
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A B C D E 
OH
H3CO





Figure 2.4 Substituted (1-aryl) ethanols with different substituents at the para 
position of aromatic ring 
The above results demonstrate that the electron donating (e-donating) or 
withdrawing (e-withdrawing) abilities of the substituents at the aromatic rings play an 
important role in enantioseparation. From A to E, the e-donating ability of p-
substituent decreased, while D and E are exhibiting e-withdrawing properties. 
Therefore, it suggests that for our CSPs, chiral discrimination may be largely the result 
of p-p  interaction or dipole-dipole interaction. When the p-substituent is e-
withdrawing, it may reduce the density and shape of the electron cloud of the aromatic 
ring, thus influencing on the chiral center and making the –OH group adjacent to chiral 
center more acidic.  
On the other hand, since our CSPs comprise numerous aromatic rings in the 
substituents, the p-p  interaction is likely to be strong, thus making it a good e-donor by 
being p-basic in nature. Consequently, when the analyte has stronger p-accepting 
ability or being p-acidic, its interaction with CSP will be stronger that leads to a better 
enantioseparation.  
Steric effects can also largely affect the enantioseparations. As a result, o- and 
m-substituted ethanols were less efficiently resolved than their p-isomers. For example, 
from the results in Table 2.5, o-bromo compound S/n 11 and m-methoxy compound 
S/N 8 gave lower a and Rs than their p-compounds S/N 10 and 7, respectively. This 
may be due to the larger steric hindrance in their interactions with CSPs.  
It is also interesting to note that some samples could be separated under both 
NP and RP. Table 2.8 gives the enantioseparations and chromatograms of 1-(4-
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bromophenyl) ethanol and 1-(4-chlorophenyl) ethanol under different conditions on 
SINU-PC-BDS3 and SINU-PC-BDS5. These two samples obtained baseline 
resolutions under NP and RP, with /without the help of aqueous buffer. These results 
demonstrate that these CSPs are operating in multi-model modes. 
Table 2.8 Enantioseparations of 1-(4-bromophenyl) ethanol and 1-(4-chlorophenyl) ethanol 
on SINU-PC-BDS3 and SINU-PC-BDS5. 
A Hexane/IPA =90/10 
k1 = 1.04 
k2 = 1.70 
a  = 1.63 




B H2O/CH3CN =60/40 
k1 = 0.98 
k2 = 1.31 
a  = 1.34 




C H2O/MeOH =60/40 
k1 = 9.52 
k2 = 13.68 
a  = 1.44 





k1 = 3.46 
k2 = 4.64 
a  = 1.34 



















k1 = 1.24   
k2 = 2.51 
a  = 2.02 




B H2O/CH3CN =60/40 
k1 = 1.15  
k2 = 1.71 
a  = 1.49 




C H2O/MeOH =60/40 
k1 = 13.32  
k2 = 21.66 
a  = 1.63 





k1 = 4.26  
k2 = 6.51 
a  = 1.53 


















However, enantioseparations did not show any advantage for BDS3 over BDS5 
although the former has higher column efficiency because of the smaller particle size. 
This result indicates that the column efficiency is not the dominating factor affecting 
the enantioseparation abilities of CSPs. 
 
B. b-Adrenergic blocking agents 
b-Adrenergic blocking agents (or b-blockers) are drugs that produce an anti-
hypertensive effect, which help to lower the blood pressure. They competitively bind 
to beta-adrenergic receptor sites on the heart (cardiac) and /or nonvascular smooth 
muscle. In doing so they inhibit the action of adrenergic agents (e.g., stimulants) such 
as amphetamine, adrena line, catecholamines and so on.  
After the first successful introduction of propranolol (Inderal) to the market, a 
variety of analogous compounds have been developed. However, currently most b-
blockers are still marketed as racemic compounds and usually their enantiomers have 
different potencies and effects. For example, the isomer of propranolol that is most 
active in correcting ventricular arrhythmias is much less active as a b-blocker.187 
Similarly, one of the four isomers of labetalol is an effective b-blocker while another is 
thought to be an alpha-blocker.188  
In their structures, b-blockers are chiral hydroxyl-amine containing compounds. 
Their typical structure is shown in Figure 2.5. They contain at least one aromatic in the 
molecules, with different substituted moieties, while the amine functional group is 
always secondary, and many of them are N-isopropyl amines.  
There are several reports on the enantioseparation for one or more b-blockers.67, 
151, 189-195 Hermansson successfully separated this entire class of compounds using an 
a1-acid glycoprotein (AGP)-CSP.67 Armstrong also obtained enantioseparations on ten 
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b-blockers on a native b-cyclodextrin column CYCLOBOND I151 using the mixtures 
containing CH3CN, MeOH, AA and TEA with different ratios as mobile phases.  
However, these applications are not without limitations. First, the AGP column, 
like all protein-based CSPs, has a very low capacity thus leading to the problem of 
easy overloading, which makes the column unstable, and furthermore, applications in 
scale-up separations are very difficult or impossible. On the other hand, Armstrong 
failed to separate the samples under NP on his native b-CD columns. All these 
previous work and their drawbacks prompted us to prepare a CSP possessing high 






Figure 2.5 Typical structure of b-blockers 
In this work, ten b-blockers were employed to investigate their 
enantioseparations on CSPs. Of these, alprenolol and oxprenolol have substituents in 
R1 position, atenolol and metoprolol have one substituent group in R3 position, 
acebutolol has two groups at the R1 and R3 positions. (Table 2.9) Pindolol, propranolol 
and O-acetyl propranolol have one pyridine or aromatic ring adjacent to the basic 
benzene ring. (Table 2.10) (The structures can be referred to Appendix I) 
The CSPs derived in our laboratories proved efficient for the above mentioned 
requirements. Thus, eight b-blockers were separated on SINU-PC, SINU-NC, SINU-
ME, SINU-PC-BDS3 and SINU-PC-BDS5 under both NP and RP. (Tables 2.9-2.11) 
Of those tested, five were enantioseparated on SINU-PC, seven were resolved on 
SINU-NC while one obtained enantioseparation on SINU-ME. SINU-PC-BDS3 and 
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BDS5 afforded better enantioseparations than the former three CSPs in that all nine 
analytes were successfully separated on SINU-PC-BDS5. (Table 2.11, Figures 2.7 and 
2.8) In general, for the same racemate under similar conditions, BDS3 and BDS5 
afforded better enantioseparations than the remaining three. Figure 2.6 depicts 
representative chromatograms for alprenolol in RP. 
Table 2.9 Enantioseparations of b-blocking agents on SINU-PC, SINU-NC and SINU-ME  
S/n Analytes  Substituents k1’ a Rs Conditions Columns 
12.6 1.15 1.25 H2O/CH3CN=85/15  SINU-PC 1. Alprenolol R1= CH2CH CH2
1.82 1.71 1.38 Hexane/IPA=90/10  SINU-NC 
3.67 1.20 1.00 Hexane/ IPA=95/5  SINU-PC 
2. Oxprenolol R1= OCH2CH CH2
0.15 1.73 0.53 H2O/CH3CN=85/15 SINU-ME 




0.02 7.37 0.44 A / MeOH = 60/40  SINU-NC 
2.62 1.38 0.83 Hexane/IPA=80/20  SINU-NC 




CH3  5. Acebutolol  
R3= 
NHCCH2CH2CH3
O 0.83 1.22 0.79 A / MeOH = 60/40  SINU-NC 
Mobile phase: A: 1% TEAA (pH 4.10); B: 1% TEAA(pH=5.59) 
Of the eight analytes, metoprolol (S/n 4 in Table 2.9) could only be separated in 
NP with mixtures of hexane/IPA as mobile phase, while alprenolol, oxprenolol and 
propranolol afforded enantioseparations under both NP and RP. For the rest of the 
analytes, good resolutions were achieved under RP using typically aqueous phases 
comprising aqueous triethylammonium acetate (TEAA) buffer and MEOH or CH3CN. 
Since the pKa values of these drugs are around 6.0, it is expected that the separation 
proceeds well in media with the pH value below 6.0 which will suppress ionization of 
these drugs which may otherwise weaken the interactions with the CSPs and allow for 
a more facile elution from the CSPs. 
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Table 2.10 Enantioseparations of pindolol, propranolol and O-acetyl propranolol on SINU-
PC and SINU-NC  







0.41 2.09 1.53 A / MeOH = 60/40  SINU-NC 
3.56 2.26 1.97 B / MeOH = 60/40  SINU-NC 




 3.91 1.27 3.08 H2O/CH3CN=70/30  SINU-PC 





2.83 2.40 2.74 A / MeOH = 60/40  SINU-NC 
Mobile phase: A: 1% TEAA (pH 4.10); B: 1% TEAA (pH 5.59) 
Table 2.11 Enantioseparations of b-adrenergic blocking agents in RP  on SINU-PC-BDS3 and 
BDS5 
S/n Drugs k1’ k2’ a Rs Condition Columns 
1.70 1.83 1.07 0.84 A / MeOH=65/35 SINU-PC-BDS5 1. Acebutolol  
3.37 3.89 1.15 0.94 B / MeOH =80/20 SINU-PC-BDS3 
0.98 1.59 1.62 2.46 A / MeOH=65/35  SINU-PC-BDS5 2. Alprenolol 
3.12 4.47 1.43 1.79 B / MeOH =70/30  SINU-PC-BDS3 
2.80 5.37 1.92 2.49 Hexane/IPA= 90/10  SINU-PC-BDS5 3. Metoprolol 
2.01 3.62 1.80 2.88 Hexane/IPA=90/10  SINU-PC-BDS3 
4. Pindolol 0.53 0.67 1.27 0.94 A /MeOH= 65/35 SINU-PC-BDS5 
4.07 4.92 1.20 1.80 H2O/CH3CN=70/30  SINU-PC-BDS5 
1.33 1.61 1.21 1.30 H2O/CH3CN=60/40  SINU-PC-BDS3 
1.57 2.87 1.83 3.26 A / MeOH=65/35  SINU-PC-BDS5 
1.85 2.61 1.41 1.73 A / MeOH=60/40  SINU-PC-BDS3 
2.65 3.57 1.35 1.26 Hexane/IPA= 90/10  SINU-PC-BDS5 
5. Propranolol 
1.40 1.96 1.40 1.83 Hexane/IPA=90/10  SINU-PC-BDS3 
1.53 2.90 1.89 3.24 A /MeOH= 65/35  SINU-PC-BDS5 6. O-Acetyl propranolol 1.88 2.50 1.32 1.21 A / MeOH=60/40  SINU-PC-BDS3 
0.03 0.38 11.6 2.29 A / MeOH=65/35  SINU-PC-BDS5 7. Isoproterenol 
0.96 1.42 1.48 1.86 Buffer1/MeOH=60/40 SINU-PC-BDS3 
Mobile phase: A: 1% TEAA, (pH 4.65); B: 1% TEAA (pH 5.12) 
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Alprenolol   
1% TEAA (pH 4.1) / MeOH = 60/40 (v/v)  
t1 = 16.12 
t2  = 24.38 
k1 = 1.30 
k2 = 2.48 
a = 1.91 







Figure 2.6 Chromatogram of alprenolol on SINU-PC. 
Due to the complicated structures of these drugs, the enantioseparation 
mechanism is hard to predict. Inclusion complex, H-bonding, p-p  interaction, dipole-
dipole interaction and steric hindrance may contribute to the enantioseparation. In 
particular, when the analytes achieve separation in RP, their molecular size, shape, 
spatial geometry and polarity may affect stabilities of the inclusion complexes formed 
with b-CDs thus affecting their enantioseparations greatly.  
The aromatic moiety in molecules of b-blockers may have the ability to share 
electrons with the glycosidic oxygens in the CD cavity, given the proper orientation.51, 
196 Meanwhile, the hydroxyl and amines groups present in their molecules are also 
available for H-bonding, presumably with the -OC(O)NH groups in CSPs. p-p 
Interaction may be possible between the aromatic rings present in both the analytes and 
CSPs. All these interactions tend to make the analyte molecules more rigid which 
adopt higher energy and less preferred conformations, thus, improving the 
enantioseparation.  
Alprenolol and oxprenolol gave very different results under the same conditions 
although their chemical structures are similar except for the substituted groups which 
are -CH2CH=CH2 and –OCH2CH=CH2, respectively. It is obvious that the stronger e-
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donating ability of the latter leads to a more e-excessive and consequently more p-
basic aromatic ring, which results in its poor p-p interaction with CSP whose aromatic 
rings are also p-basic. The higher a and Rs of alprenolol may be attributable to the 
increase in p-p  interaction between the solute and CSPs.  
It was previously reported116-117 that the presence of two aromatic rings in 
analytes may accentuate resolution because of the tight fitting of the two aromatic 
rings into the cavity of native b-CD. However, it was not observed with our CSPs in 
that neither propranolol nor pindolol showed enhanced enantioseparation over other 
analogues. With our CSPs, this may be attributable to the introduction of a large 
amount of the phenyl or naphthyl carbamate groups which greatly expand the cavity of 
CD, hence making the complexing interaction less crucial to other decisive interactions 
such as H-bonding and p-p  interactions.  
Most of the b-blockers have only one stereogenic center in the molecule except 
for labetalol and nadolol. Labetalol has two stereogenic centers thus gives two pairs of 
enantiomers. Nadolol has 3 stereogenic centers but only isomers of the cis-cyclohexyl 
diol are present. On CSPs with phenyl or naphthyl carbamate groups, labetalo l and 
nadolol afforded three peaks with one pair of enantiomers separated. (Figure 2.7) 
Similar to racemic (1-aryl) ethanols, (Table 2.8) some of the analytes could be 
separated under various conditions, such as NP / polar organic / RP. Propranolol is a 
typical example that it could be separated in mixture of hexane/IPA, water (buffer) 
/CH3CN and water (buffer)/MeOH. Typical chromatograms and enantioseparations of 
propranolol on SINU-PC-BDS3 and SINU-PC-BDS5 are summarized in Figure 2.8. 
As discussed for 1-(4-chlorophenyl) ethanol and 1-(4-bromophenyl) ethanol under 
various conditions, the results demonstrated that the CSPs are real bi- functional that 
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Figure 2.8 Enantioseparations of propranolol on SINU-PC-BDS3 and SINU-PC-
BDS5. 
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C. Atropine and scopolamine derivatives 
Atropine and scopolamine belong to the tropane alkaloid family which can be 
obtained from various solanaceous plants.197-198 Homatropine is a synthetic alkaloid 
which is commercially available. They have been found extensive applications in 
pharmaceutical preparations as anticholinergic, antispasmodic and preanesthesic 
agents.199 
The chiral resolutions of racemic atropine, homatropine and scopolamine by 
HPLC, TLC and CE have been described in a few reports. For example, the 
enantioseparations of atropine, homatropine and scopolamine on a chiral b-CD bonded 
phase were investigated by Armstrong200 and Schill,143 while Arvidsson201 achieved 
the enantioseparation of racemic atropine and homatropine on a protein bonded LC 
column and a1-acid glycoprotein-bonded stationary phase, respectively. Tang202 used a 
cellulose-bonded CSP to separate homatropine, while that for atropine on silica gel 
impregnated with optically active acid, L-aspartic acid (0.03%) as the chiral selector, 
was reported by Bhushan.203 
In this thesis, eight tropinyl and piperidinyl esters derived from atropine and 
scopolamine namely TCPA, TCPG, TCPP, TPP, NCPA, NCPG, NCPP and NPP 
(Structures listed in Table 2.13) have been synthesized in-house which are also 
included in synthetic alkaloids.  
Atropine, homatropine, scopolamine and eight tropinyl and piperidinyl esters, 
each possessing in their molecular structure a chiral center and exists as racemates or 
single enantiomer. (Figure 2.9) Atropine and scopolamine have the same group B and 
different group A in the molecules, while homatropine has same group A but a 









































Figure 2.9 Typical structures for atropines and scopolamines 
In this thesis, atropine, scopolamine and their derivatives were tested on SINU-
ME, SINU-PC, SINU-NC, SINU-PC-BDS5 and SINU-PC-BDS3. Of which, atropine 
was separated on CSPs with phenyl /naphthyl carbamate substituents, while the other 
six achieved enantioseparations on SINU-ME. Enantioseparation of homatropine was 
not successful on these CSPs under the experimental conditions investigated. (Table 
2.12 and 2.13) 
Atropine gave excellent separation on SINU-PC-BDS3, SINU-PC-BDS5 and 
SINU-NC with the best a of 4.91 and Rs of 5.4 under the similar condition. (Table 
2.12) We also notice from Table 2.12 that the best resolution was achieved on SINU-
PC-BDS5, which further demonstrated that higher column efficiency is not the 
decisive factor for the enantioseparation ability of CSP.  
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Table 2.12 Chromatograms of Atropine.  
Atropine 
t1 = 4.10 
t2  = 8.39 
k1 = 0.36 
k2 = 1.77 
a = 4.91 








Mobile phases: 1% TEAA (pH=4.65) / MeOH = 65/35 
S/N k1’ a Rs Conditions CSPs 
A 0.39 1.48 1.18 A / MeOH=60/40  SINU-NC 
B 0.36 4.91 5.40 B / MeOH=65/35  SINU-PC-BDS5 
C 1.18 1.97 4.00 C / MeOH=60/40  SINU-PC-BDS3 
Mobile phase: A: 1% TEAA(pH 4.1); B: 1%TEAA (pH 4.65); C: 1% TEAA(pH 5.12). Flow rate: 1.0 ml 
min-1 for BDS5 and 0.5 ml min-1 for BDS3 and SINU-NC; l: 225nm.  
 
Table 2.13 Separation results of atropine, homatropine and eight tropinyl and piperidinyl 
esters on SINU-ME.  
Solute Substituted k1’ a Rs Conditions 
 R1 R2     
Atropine and its derivatives 
Atropine H CH2OH 0.11 1.00 0.00 A 70/30 
Homatropine H OH 0.04 1.00 0.00 A 70/30 
TCPA H 
 
1.13 1.26 1.41 A 60/40 
TCPG OH 
 
0.71 1.37 1.44 A 72/28 
TCPP CH3 
 
4.42 1.11 0.36 A 70/30 




1.17 1.31 1.65 A 62/38 
NCPG OH 
 
1.33 1.20 1.01 A 82/18 
NCPP CH3 
 
3.94 1.00 0.00 A 70/30 
NPP H CH3 0.18 1.00 0.00 A 70/30 
Mobile phase: A: 98 mM TEAA (pH 4.66)/ MeOH; B: 50mM phosphate (pH 7.36)/ MeOH 
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Table 2.13 summarizes the results for the 10 analytes achieved on SINU-ME, 
while the chromatograms of TCPA, TCPG, NCPA and NCPG are given in Figure 2.10. 
From these results we observe that tropine and its derivatives obtained better 
separation than the scopolamine’s derivatives in terms of higher a and Rs values. 
These results may be due to the differences in their structures. Since part A of atropine 
is more rigid than that of scopolamine, it leads to a greater energy difference between 
the [(R-solute)-CSP] and [(S-solute)-CSP] complexes thus resulting in better 
separations. 
 
10a TCPA 10b TCPG 
  
10c NCPA 10d NCPG 
  
Figure 2.10 Chromatograms for enantioseparation of TCPA, TCPG, NCPA and 
NCPG on HEPT-PC. 
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It is noteworthy that the steric hindrance has great influence on the 
enantioseparation; this is proven by the separations of atropine and TCPP. In the latter, 
the bigger cyclohexanyl group prevents the formation of the H-bonding thus largely 
decrease the chiral discrimination compared with the former. This phenomenon is also 
observed on the enantiomeric separation of NCPA which has the same cyclohexyl 
group with TCPP.  
It also can be seen from Table 2.13 that the enantioseparations of analytes were 
dependent on the ratio of buffer / MeOH when buffer concentration and pH were kept 
constant. We chose initial buffer / MeOH ratio at 70/30. Preliminary results showed 
certain analytes were discriminated at this ratio. Further manipulation of buffer/ MeOH 
ratio proved to improve recognition of enantiomeric pairs. On SINU-ME, increasing 
buffer/MeOH ratio was normally favorable for chiral recognition. This may be due to 
the weak interaction between the analytes and methyl groups on CSP. 
pH also plays an important role in the separation. Atropine has pKa value of 
9.85 and homatropine’s pKa is 9.41. As the eight synthetic derivatives have similar 
structures with atropine and homatropine, they are expected to have similar pKa values 
around 9. Therefore, changing pH may have certain effects on the separation of this 
series of compounds. TPP and TCPP were chosen as test solutes for optimization of 
pH on SINU-ME. Results show that TPP was not resolvable in TEAA/MeOH (pH 
4.66) mobile phase. Therefore, raising the pH value was considered in order to increase 
the hydrophobicity of TPP which would probably enhance the interaction with CSP. 
Initially, 50 mM phosphate buffers at pH 6.36 and 6.86 were selected but no chiral 
discrimination was observed at 50/50 buffer to MeOH ratio. After the pH values of 
buffer was further raised to 7.36 and 7.56, chiral recognition was then observed and 
further adjustment of buffer/MeOH ratio to 20/80 improved resolution. However, 
increase of buffer/MeOH ratio to 60/40 led to the loss of the enantioseparation. This is 
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probably because the increased hydrophobicity of TPP at pH 7.36 and 7.56 required 
mobile phase with stronger eluting ability to achieve discrimination.  
TCPP was resolved on this column as two broad peaks. We intended to 
optimize the pH to improve peak shape and resolution. pH values from 4.16 to 5.16 at 
intervals of 0.2-0.3 were investigated but no improvement was obtained relative to pH 
4.66 in terms of resolution and peak shape.  
 
D. Racemic primary, secondary and tertiary amines 
The chiral recognition abilities of CSPs towards the amines were investigated 
under both NP and RP using five different racemic amines including one primary 
amine, one secondary amine and three tertiary amine derivatives. Their separations are 
summarized in Table 2.14.  
The results show that to 1-phenylethylamine (S/n 1) and ketamine (S/n 2), 
which are primary and secondary amines, respectively, no enantioseparation was 
achieved using CSPs with phenyl or naphthyl carbamate groups under both NP and 
RP. However, the tertiary amines (S/n 3 to 5) afforded separations under various 
conditions. Under RP conditions, only chlorpheniramine and brompheniramine were 
resolved whereas pheniramine was not separated at all, although it could be resolved 
under NP. Chlor- and brom-pheniramine obtained chiral recognition under both NP 
and RPs. Surprisingly, towards these three analytes, SINU-NC exhibited chiral 
recognition ability under NP, although it is regarded as a typical RP-typed CSP.  
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Table 2.14 Enantioseparations of amines 
S/n Analytes  k1’ a Rs Conditions Columns 





0.23 1.00 N.A. Hexane/IPA=90/10 SINU-PC 












2.41 1.20 0.94 Hexane/IPA=90/10  SINU-NC 







1.30 1.17 1.01 A / MeOH =65/35  SINU-PC-
BDS5 
1.12 2.02 2.24 Hexane/IPA=70/30  SINU-NC 







1.28 1.17 1.14 A /MeOH= 65/35  SINU-PC-
BDS5 
Mobile phase: A: 1% TEAA (pH 4.65) 
It is interesting to note that in compounds S/n 3-5, p-substituted groups at the 
aromatic rings greatly affected their enantioseparations. When the p-substituent is a 
bromide, the compound S/n 5 gave the highest a of 2.02 and Rs of 2.24 in NP on 
SINU-NC. Meanwhile, when the p-position was substituted by a chloride, the a and Rs 
fell in between those of brompheniramine and pheniramine of 1.94 and 2.02, 
respectively, under the same condition. A similar trend could also be observed under 
RP. Therefore, when the substituents change from H-, Cl- to Br, the following trend 
was observed on the retention and enantioseparation:  
Br-pheniramine > Cl-pheniramine > pheniramine 
This trend is consistent with the separation results of the (1-aryl) ethanols 
discussed previously for similar reasons. This result also reveals that, although the 
 74
enantiomeric separation mechanism under NP and RP is different, the 
enantioseparation mode for the same analyte is similar.  
 
E. Weak acids 
To some chiral analytes, although they do not have an acidic group in the 
molecule, they can behave as a Lewis acid, which provides electron pairs during the 
process of structural transformation in certain solvent system. With benzoin for 
example, in acidic medium the epimerisation is possible based on the following 

















Figure 2.11 Structural transforming of benzoin in acidic media  
Therefore, this type of analytes is also considered as weak acids. Besides 
benzoin, dihydrobenzoin and 1,1’-binaphthol are also included in weak acids.  
In this thesis, bendroflumethiazide, benzoin, dihydrobenzoin and 1, 1’-
binaphthol were enantioseparated on our CSPs with their results summarized in Table 
2.15. Of these, bendroflumethiazide afforded enantioresolutions on the four columns 
under various conditions with the best resolution of 3.03 on SINU-PC. The other three 
analytes could only be separated on SINU-ME with low resolution without the help of 
any buffer. Figure 2.12 shows a representative chromatogram of bendroflumethiazide 
on SINU-PC-BDS5.  
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Table 2.15 Enantioseparations of weak acids  
S/n Analytes k1’ a Rs Conditions CSPs 
5.91 1.46 3.03 H2O/CH3CN=70/30 SINU-PC 
12.80 1.05 0.71 H2O/CH3CN=70/30 SINU-ME 
2.40 1.21 2.84 A / CH3CN=60/40 SINU-PC-BDS5 
1  Bendroflumethiazide 
4.46 1.20 2.67 A / CH3CN=60/40 SINU-PC-BDS3 
2  Benzoin 1.79 1.08 0.84 H2O/CH3CN=70/30 SINU-ME 
3  Dihydrobenzoin 4.88 1.15 1.21 H2O/CH3CN=70/30 SINU-ME 
4  1, 1’-Binaphthol 15.41 1.09 0.91 H2O/CH3CN=70/30 SINU-ME 
Mobile phase: A: 1% TEAA (pH 4.65), Flow rate : 1ml min-1 ; l = 225nm 
Bendroflumethiazide 
 1% TEAA (pH 4.65) /CH3CN = 60/40 
t1 = 10.21 
t2  = 11.65 
k1 = 2.40 
k2 = 2.89 
a = 1.21 















Figure 2.12 Chromatogram of bendroflumethiazide. 
These results can be explained by the structures of these analytes. 
Bendroflumethiazide has a chiral carbon next to a -NH- group and a SO2NH group, 
and consequently has a strong tendency to form H-bonds with CSPs. This can be 
proved by the fact that a stronger eluting solvent of CH3CN instead of MeOH was 
applied in the mobile phases and the best resolution was achieved on a CSP comprising 
excessive –NH and –CO- groups which provide many interacting sites for H-bonding.  
The other three samples were separated using the mobile phases comprising 
CH3CN /water on SINU-ME. In this study, TEAA and phosphate buffer with different 
concentration and pH value were applied, however, no enantioseparation was observed 
under these conditions.  
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The less enantioseparation ability for these samples on CSPs with phenyl or 
naphthyl carbamate groups may be partly due to the excessive –NH groups in the CSPs 
because the acetic groups from analytes may have strong interaction to form a salt with 




Other drugs such as proglumide and 5-(4-methylphenyl)-hydantoin were also 
tested and afforded good resolutions on the CSPs with phenyl or naphthyl carbamate 
substituents. From Table 2.16 it is noted that these compounds have a chiral carbon 
next to an -NHC=O group. Generally, racemates containing such a group will afford 
good enantioseparation on our CSPs.  
Table 2.16 Enantioseparations for other drugs in the RP mode.  
S/n Analytes Structures k1’ k2’ a Rs Conditions Columns 










2.62 2.81 1.07 0.70 A / CH3CN =60/40 BDS3 






















1.18 3.31 2.80 4.53 A / MeOH =60/40 BDS3 
Mobile phase: A: 1% TEAA(pH 4.65), B: 1% TEAA(pH 5.12); Flow rate= 0.5ml min-1 ; l = 254nm 
(2) and 225nm (1 & 3)  
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2.4.3 Comparative study on chromatographic properties of SINU-
NC and CYCLOBOND I 2000 SN columns 
With a view of investigations, differences in the chromatographic properties of 
our SINU-NC and a commercial column, CYCLOBOND I 2000 SN (CYCLOBOND 
in follows), were selected to conduct the comparative study on the chiral recognition 
abilities using a variety of racemates. The consideration of choosing this commercial 
column is based on the similarity in both structure and separation mechanism with 
SINU-NC.  
Difference SINU-NC CYCLOBOND I 2000 SN 
































Immobilization Pre-immobilization Post-immobilization 
Functionalization Full functionalization Partial functionalization 
Structure of CSPs  Well-defined structure Obscure structure 
Surface properties of 
silica gel 
Amino functionalised silica gel Unfunctionalized silica gel 
Linkages to silica gel Urea linkage Ether linkage 
Figure 2.13 Diagrammatic difference in SINU-NC and CYCLOBOND I 2000 SN 
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Figure 2.13 gives six major differences in the two CSPs. Firstly, the 
substituents for SINU-NC and CYCLOBOND are 1-naphthyl carbamate and S-(+)-1-
naphthylethyl carbamate, derived from the 1-naphthyl isocyanate and S-(+)-1-
naphthylethyl isocyanate as substituted reagents, respectively. The introduction of one 
chiral center in the substituent of CYCLOBOND is expected to enable the resulting 
CSP to exhibit unique enantioseparation abilities, such as reversed elution orders for 
enantiomers.138 Secondly, the linkages between the chiral selectors and silica gel are 
urea and ether linkages for SINU-NC and CYCLOBOND, respectively, on account of 
different immobilization approaches.  
The synthesis procedure also has key difference. CYCLOBOND was prepared 
by the pre- immobilization procedure, which involved the immobilization of pristine b-
CD onto silica gel before functionalizaiton, thus resulting in the partial 
functionalization of CSP on account of the following heterogeneous solid-liquid phase 
reaction, thus, leading to not well-defined structure of CSP. In comparison, SINU-NC 
was prepared by the pre-functionalized procedure that involving simple homogeneous 
reaction, thus leading to the well-defined structure and full functionalization of b-CD 
chiral selectors.  
Different chromatographic and enantioseparation properties will be expected on 
account of the differences in the structures of these two CSPs. 
Using biphenyl as the test probe, CYCLOBOND gave column efficiency of 
42,000 plates /meter which is higher than 32,000 obtained on SINU-NC.  
Applying a wide variety of racemates, enantioseparation results showed that 
SINU-NC was effective to b-adrenergic blockers and amine-containing racemic 




1 Simple aromatic alcohols 
Several aromatic alcohols such as 1-(4-bromophenyl)- and 1-(4-chlorophenyl) 
ethanol, which obtained good enantioseparations on SINU-NC were tested on these 
two columns under the same conditions. However, no enantioseparation result was 
obtained on CYCLOBOND.  
 
2 Pharmaceutical analytes 
Various pharmaceutical analytes such as amines, b-blockers and weak acids 
were tested on the two columns. Table 2.17 summarizes the enantioseparations of 
analytes obtained on CYCLOBOND.  
Table 2.17 Enantioseparations on CYCLOBOND I 2000 SN. (Structures can be found at 
Appendix I) 
S/n Analytes k1’ k2’ a Rs Conditions 
1. Ketamine 1.55 1.63 1.06 0.55 A 
2. Proglumide 3.35 4.18 1.26 3.20 A 
3. Praziquantel 0.70 0.76 1.07 0.60 A 
4. Tolperisone  0.96 1.09 1.14 1.25 C / CH3CN = 80 / 20  
5. Ancymidol 3.65 4.17 1.14 1.38 B/CH3CN= 80/20  
6. Tetrahydrozoline 0.38 0.45 1.11 0.80 C / CH3CN = 80 / 20  
7. Promethazine  1.56 1.74 1.11 0.80 A 
8. Propranolol 3.17 3.29 1.04 0.50 A 





  C / CH3CN = 85 / 15  
11. Bendroflumethiazide 3.19 3.66 1.15 1.50 C / CH3CN = 70 / 30  
12. Indapamide 3.04 3.57 1.17 2.00 B/CH3CN= 80/20  
13. Benzoin 5.05 5.26 1.04 0.38 C / CH3CN = 85 / 15  
14. Dihydrobenzoin 1.79 1.92 1.07 0.55 C / CH3CN = 80 / 20  
15. Althiazide 3.82 4.05 1.06 0.62 B / CH3CN = 80 / 20  
16. Ibuprofen 0.98 1.09 1.12 1.00 C / CH3CN = 20 / 80  
17. Suprofen 2.58 2.70 1.05 0.40 C / CH3CN = 60 / 40  
Mobile phases: A: CH3CN /MeOH/ TEA/ AA (95/5/0.2/0.3); B: 1%TEAA (pH: 7.1), C: 1%TEAA (pH: 
4.5).Flow rate = 1.0 ml min-1 for A and 0.5 ml min-1 for B and C 
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Results from Table 2.17 and the data on SINU-NC summarized previously 
indicate that the two columns exhibit great difference in the species for the analytes 
and optimal HPLC conditions for the enantioseparation. Table 2.18 gives the detailed 
information about the analytes suitable for each column. 
Table 2.18 indicates that for amines, these two columns have their own 
preferable analytes. Atropine, chlorpheniramine and brompheniramine etc which 
obtained excellent enantioseparations on SINU-NC were not resolved on 
CYCLOBOND. However, some amines such as ketamine, proglumide etc could be 
separated exceptionally on latter. Of all the 11 samples, only tolperisone was separated 
on both columns with resolution of 1.54 on SINU-NC and 1.25 on CYCLOBOND, 
respectively. 
Table 2.18 Enantioseparations of drugs onCYCLOBOND and SINU-NC 


























The situation is similar for b-blockers. For example, 9 b-blockers, including 
propranolol, acebutolol, alprenolol, oxprenolol, pindolol, metoprolol, isoproterenol and 
two multi-chiral–center enantiomers: nadolol and labetolol which were successfully 
separated on SINU-NC were tested on the CYCLOBOND. However, only propranolol, 
metoprolol and labetolol were separated with low resolutions on the latter.  
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The reversed trend was observed for weak acids. Most of the weak acids, 
including ibuprofen, suprofen, althiazide, dihydrobenzoin were separated on 
CYCLOBOND columns but exhibited poor recognition or even non-separation on 
SINU-NC.  
Based on the chromatographic data in Table 2.17, we may be able to draw a 
conclusion that Astec CYCLOBOND column seems likely more suitable for weak 
acids and amino acids, whilst SINU-NC is more effective in amines, b-blockers and 
substituted (1-aryl) ethanols.  
The two CSPs also exhibited difference in the mobile phases conditions to the 
same analytes. For example, SINU-NC generally applies simple mobile phase 
comprising mixture of aqueous buffer (mostly it is 1% TEAA with different pH value) 
and MeOH, while CYCLOBOND always adopt the mixture of CH3CN and buffer or 
polar-organic phase consisting of MeOH, CH3CN and a small amount of modifier such 
as TEA and AA.  
These phenomena may probably be attributed to the different structures of 
CSPs. SINU-NC has excessive –NHC=O groups in chiral selectors and amino groups 
in silica gel, which may have strong retentions with analytes particularly to acids, and 
result in the poor resolutions. However, to CYCLOBOND, the less –NHC=O groups 
and native surface of silica gel will help to improve the resolution for acids.  
The chiral centers of the substituted groups did not show much contribution to 
the improvement of enantioseparation in RPs which adopt the inclusion complex as the 
dormant factor for chiral recognition. Since the chiral center is relatively far from the 
cavity, it may form a competitive interaction with the chiral cavity thus weakening the 
formation of inclusion complex, which results in a decreasing enantioselectivity. 
However, it may lead to the reversing elution orders for enantiomers under a different 
separation mechanism.  
 82
Another possible reason may be due to the different enlargement of the CD 
cavity by the different substituted groups. To SINU-NC, the 1-naphthyl carbamate 
groups are very rigid that the extended opening mouth of b-CD could not transform 
easily. However, to CYCLOBOND, naphthyl groups have the possibility of rotating 
freely along the chiral carbon, affording a more facile inclusion cavity for bulky 
solutes by facilitating the formation of the inclusion complex to let the bulky 
molecules enter deeply into the cavity. It can be assumed that bulky samples may be 
better resolved on CYCLOBOND column. This can be demonstrated by the 
enantioseparations of three compounds: promethazine, bendroflumethiazide and 
tolperisone which have relatively larger steric structures. (For the first two compounds, 
at least two aromatic rings share one plane. The last one, is also sterically encumbered 
due to the presence of extensive p-p  electron delocalisation). These analytes have 
relatively good separation in comparison to that on SINU-NC. Furthermore, the above 
results can also be proven by the chiral recognition of some sterically encumbered 
racemic compounds such as althiazide, indapamide, ancymidol and tetrahydrozoline on 
CYCLOBOND. Obviously, for this type of compounds, CYCLOBOND is a suitable 
choice.  
From Table 2.18 we also note that SINU-NC is weakly basic in nature while 
CYCLOBOND is acidic. This is supported by the fact that most of the weak acids such 
as ibuprofen and suprofen cannot be enantioseparation on SINU-NC with long 
retention time and broad tailing peaks, while some of samples did not elute out. On the 
other hand, the reverse trend was observed on the commercial column where basic 
samples could not afford the enantioseparation. The failure of separation for 
dihydrobenzoin can be explained by the formation of intramolecular H-bonding which 
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In chapter 2, a series of novel b-cyclodextrin (CD)-bonded-chiral stationary 
phases (CSPs) were prepared by immobilizing mono-(6-azido-6-deoxy)-
perfunctionalized-b-CDs onto the surface of amino-functionalized silica gel via single 
urea linkage.153-156 These CSPs exhibited excellent enantioseparation abilities and 
durability.  
In this chapter, on the basis of our previous work, we report on the extension to 
perfunctionalized-b-CD bonded onto silica gel via multiple urea linkages.204 The 
procedure involved immobilizing heptakis-(6-azido-6-deoxy-2,3-di-O-phenyl- or -
naphthylcarbamoylated)-b-CDs onto the surface of amino-functionalized silica gel via 
multiple urea linkages employing the Staudinger reaction. These multiple linked 
functionalized-CDs on the silica gel present also the likelihood of urea linkages 
between the CD molecules. 
On account of this structure, the CSPs have strong hydrophobic ability and 
improved stability, particularly in mobile phases with high aqueous content, and thus 
are expected to exhibit novel enantioseparation ability. Accordingly, a wide range of 
structurally divergent racemic drugs / compounds were successfully separated into 
their enantiomers under both normal and reversed-phases (NP and RP) conditions. 
Chromatographic results indicated that b-adrenergic blockers (amino alcohol), racemic 
tertiary, secondary and primary amines were readily separated using a mixture of 
methanol (MeOH) and aqueous triethylammonium acetate (TEAA) buffer. The optimal 
pH value for the separation falls in the range of 4.65 to 6.3. With atropine and 
isoproterenol, excellent enantioseparation with selectivities of a>5 are easily 
attainable. 
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3.2 Syntheses  
3.2.1 General overview 
The synthetic schemes for preparation for the multi- linked CSPs are similar to 
that for the preparation of mono azido-perfunctionalised b-CD-CSPs and are depicted 
in Scheme 3.1. Heptakis iodinated b-CD (3.1)205, 206 was reacted with sodium azide to 
afford the heptakis-(6-azido-6-deoxy)-b-CD (3.2).207 It was then derivatized by 
treatment with phenyl isocyanate or 1-naphthyl isocyanate to afford the heptakis-(6-
azido-6-deoxy-2,3-di-O-perfunctionalized)-b-CDs (3.3a-b). Thereafter, reaction of 
3.3a/b with amino-functionalized silica gel afforded the required CSPs. The resulting 












































a: R= phenylcarbamate;  b: R= 1-naphthylcarbamate 
Reagents and conditions: 
i. Phenyl isocyanate / 1-naphthyl isocyanate, / pyridine / 95 °C, 12 hrs 
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To ensure the full substitution of primary hydroxyl groups by azides, a good 
leaving group should be used, followed by the nucleophilic replacement reaction of 
azides. Defaye 205 reported a bromination procedure using Br2/PPh3 in DMF, but this 
afforded a difficult work-up process. In 1996, Gorin used an improved procedure 
involving the preparation of Vilsmeier-Haack reagent [(CH3)2NCHBr]+Br— which 
reacted with unprotected CD. 206, 208 However, the bromide moiety does not lend itself 
to facile SN2 reactions with the azide anion. Accordingly, we herein used iodine/ PPh3 
since the iodo moiety is easily displaced by azide group in DMF with high yields.  
The free 2-, 3-O secondary hydroxyl groups were fully functionalized by the 
phenyl isocyanate/1-naphthyl isocyanate under the same condition reported in Chapter 
2. After purification, the functionalized b-CDs (7PPHCD and 7PNACD for 3.3a and 
3.3b, respectively) were immobilized onto the surface of amino-functionalized silica 
gel.  
 
3.2.2 Preparations of the HPLC columns HEPT-PC and HEPT-NC 
According to the procedure described in 8.3.3, 3.2 g of 7PPHCD-CSP or 7-
PNACD-CSP 3.4a/b was packed into stainless steel HPLC columns to give the 
columns named HEPT-PC / HEPT-NC. 
 
3.3 Characterizations  
The proposed structures of the b-CD derivatives and derived CSPs were 
corroborated by elemental analysis, NMR and FT-IR.  
Table 3.1 summarizes the yields and physical properties of the b-CD 
derivatives obtained. From the table, we may notice the high yield of iodination 
process, which is attributable to the high reactivity of the hydroxyl groups at 6-O 
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position of b-CD. The iodo groups were also easily converted to azide groups with 
high yield of 82%. After full functionalization of the remaining hydroxyl groups, the 
CD derivatives remained optical properties and thus play as a real chiral selector for 
enantioseparation of racemates. 
Table 3.1 Physical properties of the b-CD derivatives 
Compounds b-CD derivatives Yield (%) Mp (°C) 25][ Da   
3.1 7IODOCD 84 205.7 +180° (c 1.0, DMSO) 
3.2 7AZIDOCD 82 220.4 +240° (c 1.0, DMSO) 
3.3a 7PPHCD 56 202-204.8 +150° (c 0.05, in CHCl3) 
3.3b 7PNACD 48 204-206.8 +155° (c 0.05, in CHCl3)  
 
The iodo groups were substituted by azide groups via a SN2 reaction and the 
resulting structures are confirmed by the appearance of the azido vibrational bands at 
2106 cm-1. After full functionalization, phenyl/ naphthyl carbamate groups were 
introduced with structures confirmed by the characteristic N-H stretching in the region 
of 3393-3309 cm-1, aromatic C-H stretching at 3053 cm-1, C=O stretching of the urea 
linkages at 1738 cm-1, aromatic C=C ring stretching of the phenyl group at 1542 cm-1 
and 1497 cm-1, symmetric C-O-C stretching at 1041 cm-1 and C-H out of plane 
bending at 767 cm-1. In particular, the appearance of the vibrational bands in the range 
of 1800-1600 cm-1 attributable to carbonyl stretching in 7PPHCD and 7PNACD 
provided corroborating evidence for the occurrence of derivatization. 
Full functionalization of the hydroxyl groups with phenyl carbamate groups at 
2- and 3-O position of b-CD residues are also confirmed by matrix-assisted laser 
desorption ionization mass spectrometry (MALDI-MS) using 2,4,6-trihydroxy 
acetophenone (THAP) as matrix. The intense and exclusive molecular ion [M+Na]+ in 
Figure 3.1 further confirmed the proposed structure of 7PPHCD. 
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2774.3901 2963.5132 997.9722 2670.2903 2984.5831 1354.7147 957.7874 
2759.2517 1171.2247 2525.2368 3124.5846 921.7751 1541.2678 2250.3053 2067.6323 3678.9528 3308.6654 
 
Figure 3.1 MALDI-MS spectra of heptakis-(6-azido-6-deoxy-2,3-di-O-
phenylcarbamoylated)-b-CD. (C140H133O42N35, M = 2977.80 Da) 
The existence of the cross- linkages between the CD molecules is proposed 
because in the presence of CO2/THF/PPh3, the azide group can easily react with 
primary amine or condense with each other to form stable urea linkages.209  
The carbon contents in the elemental analysis as well as the appearance of FT-
IR vibrational bands in the 1800-1600 cm-1 range attributable to carbonyl stretching in 
CSPs provide for convincing evidence that the CD moieties have been successfully 
immobilized onto silica gel. (Table 3.2) The experimental results for 3.1, 3.2 and 3.3 
are very close to the calculated values, and therefore confirm the complete substitution 
of the iodo, azido and perphenyl / naphthyl carbamate groups of b-CDs. 
More importantly, the determined carbon contents in 7PPHCD-CSP and 
7PNACD-CSP are 13.78 and 8.35%, respectively, are much higher compared with that 
of amino-functionalized silica gel (3.42%), which further corroborated the strong 
evidence of the immobilization of chiral selectors. 
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However, in comparison to the mono azido-perfunctionalized-b-CDs, heptakis 
azido-functionalized-b-CDs have a lower carbon content, which seems to conflict with 
the assumption that the cross- linking of the functionalized-b-CD may result in a higher 
concentration of introduced b-CDs onto the silica gel. This may be explained by the 
large steric hindrance of the functionalized-b-CD. Since the reaction of azide groups 
with the amino groups is faster than that between azide groups themselves, the chiral 
selectors will be immobilized onto silica gel preferably. However, not all the seven 
azido groups can fully react with amino groups because of the large steric hindrance 
and the rigid structure of the b-CD. Since one b-CD molecule may have more than one 
linkage with the silica gel, the surface of the silica gel is easily saturated. Therefore, 
the number of b-CDs linked directly onto the silica gel will be lower than that of the 
mono-azido-b-CD which has only one linkage with the silica gel. Although the rest of 
the free azide groups may react with other b-CDs, it could not increase the coverage of 
b-CD onto the surface of the silica gel. This may explain the result of the lower carbon 
content of the 7PPHCD-CSP. 
Table 3.2 Elemental analysis of the b-CD derivatives, amino-silica gel and CSPs  
Materials Empirical formula 
MW 
(g/mol) Expected value (%) Determined value (%) 
3.1 C42H63O28I7 1904.98 C, 26.46; H, 3.31% C, 27.11; H, 2.96% 
3.2 C42H63N21O28 1309.98 C, 38.47; H, 4.81; N, 22.44% C, 37.90; H, 4.85; N, 22.11% 
3.3a C140H133O42N35 2977.80 C, 56.45; H, 4.50; N, 16.46% C, 56.65; H, 4.47; N, 16.84% 
3.3b C196H161O42N35 3675.0 C, 64.00; H, 4.38; N, 13.33%  C, 64.55; H, 4.47; N, 12.99% 
NH2-silica gel NA NA NA C, 3.42; H, 0.9; N, 1.11%  
3.4a NA NA NA C, 13.78; H, 2.02; N, 2.38%  
3.4b NA NA NA C, 8.35; H, 0.48; N, 1.75%  
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3.4 Enantioseparation abilities of the CSPs 
 
3.4.1 Column efficiencies, theoretical heights of plates and surface 
concentrations 
Using biphenyl as the test probe in mobile phase of hexane/2-propanol=90/10, 
column efficiencies for HEPT-PC and HEPT-NC are 38,000 and 35,000 plates per 
meter respectively. Therefore, the theoretical heights of plates are 0.026 and 0.029 mm 
per plate, respectively. The surface concentrations of the chiral selectors on the silica 
gel cannot to be measured because of the undefined structures of the CSPs.  
 
3.4.2 Enantioseparation results on HEPT-PC and HEPT-NC 
1 Substituted (1-aryl) ethanols 
Table 3.3 summarizes the enantioseparation results for six racemic (1-aryl) 
ethanols on HEPT-PC, while no enantioseparation of these samples were obtained on 
HEPT-NC. Out of the six samples, five exhibited excellent enantioseparations, while 
no enantioseparation was observed for the sixth sample, 1-phenyl-2-propanol, with the 
chiral carbon one remove from the aromatic ring.  
With chiral aromatic compounds S/n 1 to 4, it is apparent that the retention 
time, selectivity (a) and resolution (Rs) increased when the para substituent on the 
aromatic ring is changed from methyl to H to chloro / bromo. This tendency is similar 
to that of the mono-urea-linkaged CSPs described in Chapter 2. This indicates that 
although the structures of CSPs are slightly different, the enantioseparation occurs in 
the similar mode towards same analytes.  
Similar to that for SINU-PC, steric effect of analytes also appears to play an 
important role. Thus, o-bromo compound 5 was less efficiently resolved than the para 
isomer 4. This may be due to its larger steric hindrance in its interaction with the CSP.  
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No enantioseparation was observed for compound S/n 6 indicating that the 
chiral carbon adjacent to the aromatic ring may be essentia l for the enantioseparation. 
Table 3.3 Enantioseparations of substituted (1-aryl) ethanols 






























N. A. N. A. N. A. 
Mobile Phase: (Hexane / IPA = 90 / 10 )  








k1=1.02, a=1.65, Rs=4.03 
Water/MeOH=90/10 







k1=1.10, a=1.98, Rs=5.62 
Water/MeOH=90/10  
k1=9.78, a=1.31, Rs=2.97 
Figure 3.2 Chromatograms for 1-(4-chlorophenyl)- and 1-(4-bromophenyl) ethanol 
under both NP and RP  
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Similar to SINU-PC, HEPT-PC also proved to be a real multi-model CSP in 
that some samples can undergo enantioseparations under both NP and RP. 
Representative chromatograms for compounds S/n 3 and 4 under both NP and RP are 
shown in Figure 3.2.  
 
2 Primary, secondary and tertiary amines 
We investigated the enantioseparation abilities of HEPT-PC and HEPT-NC 
towards six different primary, secondary and tertiary racemic amines. Table 3.4 
summarizes their retention factors (k1’) for the first eluted enantiomers, selectivities 
(a) and resolutions (Rs).  
Table 3.4 Enantioseparations of amines  
S/n Racemates k1’ a Rs CSPs 
1  Phenylethylamine 0.16 1.00 -- HEPT-PC 
2  Ketamine 0.48 1.10 0.71 HEPT-PC 
0.90 1.27 1.22 HEPT-PC 3  Bupivacaine 1.00 1.16 0.69 HEPT-NC 
4  Pheniramine 0.96 1.12 0.73 HEPT-PC 
5  Chlorpheniramine 2.16 1.20 1.18 HEPT-PC 
6  Brompheniramine 2.27 1.25 1.77 HEPT-PC 
Mobile phases:  for HEPT-PC: MeOH/ 1% TEAA Buffer (pH 5.33) = 30 / 70 ;  
for HEPT-NC: MeOH/ 0.5 % TEAA Buffer (pH 5.0) = 15 / 85) 
The results indicate that the enantioseparation ability of HEPT-PC increased 
from primary through secondary to tertiary amines. In details, no enantioseparation 
could be achieved for 1-phenylethylamine (a primary amine) (S/n 1) on the two CSPs, 
while the Rs and a values of ketamine (a secondary amine) (S/n 2) fell in between 
those of primary and tertiary amines. Among these amines, tertiary amines afforded the 
best enantioseparation results. Thus, the resolution order of this column towards these 
samples is tertiary > secondary > primary amine. 
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In the case of tertiary amines S/n 4 to 6, the enantioseparation was improved 
from H through chloro to bromo substituents at the p-position of the aromatic ring of 
analytes. When substitutent is a bromide, the brompheniramine separated the best with 
an a of 1.25 and Rs of 1.77. When the substituents are Cl- and H-, the 
enantioseparation decreased. Consequently, the resolution is in the order of Br-
pheniramine > Cl-pheniramine > pheniramine, which is consistent with the separation 
results discussed in Chapter 2.  
On the other hand, HEPT-NC exhibited poor enantioselectivity in comparison 
to HEPT-PC where only bupivacaine (S/n 3) of the six racemic amines was separated 
with poor a and low Rs. 
 
3 b-Adrenergic blockers  
Among ten b-adrenergic blockers, seven were separated on HEPT-PC and three 
afforded poorer enantioseparation on HEPT-NC, under both NP and RP conditions. 
(Table 3.5) Good enantioseparations were achieved for most of these drugs under RP 
conditions using mixtures of aqueous TEAA buffer and MeOH.  
Table 3.5 Enantioseparations of b-blocking agents  
S/n Racemates k1’ a Rs Conditions CSPs 
0.22 5.06 3.88 MeOH / A=20/80  HEPT-PC 1  Isoproterenol 
0.09 3.80 0.91 MeOH / C=35/65  HEPT-NC 
2  Acebutolol 1.39 1.30 3.00 MeOH / A=20/80  HEPT-PC 
2.02 1.50 2.18 MeOH / A=20/80  HEPT-PC 3  Alprenolol 
1.19 1.28 0.64 MeOH / C=35/65  HEPT-NC 
4  Atenolol 0.34 1.31 0.98 MeOH / A=30/70  HEPT-PC 
5  Oxprenolol 1.10 1.09 <0.5 MeOH / A=30/70  HEPT-PC 
4.29 1.43 1.79 Hexane / IPA=80/20  HEPT-PC 6  Propranolol 
2.23 1.71 3.30 MeOH / C=35/65  HEPT-NC 
7  Metoprolol 4.04 1.26 1.18 Hexane / IPA=90/10  HEPT-PC 
Mobile Phases: A: 1% TEAA (pH 4.33); B: 1% TEAA (pH 5.33), C: 1% TEAA (pH 4.65) 
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In particular, on HEPT-PC, isoproterenol afforded the best selectivity of 5.06 
and resolution of 3.88. This was anticipated since it has a chiral center at the a position 
of the aromatic ring while other drugs have the chiral centers more remote from the 
chiral center. (See structures in Appendix I) This tendency coincided with the 
separation of aromatic alcohols discussed in Chapter 2, where the best resolution 
occurred when the chiral center was at the a-position of the aromatic moiety.  
Similar to the results for b-blockers discussed in Chapter 2, alprenolol and 
oxprenolol gave very different results under the same conditions although their 
chemical structures are similar except for the substituents  –CH2CH=CH2 and –
OCH2CH=CH2, respectively. Alprenolol was successfully separated on the two CSPs, 
while oxprenolol was only separated on HEPT-PC. Of the seven separated b-blockers, 
metoprolol S/n 7 could only be separated in NP.  
Similar to the results in Chapter 2, propranolol was separated under different 
conditions on HEPT-PC. Figure 3.3 depicts its representative chromatograms and 




k1=0.87, a=1.11, Rs=0.55 
Water/MeOH=70/30 
k1=5.53, a=1.41, Rs=0.97 
Figure 3.3 Enantioseparation of propranolol under both NP and RP on HEPT-PC.  
  Flow rate: 1.0 ml min-1for NP and 0.5 ml min-1 for RP. Detection: 254 nm. 




4 Nonprotolytic drugs and weak acids 
Enantioseparation of bendroflumethiazide, benzoin and dihydrobenzoin was 
attempted on these two columns and the results are summarized in Table 3.6. On 
HEPT-PC, benzoin and dihydrobenzoin were separated under RP using the mixture of 
TEAA/ MeOH, while bendroflumethiazide gave good enantioseparation with Rs > 3 
using a mobile phase comprising CH3CN and water without any additive. However, on 
HEPT-NC, only bendroflumethiazide obtained enantioseparation without the help of 
any additive.  
Table 3.6 Enantioseparations of nonprotolytic drugs and weak acids.  
S/n Racemates k1’ a Rs Conditions CSPs 
5.80 1.49 3.76 CH3CN / B=30/70 HEPT-PC 1  Bendroflumethiazide 
7.78 1.10 0.74 CH3CN / B=30/70 HEPT-NC 
2  Benzoin 1.18 1.09 1.00 MeOH / A=50/50 HEPT-PC 
3  Dihydrobenzoin 4.90 1.05 0.77 MeOH / A=30/70 HEPT-PC 
Mobile Phases: A: 1% TEAA (pH 5.60); B: Water 
As discussed in Chapter 2, bendroflumethiazide afforded enantioseparations 




k1=1.10, a=4.42, Rs=8.3 
MeOH/Water=30/70 
k1=6.41, a=1.48, Rs=2.78 
Figure 3.4 Enantioseparation of bendroflumethiazide under both NP and RP.  
  Flow rate: 1.0 ml  min-1 for NP and 0.5 ml min-1 for RP. Detection: 254 
nm. Injection volume: 20 ml. 
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Benzoin and dihydrobenzoin were separated by using TEAA as the additive in 
the buffer/ MeOH system. The results indicate that the resolution of dihydrobenzo in 
was lower than that of benzoin on the same column.  
 
5 Miscellaneous 
Other drugs, such as proglumide, praziquental and 5-(4-methylphenyl)-
hydantoin also afforded excellent enantioseparations on HEPT-PC, but not on HEPT-
NC. (Table 3.7) We observe that chiral drugs with chiral carbon adjacent to –NHC(O)- 
can be successfully separated. This may be explained by the rigid structure of such 
group and the ease of forming the interactions required for enantioseparation.  
Table 3.7 Enantioseparations of other drugs on HEPT-PC.  
S/n Racemates k1’ a Rs Conditions 
1  Proglumide 3.86 1.09 1.44 A / MeOH = 50/50 
2  Praziquental 4.89 1.14 1.42 A / MeOH = 50/50 
3  5-(4-methylphenyl)-hydantoin 1.55 1.18 1.70 B / MeOH = 80/20 
Mobile Phases: A: 1% TEAA (pH 5.33); B: 1% TEAA (pH 4.67) 
 
6 Atropine and derivatives of scopolamine 
Atropine and derivatives of scopolamine were also tested on HEPT-PC with the 
enantioseparation results summarized in Table 3.8. Results indicate that this series of 
drugs afforded good enantioseparation on this column.  
Table 3.8 Enantioseparations of atropine and its derivatives on HEPT-PC.  
S/n Racemates k1’ a Rs Conditions 
1  Atropine 0.15 5.62 5.26 A / MeOH = 50/50 
2  TCPP 0.39 1.45 1.62 A / MeOH =70/30 
3  NCPA 0.56 1.34 1.29 A / MeOH =70/30 
4  NCPP 0.36 1.32 1.03 A / MeOH =70/30 
5  NPP 2.94 1.13 0.90 B / MeOH =80/20 
Mobile Phases: A: 1% TEAA (pH 4.67); B: 1% TEAA (pH 5.05 )  
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Figures 3.5 and 3.6 also gave the chromatograms of atropine, TCPP (one 
derivative from atropine) and NCPA (one derivative from scopolamine) under various 
conditions on HEPT-PC.  
Atropine 
 
MeOH/ TEAA (1% , pH: 4.65)= 50/50 
Figure 3.5 Representative chromatogram of enantioseparation of atropine. 
6c NCPA 6d TCPP 
  
Figure 3.6 Chromatograms for enantioseparations of TCPP and NCPA on HEPT-PC. 
 
 
3.4.3 Stability of the columns under RP condition 
The network polymer structures afforded these CSPs with good stability in a 
mobile phase with high aqueous content. Some drugs, such as isoproterenol, can be 
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separated using a mobile phase with very high aqueous content up to 99%. Under such 
conditions, the baseline is stable and the resolution results are readily reproducible.  
The two columns also showed excellent properties under media with a wide 
range of pH values from 2.5 to 7.1, and the concentration of TEAA buffer fell in range 
of 0 to 2.0% (w/v). With drugs, which were applied under very severe conditions such 
as high acetic media, the two columns still exhibited significant stability.  
 
3.4.4 Loading capacity of the HPLC column 
Many racemic drugs /compounds can be resolved on some commercial chiral 
columns such as Chiral-AGP. However, the low loading capacity of these columns 
became a great limitation on their application, particularly on preparative or industries 
scales. In order to overcome these limitations, the loading capacity of HEPT-PC was 
determined and found promising.   
1-(4-bromophenyl) ethanol and atropine were chosen as the test candidates 
under NP and RPs using 4.6 mm diameter analytical columns. Consider 1-(4-
bromophenyl) ethanol for example, the peak asymmetry kept unchangeable until the 
injected sample amount reached 5.0 mg in NP. When the resolution (Rs) dropped to 
0.85, the injected sample amount was 15.0 mg, which was considered as the loading 
amount of this sample. Similarly, the loading capacity of atropine was obtained as 1.02 
mg in RP. Since the loading capacities of HEPT-PC are greatly improved, further 






Chiral Stationary Phases Derived from Partial-6-(5-
Pent-1-Enylated)-Functionalized b-Cyclodextrins 




In Chapters 2 and 3, approaches for immobilizing mono- and heptakis azido-
perfunctionalized b-cyclodextrin (b-CD) onto the surface of amino-functionalized 
silica gel via single/ multiple urea linkages, respectively, have been reported. These 
approaches represented efficient methods for the preparations of chiral stationary 
phases (CSPs) having well-defined chemical structures. The resulting CD-CSPs exhibit 
excellent chiral recognition abilities and anti-elution stabilities, thus making them 
extremely useful for applications under both normal (NP) and reversed-phases (RP) 
conditions, particularly in mobile phases with high aqueous content.  
However, in these cases, since there are unreacted amino groups on the surface 
of silica gel which can interact chemically with acidic compounds, making their 
separations more optimal, arising from strong retention in the column. In addition, the 
urea linkages between chiral selector and support presented in the above two series of 
CSPs can provide numerous interaction sites for strong hydrogen bonding (H-
bonding), which is exert negative effects in the enantioseparations.   
Alkyl-substituted b-CD is a very important host body for cooperative binding,  
especially alkenyl-substituted b-CD, which is one of the key compounds for 
preparation of CSPs for chromatography, because via hydrosilylation, they can be 
easily anchored to the backbone of polysiloxane for CSPs for GC116, 170-172 or 
immobilized onto the surface of silica gel for HPLC.173-174 Meanwhile, b-CDs 
functionalized with mono- or di- aryl side chain had been synthesized with good 
enantioseparation abilities in GC and SFC applications.210 However, there is currently 
no report on the immobilized polysiloxane polymer anchored with CD and its 
application in chromatographic enantioseparation in HPLC.  
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On the above basis, we developed an approach comprising the immobilization 
of perfunctionalised b-CDs chemically bonded with underivatised silica gel via 
hydrosilylation. This procedure afforded materials derived from perfunctionalised b-
CD with reactive C=C terminal bonds at the side chain. These materials may be 
bonded to the support via stable ether linkages. 
There are two main objectives for the developments of these novel CSPs. First, 
since pristine silica gel will be employed in the procedure as a support material, the 
surface effects caused by the functional groups (eg. –NH2 in amino functionalized 
silica) would not affect enantioseparation greatly.  Moreover, changing the carbon 
chain length of primary alkenyl halide or alkyl halide will vary the distance between 
the support materials and the chiral selector, thus reducing surface effects. 
Furthermore, the CSPs can, if desired, be further subjected to an “end-capping” 
reaction to “block” the free hydroxyl groups on the surface of silica gel using a 
reactive silane, such as trimethylchlorosilane or alternatively hexamethyldisilazane, to 
improve the properties of the supports. 
On the other hand, the reactive terminal C=C group can be appropriately 
modified to afford materials which are applicable for GC, SFC, CEC 
enantioseparations.   
We report herein two novel CSPs namely ETHR-PC and ETHR-NC, derived 
from partial-6-(5-pent-1-enylated)-perphenyl-  and partial-6-(5-pent-1-enylated)- 
pernaphthylcarbamoylated-b-CDs, respectively. The alkenyl groups were subsequently 
hydrosilylised and immobilized onto the surface of silica gel. Chromatographic studies 
indicated that ETHR-PC exhibited excellent chiral recognition ability under both NP 
and RP, whilst ETHR-NC proved to be effective in RP. A wide range of racemic 
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compounds and pharmaceutical drugs/intermediates were successfully separated on 
these two CSPs.  
 
4.2 Syntheses  
4.2.1 General overviews 
The synthetic schemes for the preparations of perfunctionalised b-cyclodextrin 
are shown in Schemes 4.1.  
In the first step, b-CD was reacted with 5-bromo-1-pentene in NaH/ DMF to 
afford a partial-6-(5-pent-1-enylated) b-CD 4.1.211  
Scheme 4.1 
a: R= phenylcarbamate,                b: R= naphthylcarbamate
4.2a/b
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Reagents and conditions:  
i. a-b. Phenyl isocyanate / Pyridine or Naphthyl isocyanate / Pyridine, 95  C, 15hrs 
 
The rest of the hydroxyl groups at the 2-, 3- and 6-O positions at the rim of the 
b-CD were further fully functionalized with phenyl isocyanate and naphthyl isocyanate 
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to afford the corresponding carbamoylated b-CDs 4.2a/b in the presence of anhydrous 
pyridine.153-154 
After purification, the partial-6-(5-pent-1-enylated)-perfunctionalized b-CDs 
were hydrosilylated by the reaction of the terminal C=C at the side chain of the b-CD 
and silica gel using triethoxysilane (HSi(OEt)3) as polysilane reagent. The reaction was 
catalyzed by tetrakis(triphenylphosphine) platinum(0),212 followed by the further 
reaction with the hydroxyl groups onto silica gel to form a polysiloxane polymer 
anchored b-CD-based CSPs.   
 
4.2.2 Preparations of chiral HPLC columns 
According to the standard slurry method, 3.5 g of ETHR-PC or ETHR-NC were 
packed into stainless steel HPLC columns to afford chiral HPLC columns named 
ETHR-PC and ETHR-NC, respectively. 
 
4.3 Characterizations 
The physical properties of the b-CD derivatives are summarized in Table 4.1. 
We note from the table that the functionalizations of partia l-6-(5-pent-1-enylated)-b-
CD were successful in fairly high yields (ca. 80%).   
Table 4.1 Physical properties of partial-6-(5-pent-1-enylated)-functionalized b-CDs 
Products Out-looks Yield (%) 25][ Da  (c0.01, CHCl3) M. P. ( C) 
4.1 White powder 26% N. A. > 320, decomposed. 
4.2a White powder 85% +8.56 190-200 
4.2b White powder 76% +77.50 230-250 
 
FT-IR data corroborate to the presence of terminal reactive C=C bonds that the 
vibrational bands in the range of 1400 to 1660 cm-1 attributed to the characteristic C=C 
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bond can be observed in 4.1 and 4.2a/b. Furthermore, after functionalization, the –NH, 
-C=O and aromatic rings are also corroborated by the data summarized in Table 4.2.  
Table 4.2 FT-IR data for partial-6-(5-pent-1-enylated)-perfunctionalised b-CD 
 N-H C=O C=C Asym C-O-C Sym C-O-C 
4.2a 3393, 3313 1732 1604, 1537, 1443 1221 1053 
4.2b 3401, 3308 1738 1549, 1505 1221 1043 
 
1H-NMR data also confirm the full functionalization of b-derivatives. For 4.2a, 
the multiple signals in the region of d 7.50-6.50 attributable to hydrogen atoms in the 
aromatic rings, while  multiple peaks in the region of 5.80-3.75 attributed to hydrogen 
atoms in CD rings were observed. Similarly, multiple peaks correspondent to the 
hydrogen atoms in atomatic rings and b-CD residues in the range of 7.95-6.4 and 6.1-
4.0, respectively, were also observed in the spectra of 4.2b. 
Being different with the CSPs developed by the two approaches described 
previously, ETHR-PC and ETHR-NC have the stable covalent ether linkages between 
the chiral selector molecules with silica gel. The immobilization of chiral selectors 
onto the surface of silica gel was confirmed by the appearance of the peaks ranged 
from 1600 to 1800 cm-1 in FT-IR spectra.  
Elemental analyses provided further corroboration for the successful 
immobilization of the chiral selectors. However, it should be noted that it is difficult to 
determine the precise structures for the resulting CSPs due to uncertainty in the 
number of allyl groups introduced. Therefore, immobilization was only confirmed by 
the increased carbon content in the CSPs which were brought by the chiral selectors. 
Table 4.3 Elemental analyses for ETHR-PC and ETHR-NC.  
CSPS C% H% N% 
ETHR-PC 7.6 0.94 0.8 
ETHR-NC 8.13 0.95 0.81 
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4.4 Enantioseparation results on ETHR-PC and ETHR-
NC 
Using biphenyl as the testing probe under normal phases with mixture of n-
hexane/2-propanol (IPA) = 90/10 (v/v), the two columns gave column efficiencies of 
38,000 and 37,000 plates per meter. 
Under reversed-phase (RP) conditions using mobile phases comprising 
mixtures of MeOH / CH3CN and aqueous buffer (generally triethylammonium acetate) 
with pH between 4 to 6, both ETHR-PC and ETHR-NC exhibited excellent 
enantioseparation abilities towards a wide variety of racemic compounds/ drugs/ 
intermediates such as b-blockers and racemic amines. However, in normal phase (NP) 
condition using hexane/IPA , only ETHR-PC exhibited chiral recognition ability. 
 
A. Substituted (1-aryl) ethanols   
Table 4.4 gives the optimal enantioseparation results for nine racemic (1-aryl) 
ethanols and one simple aromatic compound on the two CSPs under both NP and RP. 
Results indicate that out of ten analytes, eight were separated on ETHR-PC, while only 
two obtained separations on ETHR-NC with relatively lower selectivity (a) and 
resolution (Rs).  
Of the 8 analytes separated on ETHR-PC, only compound S/n 9 gave resolution 
in RP with the help of TEAA, while the rest seven (1-aryl) ethanols were separated in 
NP. Meanwhile, similar to the data obtained on the first two series of CSPs, 1-(4-
bromophenyl) ethanol and 1-(4-chlorophenyl) ethanol obtained separations under 
various conditions on ETHR-PC, using the mixtures of hexane/ IPA, H2O/ CH3CN, 
H2O/ MeOH or Buffer/ MeOH, respectively. (Table 4.5) It is further correspondent to 
our previous statement that phenylcarbamoylated-CSPs is working in multi-model 
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mode which demonstrate chiral recognition abilities under both NP and RP, and CSPs 
with naphthyl carbamates seem likely a typical RP-HPLC column. 
 
Table 4.4 Enantioseparations of (1-aryl) ethanols on ETHR-PC and ETHR-NC.  




















1.04 (+) 1.63 4.60 Hexane/IPA =90/10 ETHR-PC 





































Hexane/IPA =90/10 ETHR-PC 
Mobile phase:  A: 1% TEAA (pH 5.01) 
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Table 4.5 Enantioseparations of 1-(4-chlorophenyl) ethanol and 1-(4-bromophenyl) ethanol 
on ETHR-PC under different mobile conditions  
Cl
OH  
A. Hexane/IPA=90/10  k1 = 1.04 (+) 
k2 = 1.70 (-) 
a = 1.63 
Rs = 4.60 
 
B. H2O/CH3CN=60/40 
k1 = 0.98(+) 
k2 = 1.31(-) 
a = 1.34 
Rs = 2.85 
 
C. H2O/MeOH=60/40  
k1 = 9.52(+) 
k2 = 13.68(-) 
a  = 1.44 
Rs = 3.21 
 
D. Buffer/MeOH=60/40  k1 = 3.46(+) 
k2 = 4.64(-) 
a  = 1.34 




E. Hexane/IPA=90/10  k1 = 1.24  (+) 
k2 = 2.51(-) 
a  = 2.02 
Rs = 6.24 
 
F. H2O/CH3CN=60/40 
k1 = 1.15 (+) 
k2 = 1.71(-) 
a  = 1.49 
Rs = 3.82 
 
G. H2O/MeOH=60/40 
k1 = 13.32 
(+)  
k2 = 21.66(-) 
a  = 1.63 
Rs = 3.69 
 
H. Buffer/MeOH=60/40 k1 = 4.26 (+) 
k2 = 6.51(-) 
a  = 1.53 
Rs = 3.73 
 
Buffer: 1% TEAA ( pH=4.65) 
When the para-position of aromatic ring was substituted with methoxy, methyl, 
chloride and bromide, similar trend with that in the previous work was observed, that 
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the enantioseparations of these analytes following the sequence of: methoxy < methyl 
< hydrogen < chloride / bromide. It could be demonstrated by the data from Table 4.4 
that, the compound S/n 1 did not afford enantioseparation, while compound S/n 2 
afforded poorer resolution compared to compound 4 and 5. These results further 
confirm our previous statement in Chapter 2.  
Interestingly, the elution order of (+)- and (-)- components of analytes on 
ETHR-PC and ETHR-NC are in similar sequence under various conditions. With 1-(4-
bromophenyl) ethanol as a typical example, the elution order is always (+) before (-). 
This similarity of CSPs in selectivity toward the enantiomers indicates that the chiral 
recognition for small analytes is not essentially influenced by the size and surface 
properties of silica gel, but also by the polar carbamate groups, which can interact with 
polar groups of racemic compounds through H-bonding and dipole-dipole interaction. 
Therefore, with our CSPs, the enantioseparation modes are similar. 
 
B. Racemic amines  
Six amines including pheniramine and its analogues, atropine and indapamide 
were tested on the two CSPs. (Table 4.6) It was found that five analytes were resolved 
on ETHR-PC while only one was separated on ETHR-NC. Generally, ETHR-NC 
exhibited poorer chiral recognition ability than the former. For example, atropine 
obtained excellent separations with the highest a and Rs of 4.38 and 5.24, respectively, 
on ETHR-PC, whilst, only 1.36 and 1.28 were obtained on ETHR-NC. However, (N-
(1-methyl-allyl)-N-phenyl- formamide (S/n 5) (structure shown in Appendix I) afforded 
similar enantioseparation results on both CSPs.  
Pheniramine and its analogues afforded improving enantioseparations when the 
para-substituents changes from hydrogen to chloride to bromide, which is consistent 
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with the results obtained on the CSPs developed in Chapter 2 and 3. These results 
demonstrate that, these CSPs are operating in similar modes although the linkages to 
silica gel are different.  
Table 4.6 Enantioseparations of substituted pheniramine 
S/n Analytes k1’ k2’ a Rs Conditions CSPs 
1. Pheniramine 1.24 1.31 1.06 0.30 A / MeOH=60/40  ETHR-PC 
2. Chlorpheniramine 2.05 2.26 1.10 0.62 A / MeOH=60/40  ETHR-PC 
3. Brompheniramine 2.55 2.82 1.10 0.80 A / MeOH=60/40  ETHR-PC 
4. Indapamide 1.94 2.14 1.11 0.97 A / MeOH=65/35  ETHR-PC 
1.07 1.56 1.46 2.69 A / MeOH=65/35  ETHR-PC 
5. 
(N-(1-methyl-allyl)-
N-phenyl-formamide 0.84 1.24 1.48 2.89 A / MeOH=60/40  ETHR-NC 
0.65 2.85 4.38 5.24 A / MeOH=65/35  ETHR-PC 
6. Atropine 
0.99 1.35 1.36 1.28 B / MeOH=60/40  ETHR-NC 
Mobile phases:  A: 1% TEAA (pH 4.65); B: 1% TEAA (pH 5.01) 
 
C. b-Adrenergic blockers 
Ten b-adrenergic blockers were test on both CSPs and gave excellent chiral 
recognition under the help of TEAA. (Tables 4.7-4.8 and Figure 4.1) 
All of the ten analytes were separated on ETHR-PC while eight of them 
achieved resolutions on ETHR-NC. Propranolol obtained the highest Rs of 2.06 while 
oxprenolol gave the lowest Rs of 0.23.  
It is strange to note that to some of the analytes, ETHR-NC exhibited better 
resolution than ETHR-PC. For example, propranolol obtained resolution of 1.48 on 
ETHR-PC but of 2.06 on ETHR-NC. Pindolol gave resolution of only 0.55 on ETHR-
PC while high up to 1.06 on ETHR-NC! Other examples are O-acetyl propranolol, 
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metoprolol, labetalol and nadolol, while alprenolol obtained similar results on these 
two CSPs. 
Table 4.7 Enantioseparations on ETHR-PC and ETHR-NC under reversed-phase.  
S/n Analytes k1’ a Rs Conditions Columns 
1.29  1.79 2.06 MeOH/ A= 40/60  ETHR-NC 1 Propranolol  
1.38 1.71 1.48 MeOH/ B = 40/60  ETHR-PC 
3.86 1.32 2.02 MeOH/ A = 40/60  ETHR-NC 2 O-acetyl Propranolol 
1.71 1.49 1.45 MeOH/ B = 40/60  ETHR-PC 
1.61 1.37 1.46 MeOH/ A = 40/60  ETHR-NC 3 Alprenolol 
0.84  1.53 1.45 MeOH/ B = 40/60  ETHR-PC 
1.60  1.36 1.33 MeOH/ A = 40/60  ETHR-NC 4 Metoprolol 
1.00 1.12 0.77 MeOH/ B=35/65  ETHR-PC  
0.15  4.73 1.27 MeOH/ A=40/60  ETHR-NC 5 Isoproterenol 
0.10  3.96 1.64 MeOH/ B = 35/65  ETHR-PC 
6 Acebutolol 2.11 1.16 1.15 MeOH/ B = 25/75  ETHR-PC 
7 Oxprenolol 0.74 1.07 0.23 MeOH/ B= 35/65  ETHR-PC  
0.63  1.29 1.06 MeOH/ A =40/60  ETHR-NC 8 Pindolol 
0.47  1.15 0.55 MeOH/ B= 40/60  ETHR-PC 
Mobile phase:  A: 1% TEAA (pH 5.01); B: 1% TEAA (pH 4.65) 
In particular, nadolol and labetalol, which have two and three chiral centers in 
the molecules, respectively, that normally did not show excellent resolutions on other 
columns, obtained unique chiral recognition on our homemade CSPs. Although the 
four components in racemic mixtures did not afford baseline resolution, they could be 
clearly identified from the chromatograms. (Figure 4.1) 
Chromatographic data in Table 4.8 show that labetalol and nadolol gave better 
resolution on ETHR-NC than that on ETHR-PC. On ETHR-PC, labetalol showed four 
closer peaks but only three were recognized for nadolol. No improvement in 
enantioseparation could be observed even after many attempts by optimizing the 
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conditions.  However, on ETHR-NC, both two analytes afforded four obvious peaks 
corresponding to the four components. 
Analytes Condition Chromatograms 
Labetalol MeOH/1% TEAA (pH 5.01) = 50/50 
 
Nadolol MeOH/1% TEAA (pH 5.01) = 40/60 
 
Figure 4.1 Chromatograms of labetalol and nadolol on ETHR-NC. 
Table 4.8 Chromatographic data of nadolol and labetalol on ETHR-PC and ETHR-NC.  



































MeOH / B=40/60  ETHR-NC 
Mobile phases:  A: 1% TEAA (pH 4.65); B: 1% TEAA (pH 5.01) 
In order to optimize the separation conditions, we changed pH values of TEAA 
from 6.65 to 4.01. The experimental results indicate that the optimal pH fell in range of 
4.65 to 5.01. Meanwhile, when the ratio of organic solvent such as MeOH or CH3CN 
increased to 35% or 40%, the analytes eluted out in less than 10 minutes with high 
selectivity and resolution factors.  
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D. Racemates with more than one optical center on ETHR-PC 
On the basis of the above results obtained for labetalol and nadolol, two organic 
compounds, namely 2-(phenyl-phenylamino-methyl)-cyclopentanone (PPMC) and 2-
(phenylamino-pyridin-3-yl-methyl)-cyclopentanone (PAPM), with two chiral centers 
in the molecules were tested on ETHR-PC with results summarized in Table 4.9. The 
representative chromatogram in terms of PPMC is depicted in Figure 4.2.  
Table 4.9 Enantioseparations of PAPM and PPMC  




























MeOH / A =40/60  





Figure 4.2 Chromatogram of 2-(phenyl-phenylamino-methyl)-cyclopentanone 
In Figure 4.2, four peaks relating to two pairs of enantiomers can be easily 
recognized. Since this compound was produced by asymmetric method, the first two 
components were proved to be the major enantiomers.  
Results indicated that both ETHR-PC and ETHR-NC are very suitable for the 
enantiomers with two chiral centers.  
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E. Chiral phenyl dihydrotriazines 
Phenyl dihydrotriazines (4,6-diamino-2,2-dialkyl-1,2-dihydro-1-phenyl-s-
triazines) are known to be potent inhibitors of mammalian DHFR (Dihydrofolate 
Reductase).213 Inhibition of cellular DHFR reduces the source of tetrahydrofolates 
which eventually leads to cell death as a result of deficient DNA biosynthesis due to 
the lack of the availability of nucleic acids. Different dihydrophenyl triazines have 
been used therapeutically as antimalarial,214 anticancer,215-216 as well as antiparasitic 
agents.217-218  
Researchers also found that the physicochemical properties of the 
dihydrophenyl triazines are very much dependent on the nature of the substituents on 
both the phenyl ring and the dihydrotriazine ring, by the reason that these properties 
have a great influence on the way these molecules would bind to the enzyme and also 
their transport across the membranes.219 In 1954, Modest reported that dihydrophenyl 
triazines having either para- or meso-halogen substitution in the phenyl ring and either 
a 2,2-dimethyl or a 2-n-hexyl substitution in the dihydro triazine ring showed 
promising inhibitory action against murine DHFR.220 Roth also did a study on the 
DHFR inhibitory activity of pyrimidine analogues where R was changed from H to an 
ethyl group and found that compounds with an ethyl substituent at C6 position of the 
pyrimidine ring is important in conferring activity. If the R1 and R2 substituents in the 
triazine ring are different, a chiral compound is formed. The two enantiomers may bind 
to the enzyme with different affinity and this may result in a difference in inhibitory 
activity.221 
In this thesis, 18 synthetic chiral phenyl dihydrotriazines (4,6-di-amino-1,2-
dihydro-2,2-dimethyl-1-(substituted phenyl)-s-triazide hydrochlorides) with unknown 
biological activity were tested on both ETHR-PC and ETHR-NC. 222 
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The typical structure of these compounds is shown in Figure 4.3, with different 














Figure 4.3 Basic structure of chiral phenyl dihydrotriazines. 
In order to investigate the difference in enantioseparation brought by different 
substituents at the aromatic ring of these samples, they were divided into four major 
groups. The para-substituted samples were included in group 1, while those at R2 and 
R3 were included in group 2 and 3, respectively. Those samples with more substituents 
were included in group 4.  
Successful enantioseparations of the 18 samples were obtained on ETHR-PC, 
while 16 were resolved on ETHR-NC. In general, ETHR-PC showed better 
enantioseparation ability towards this series of analytes than ETHR-NC in terms of 
higher a and Rs. 
The data in Table 4.10 show that with change in substituents from chloride / 
bromide through methyl to methoxy groups, resolutions will follow the sequence 
showed in Table 4.11.It is noticed that on ETHR-PC, when -NO2 group is present in 
the analytes, the sample showed good enantioseparation. Take compound S/n 8, 16 and 
17 (in Table 4.10) as examples, S/n 16 afforded the best resolution with the highest Rs 
of 3.13, followed by 8 of 2.83 and 17 with 2.62, respectively. Their selectivities also 
followed the similar trend. When there are more than one substituents, the 
enantioseparation results are complicated and the trend is not easy to predict. 
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Table 4.10 Enantioseparations of (4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(substituted 
phenyl)-s-triazines)  
Groups S/n Substituent Abbrev. k’1 k’2 a Rs CSPs 
0.89 1.31 1.47 2.38 ETHR-PC 1 R1= Cl P-Cl 
0.85 0.97 1.14 0.48 ETHR-NC 
1.10 1.56 1.42 2.35 ETHR-PC 2 R1= Br P-Br 1.18 1.56 1.32 0.86 ETHR-NC 
0.89 1.07 1.20 1.25 ETHR-PC 3 R1= CH3 P-Me 0.69 0.83 1.21 0.60 ETHR-NC 
0.84 1.10 1.31 1.68 ETHR-PC 
P-substituted 
4 R1= OCH3 P-OM 1.11 1.36 1.22 0.68 ETHR-NC 
0.84 1.16 1.38 2.08 ETHR-PC 5 R2= Cl M-Cl 1.05 1.25 1.19 0.62 ETHR-NC 
1.00 1.40 1.40 2.00 ETHR-PC 6 R2= Br M-Br 
0.77 0.84 1.09 0.34 ETHR-NC 
0.81 1.10 1.36 1.87 ETHR-PC 7 R2= CH3 M-Me 0.79 0.95 1.20 0.57 ETHR-NC 
0.69 1.09 1.57 2.83 ETHR-PC 8 R2= NO2 M-NT 0.81 1.14 1.41 0.79 ETHR-NC 
0.89 1.10 1.22 2.29 ETHR-PC 
M-substituted 
9 R2= CN M-CN 1.31 1.50 1.15 0.56 ETHR-NC 
0.57 0.88 1.54 1.64 ETHR-PC 10 R3= Cl O-Cl 
1.26 1.41 1.12 0.46 ETHR-NC 
0.74 0.96 1.30 1.48 ETHR-PC 11 R3= Br O-Br 0.88 1.10 1.25 0.69 ETHR-NC 
0.69 0.85 1.23 1.05 ETHR-PC 12 R3= CH3 O-Me 1.09 1.35 1.24 0.72 ETHR-NC 
0.69 0.76 1.10 1.00 ETHR-PC 
O-substituted 
13 R3= OCH3 O-OM 1.25 1.25 1.00 N. A. ETHR-NC 
1.37 1.72 1.26 1.75 ETHR-PC 
14 
R1= CH3,  
R2= Cl 
PM-MC 
0.55 0.67 1.23 0.62 ETHR-NC 





0.34 0.43 1.26 0.48 ETHR-NC 
1.00 1.61 1.61 3.13 ETHR-PC 
16 
R1= Cl,  
R2= NO2 
PM-CN 
1.10 1.14 1.04 0.17 ETHR-NC 
1.03 1.47 1.43 2.62 ETHR-PC 
17 
R1= CH3,  
R2= NO2 
PM-NM 
0.57 0.57 1.00 N.A. ETHR-NC 




R1= CH3,  
R2= CH3 
PM-MM 
0.59 0.72 1.23 0.49 ETHR-NC 
Mobile phase: for ETHR-PC : MeOH / TEAA (1%, pH: 4.65) = 40 / 60; for ETHR-NC: MeOH / TEAA 
(1%, pH: 5.5) = 45/55. Condition for S/n 13 and 15 are MeOH / TEAA (1%, pH: 5.0) 
= 55/45 and MeOH / TEAA (1%, pH: 6.0) = 45/55), respectively.  
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However, a reversed phenomenon was observed on ETHR-NC, that to multi-
substituents, -NO2 incurred the loss of chiral recognition. Also with S/n 16 as example, 
it obtained the lowest Rs of 0.17 while compound 17 showed no separation at all. It is 
also found in table that, to single substituents analytes on both CSPs, -NO2 group at the 
ortho-position seems to favor the enantioseparations. 
Table 4.11 Trends with substituted groups in enantioseparations on analytes (In terms of Rs)  
Substituted groups ETHR-PC ETHR-NC 
para-Substituted Cl > Br > OCH3 > CH3 Br > OCH3 > CH3 > Cl 
meso-Substituted Cl > Br > CH3 > OCH3 CH3 > Br > Cl > OCH3 
ortho-Substituted NO2 > CN > Cl > Br > CH3 NO2 > Br > CH3 > CN > Cl 
 
Interestingly, on ETHR-PC, chloride substituent seems to provide better 
enantioseparation than bromide does. This observation is supported by the fact that 
wherever the substitution occurs, chloride-substituted solute always showed higher Rs 
than bromide-substituted analyte. However, a reversed trend was observed on ETHR-
NC which bromide provide of enantioseparation.  
However, to CH3- and OCH3-substituent, it is hard to predict which is more 
favorite to enantioseparation.  
Due to the complicated structures of the library of 18 solutes, it is difficult to 
depict the separation mechanism based on the enantioseparation results. However, to 
some extent, it also demonstrates that there are many interactions playing important 









As discussed in Chapter 1, with rapid development of the pharmaceutical 
industry and tremendous requirements for optically pure enantiomers in fields relating 
to natural products and agrochemicals, analysis and purification of racemic drugs are 
of increasing importance and have attracted much attention over the past decade.  
Asymmetric synthesis and optical resolution are two methods for obtaining 
enantiopure compounds. Of these, enantioseparation of enantiomers in preparative 
scale include three disparate techniques. The oldest procedure with a history of many 
applications in organic chemistry is the classical fractional crystallization of salts 
formed from a racemic acid or base with an optically pure chiral reagent of opposite 
charge. With the development of liquid chromatography (LC) systems, enantiomeric 
mixture was first converted to covalently bonded derivatives by reaction with chiral 
reagents. The resulting diastereoisomers can be separated when injected into an achiral 
column with an appropriate mobile phase. This indirect separation approach was 
further modified by the direct method using chiral stationary phases (CSPs), with the 
final goal of isolating and collecting the pure enantiomers.   
Although in the pharmaceutical industry there is still a strong dependence on 
the first two methods, since available CSPs are useful for separating only a limited 
class of compounds with the likelihood of finding a universally applicable simple 
chiral phase being remote, CSPs have nevertheless several advantages over the above 
two techniques. Thus, they are easily manipulated through synthesis and can separate 
enantiomeric mixtures without the necessity of derivatization. Consequently, the 
preparative separation of chiral drugs and intermediates on CSPs is increasingly 
becoming a viable alternative to enantioselective synthetic routes, mainly ascribable to 
the advantages pertaining to time conservation and reliability of the scale-up 
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procedure. Some pioneering works have been accomplished on CSPs based on lactose,  
11, 223-224 cellulose225-226 and its derivatives,23, 227-228 starch229-231 and optically active 
polyacrylamides.232 Nowadays, there are many commercially available CSPs for 
preparative or semi-preparative purposes in the markets.   
 
5.1.1 General strategy  
Choosing a suitable CSP to carry out the preparative enantioseparation must 
follow a certain strategy that some of the factors have to be considered before that. 
According to Eric,233 a general strategy to be applied for preparative enantioseparations 
can be summed up in Figure 5.1.  
Selection of an appropriate CSP 
(Variation of the solute) 
 
Improvement of the separation/resolution factor by optimization of the 
chromatographic parameters (according to the chromatographic mode) 
(mobile-phase composition, modifiers, additives, flow rate, temperature) 
 
Optimization of the chromatographic throughput 
(Sample amount, column overloading) 
 
Choice of the column dimension 
(Preliminary test and adjustment of the chromatographic conditions) 
 
Performing of the preparative separation 
(Recycling, peak shaving) 
 
 
     Analytical 
     Column 
 
   Preparative 
     Column 
Figure 5.1 General strategy for preparative enantioseparation 
 
This strategy will help lead to a successful resolution of racemates on 
preparative HPLC columns.  
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5.1.2 Selection criteria for the CSPs 
The first step of the general strategy is selection of an appropriate CSP. In this 
step, several selection criteria for the CSPs should be observed to a preparative 
column. The most important criterion is obviously chiral selectivity which is expressed 
by the selectivity a. Nevertheless, when a preparative separation is required, other 
parameters such as loading capacity (loadability), low-cost route in synthesis, 
solubility of the solute in the mobile phase, or chemical stability of the CSPs can 
outweigh selectivity.  
 
(1) Selectivity  
The most important point in ensuring the successful resolution of a racemate is 
to work under high-selectivity conditions, that is, conditions that give the highest 
selectivity (a). The selectivity is first determined by the recognition ability of the CSP, 
but it can also be influenced by the composition of the mobile phase or the presence of 
modifiers, the presence of additives, pH value or the temperature.  
 
(2) Loading capacity 
The loading capacity is a critical factor in preparative separation. It indicates 
the maximum amount of racemate the column can tolerate without compromising 
resolution. The screening up using analytical columns should obviously be restricted to 
CSPs with a high enough loading capacity. Furthermore, loading amount of the sample 
will also play an important role to demonstrate the potential of this column, which will 
be highly useful in isolation of the enantiomers. 
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(3) Chemical and physical stability of CSPs 
The chemical stability of the CSPs can also be a limiting factor. For example, 
phases bearing reactive chemical functions can be altered by injection of certain 
solutes, which will fail the operation of this CSP. Meanwhile, many CSPs comprising 
organic polymeric materials have limitations relating to their chemical, physical, or 
mechanical properties.  
 
(4) Solubility of the analytes 
The solubility of the sample is also crucial to preparative enantioseparations. 
Since some of the preparative CSPs should be used under carefully chosen conditions, 
the solubilities of many samples may be essential in the separation process.  
 
(5) Scale-up procedure  
Scale-up procedures have some constraints that have to be circumvented. It is 
obvious that if an analytical method has been developed and if it can be applied for 
preparative scale, considerable amounts of time and cost will be saved. However, the 
reproducibility of procedures using CSPs, no matter whether for analytical or 
preparative scale, is another crucial consideration to the scale-up process.  
 
(6) Column packing 
Column packing fo r preparative scale CSPs is also different from that of 
analytical column. The particle size of the CSPs offered for preparative purposes is 
generally larger than that of the material used in analytical columns. In their 
chromatographic properties, such as efficiency, these preparative sorbents can differ 
from those used for analytical determinations, and therefore it may be useful to 
perform the optimization on an analytical column filled with the preparative material.  
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As the final step, isolation of the resolved enantiomers is obviously a crucial 
step in preparative chromatographic separation. 
In Chapter 2, we reported a novel and facile synthesis of a series of structurally 
well-defined b-cyclodextrin (CD)-based-CSPs by immobilization of mono-(6-azido-6-
deoxy)-perfunctionalized-b-CDs onto amino-functionalized silica gel via a single 
stable urea linkage using the Staudinger reaction in an analytical scale. As shown 
previously, these CSPs, particularly for perphenyl-carbamoylated-b-CD-CSP (SINU-
PC), exhibited excellent enantioseparation abilities and good chromatographic 
properties, such as high column efficiency and loading capacity. More importantly, 
since the synthetic process comprising the Staudinger reaction, which is a quantitative 
reaction, the whole procedure possesses the advantages of ease of control, mild 
reaction conditions, high yield and good batch-to-batch reproducibility. All these 
properties give us sufficient reasons to inspect the possibility of the scale-up procedure 
and the abilities to obtain the pure enantiomers on this CSP. 
In this chapter, we report herein the scale-up and viability of applying the 
resulting CSP for preparative HPLC enantioseparations. It was found that this column 
possessed excellent enantioseparation ability towards several drugs, such as atropine 
and propranolol, under similar reversed-phase conditions to the analytical column.  
 
5.2 Scale up procedure and preparative analyses  
Following similar synthetic procedures described in Chapter 2, using the key 
intermediate mono-(6-azide-6-deoxy)-perphenylcarbamoylated-b-CD, 2.3a, CSP 5.1 
was derived from immobilization onto preparative scale amino-functionalized 
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particulates. (Kieselgel 100, particle size: 15-35mm, pore size 100Å, surface area 400 
m2/g ). The amounts and molars of the chemicals are list in Table 5.1.  
Table 5.1 Amounts of reagents and intermediates in preparation of perphenyl-
carbamoylated-b-CD onto silica gel in preparative scale.  
Reagents or intermediate  Amounts (grams) 
Molar 
(mmol) 
b-CD 200.0 176.2 
4-Methylbenzene sulfonyl chloride 38.0 198.6 
Mono-(6-(p-tosylsulphonyl)-6-deoxy)-b-CD 2.1  49.2 38.5 
Sodium azide  50.0 769.0 
Mono-(6-azide-6-deoxy)-b-CD 2.2  26.5 38.5 
Phenyl isocyanate  120.0 142.8 
Mono-(6-azide-6-deoxy)-perphenylcarbamoylated-b-CD 2.3 51.0 13.8 
 
The CSP was slurried in acetone and packed into standard stainless steel 
column (preparative column: 10 ´ 250 mm i.d. ´ l) on an Alltech® HPLC packer, 
(Alltech Associates, Inc., USA) using acetone as solvent to afford the preparative 
HPLC column namely PREP-SINU-PC. Using biphenyl as test probe under normal 
phase, the column efficiency was determined to be 12,000 plates per meter.  
Studies on the enantioseparation of racemic drugs were accomplished at 
ambient temperatures (23°C). The flow rates are 2.0 and 1.0 ml min-1 for normal and 
reversed-phases, respectively. Detection was effected using a UV-Vis detector in 
analytical scale separations. However, UV detection is not suitable in preparative scale 
enantioseparation, because the high sensitivity which is ideal for nanogram and 
microgram concentrations and low flow rates in 8-10 ml detector cells for analytical 
scale must be reduced when higher sample concentrations and increased flow rates are 
used in preparative scale separations. Furthermore, the increased absorption will 
beyond the range of conventional UV detectors. However, change of the detection 
wavelength of the samples and reducing the path length of the cell, which is the best 
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approach to reduce sensitivity will sometimes allow the use of an analytical UV 
detector. Consequently, our experiments were carried out with a detection wavelength 
of 280 nm.  
Collection and isolation of the enantiomers were carried out using mixtures of 
MeOH-aqueous triethylammonium acetate (TEAA) buffer as the mobile phase under 
reversed-phase conditions. Subsequent to removal of the TEAA and organic solvent, 
freeze drying afforded the pure enantiomers. The preparative samples were 
enantiomerically pure as shown by analytical chiral HPLC. Meanwhile, optical 
rotations of these pure enantiomers were obtained on a polarimeter.  
In this chapter, the samples underwent the enantioseparation of different 
concentration and the loading amount was determined by the k’, a and Rs.   
 
5.3 Results and discussions 
In the preparative scale enantioseparation, several factors should be considered. 
Of which, the key factor, choosing a suitable analyte has to be carried first. However, 
there will be obvious differences in going from analytical to preparative 
enantioseparations of a given compound. On account of the lower efficiency of the 
preparative column, even if a sample afforded baseline enantioseparation on an 
analytical column, it may afford a poorer resolution or even nonseparation on 
preparative scale process. However, for analytical HPLC, whilst baseline resolution is 
desirable because we are collecting information, in the case of preparative HPLC, our 
need is to collect pure sample. Accordingly, even if baseline separation is not obtained, 
we can still collect the pure enantiomers. Therefore, a sample, which may afford above 
85% separation on preparative scale, can be chosen to carry the isolation of 
enantiomers. However, at the moment of collecting the enantiomers, the peaks of the 
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sample should be eluted fast enough for the multiple injection and the two peaks, 
particularly the first should not have extensive tailing to affect the collection of the 
second component when both enantiomers are desired.  
If the analytical method requires the use of buffers or modifiers, it is better to 
determine if they are necessary for the selectivity. Often these are used to sharpen the 
peaks but do not affect selectivity. If this is the case, it is advisable to remove or reduce 
the modifiers by the reasons that those modifiers in the mobile phase are generally 
difficult to remove, especially for non-volatile ones. However, in this thesis, buffers 
are critical to the selectivity for most of the separations. Since the buffer applied in this 
chapter is triethylammmonium acetate (TEAA), which is volatile and hence can be 
removed easily from the mobile phase after the purification by high vacuum.  
Six drugs including atropine, propranolol, bendroflumethiazide etc in salt form 
were used to test the enantioseparation ability of the PREP-SINU-PC under reversed-
phase conditions. 
Representative chromatograms for these racemic drugs are depicted in Table 
5.1 with key separation data. From these, it can be seen that PREP-SINU-PC afforded 
good enantioseparation abilities under reversed-phases conditions. Amongst these 
drugs, atropine depicted the highest selectivity (a) of 5.50 and a resolution (Rs) of 2.06 
within 20 mins. Isoproterenol afforded the shortest retention times within 12 mins with 
baseline resolution. These data pave the way to the ease of collecting large amount of 
enantiomers resulting from multiple injections of samples.  
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Table 5.1 Chromatographic data for preparative scale separation.  
S/n Analytes Chromatographic data  Chromatograms and Mobile phases 
1 Atropine 
t1 = 9.16 
k1 = 0.35 
a = 5.50 
t2 = 19.93 
k2 = 1.93 




t1 = 83.58 
k1 = 11.29 
a = 1.22 
t2 = 
100.80 
k2 = 13.82 
Rs = 1.51  
 
C 
3 Propranolol  
t1 = 19.01 
k1 = 1.80 
a = 1.86 
t2  = 29.58 
k2 = 3.35 
Rs = 1.09 
 
A 
4 O-Acetyl Propranolo l  
t1 = 21.70 
k2 = 3.73  
a = 1.70 
t2 = 32.18 
k1 = 2.19 




t1 = 7.37 
k1 = 0.083 
a = 8.65 
t2 = 11.68 
k2 = 0.72 
Rs = 1.20 
 
B 





Mobile phases:  A: 1% TEAA (pH 4.65): MeOH, 65: 35;  
B: 1% TEAA (pH 4.65) : MeOH, 80: 20;  
C: 1% TEAA (pH 4.65): MeOH, 70: 30 
The loading capacity of PREP-SINU-PC was tested to investigate its potential for 
preparative scale enantioseparation processes. Drugs chosen for this purpose should  
have good resolution and convenient capacity ratio (k¢) for the two enantiomers. From 
Table 1, atropine was chosen as representative in demonstrating the procedure and 
principle in measuring the loading capacity, which is determined by its k¢, a and Rs. 
Graphical representations of the influence of loading on k¢, a and Rs are shown in 





Figure 5.2 Chromatograms of atropine using the different injection amounts on 
PREP-SINU-PC.  
  Mobile phase: 1%TEAA (pH: 4.65) / MeOH = 65/35. Flow rate: 2.0 ml 
min-1, Detection: 225nm. Injection volume: 50 ml. A: 43.6 mg ml-1; B: 80.3 
mg ml-1; C: 160.l mg ml-1; D: 240.0 mg ml-l; E: 250.0 mg ml-1  
 
Figure 5.1 depicts the chromatograms of atropine using the different injection 
quantities. From A to E, the injection quantities are 2.18, 4.02, 8.0, 12.0 and 12.5 mg, 
respectively. From the chromatograms we can observe that with an increase in sample 
loading, the retention of the two components decreased. In going from A to E, the two 
components eluted faster with the two enantiomer peaks becoming closer. From these 
data we also observe the same trend in Figure 5.2. In Figure 5.2b, k1’, k2’ are 0.35 and 
1.93, respectively when the injection amount was 2.0 mg. They decreased with 
increasing injection amounts and obtained values of 0.25 and 0.96, respectively, when 
the loading was 12.0 mg. Even when the loading was increased to 12.5 mg with the 
resolution less than 1.0, atropine can still achieve baseline resolution. However, the 
decrease of k2’ is larger than that of k1’. As a result, k1’ and k2’ were down to 70% and 
50%, respectively, of the initial value.  
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Figure 5.3 Effects of the loading amount on k¢, a and Rs on PREP-SINU-PC.  
  Sample: atropine, Mobile phase: 1%TEAA (pH: 4.65) / MeOH = 65/35. 
Flow rate: 2.0 ml min-1, Detection: 225 nm. Injection volume: 50 ml. 
 
From Figure 5.2a, it is evident that a and Rs decrease from A to E. When the 
amount injected is 1.0 mg per injection, a is 5.51 and Rs is 2.0. However, they drop to 
5.15 and 1.85, respectively, when the injection amount is 2.0 mg. With the loading 
increased from 4.0 to 12.0 mg, a and Rs decreased from 4.75 to 3.84 and 1.5 to 1.03. 
Therefore, the loading capacity of atropine on a preparative column was determined as 
12.5 mg when the Rs value reached 0.90.  
By similar approaches, the loading capacities of other drugs were determined 
and summarized in Table 5.2. Amongst the analytes, O-acetyl propranolol had the 
lowest loading of 0.94 mg.  
The recovery yield is also very important to the preparative column because it 
is the critical parameter to determine whether our method is effective. Table 5.2 
indicate that the recovery yield of the testing drugs were relatively high as more than 
90%, which demonstrate that PREP-SINU-PC is effective for the isolation and 
collection of pure enantiomers.   
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Table 5.2 Loading amounts and recovered yield of drugs. 
Drugs Loading Amount (mg) Recovery Yields (%) 
Atropine 12.00 98 
Bendroflumethiazide 1.06 94 
Isoproterenol 1.06 93 
Propranolol 1.11 96 
O-Acetyl Propranolol 0.94 92 
 
The optical rotations of propranolol,1 isoproterenol2 and atropine were determined 
and are summarized in Table 5.3. The recovery is generally high, above 90%.  
 
Table 5.3 Optical rotations of propranolol, isoproterenol and atropine.  
Drugs a  Literature value  
Isoproterenol 
a1= + 49.6 
a2= - 49.8 ± 50 
Propranolol 
a1 = + 30.8 
a2 = - 31.2 ± 32 
Atropine 
a1= + 24.3 
a2= - 22.4 
N. A. 
Solvent:  ethanol.  
Temperature:  20 °C for propranolol and isoproterenol while 25 °C for atropine 
On the basis of the experimental results above, preparative column 
chromatography on PREP-SINU-PC proved effective for the isolation and collection of 
pure drug enantiomers. Enantiomers of b-blockers, atropine and bendroflumethiazide 
were successfully resolved on this HPLC column. The baseline of the chromatograms 
appeared stable and the results obtained were readily reproducible. This preparative 
 
1  [ ]20Da for propranolol is: the first peak: +49.6 (c=1, ethanol), second peak: -49.8. 
(Literature value: ± 50, Merck Catalogue, 1999/2000) 
2  [ ]20Da for iso-proterenol is: the first peak: +30.8 (c=1, ethanol), second peak: -31.2. 
(Literature value: ± 32.0, Merck Catalogue, 1999/2000) 
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column also exhibited good stability under a wide range of conditions and is efficient 
for preparative enantioseparation and collection of pure enantiomers.   
Techniques such as recycling and peak shaving can greatly improve yields and 
throughput, but large-scale separations may require large amounts of CSP and have 
been considered to be economically unjustifiable because of the high costs of CSPs, 
the high dilution conditions, the consumption of large amounts of mobile phase and the 
difficulties of recycling the mobile phase. However, arising from new developments, 
particularly simulated moving-bed chromatography (SMB), the technical prerequisites 
for cost-effective large-scale separations can now be met. The SMB mode can save up 









The effect of temperature on enantioseparation is important to chiral HPLC.234-
237 It is certainly a parameter, which has to be investigated during the  optimization of a 
separation procedure. For analytical or more particularly preparative chromatographic 
separations, only if good separation of the enantiomers can only be achieved at very 
high k’ values, working at elevated temperatures can often be bene ficial.  
Temperature changes have a great influence on the retention of solutes on 
cyclodextrin (CD)-bonded CSPs, particularly in reversed-phases conditions, when the 
enantioseparation is dependent mainly on the inclusion mode. This is attributable to the 
fact that the binding constant of a solute to the CD is significantly affected by 
temperature.49, 57, 100, 196, 238 For example, as temperature increases, the binding of the 
solute decreases rapidly to zero at a temperature range between 60 and 80 °C in most 
cases.  
Chromatographic studies using CD-bonded CSPs have shown that a decrease in 
the temperature almost always results in an increase in selectivity, but the same cannot 
be said for resolution. Increasing the binding constant of the solute in the CD cavity by 
lowering the temperature may lead to reduced resolution. This is due to a loss of 
efficiency, which is a consequence of a poorer mass transfer. The increasing selectivity 
and band broadening effects may work antagonistically and are hard to predict. 
Increasing the column temperature may even improve the separation of strongly 
retained solutes. Therefore, there is often an optimum temperature for a separation and 
knowledge of this temperature gives the analyst another factor to exploit in the method 
development process. It is often reported in the case of cellulose-based stationary 
phase that conformational changes from a semi-rigid form to a flexible form occurred 
with increase of temperature. This trend has been attributed to those changes of the 
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helical structure brought about by hydrogen bond breakage 239 and second-order 
transition. 240, 241 Such conformational changes should affect the geometry of the chiral 
cavities and consequently, influence the enantioselectivity of the CSP. Ringo 242 
reported on the thermodynamics on native b-CD-CSPs under reversed-phases. 
However, to our knowledge, there is no published report on the thermodynamic studies 
on fuctionalized b-CD-based CSPs in normal phase HPLC.  
In the normal phase mode, since H-bonding, p-p  interaction and dipole-dipole 
interaction are responsible for the retention and enantioseparations of the analytes, the 
temperature will greatly affect the inter-molecular interactions between CSPs and the 
analytes. However, this effect has not been studied.  
In this chapter, in detail, investigations on the thermodynamic studies of 
perfunctionalized CD-bonded CSPs in normal phase using SINU-PC, SINU-NC and 
ETHR-PC in the temperature range of 2 to 38°C are reported. Results reveal that 
enantioselectivities on these CSPs in normal phases was enthalpy dominated, with no 
conformational transitions observed within this temperature range.  
 
6.2 Theory of calculation 
In a chromatographic system, the distribution coefficient (K) of a solute in the 
stationary phase to mobile phase is a function of change of Gibbs free energy ( 0GD ) of 
the solute in two phases. 
( )000ln STHGKRT D-D-=D-=  6-1 
Where R is the gas constant, T is the absolute temperature.  
Substituting K with F/k  (is the phase ratio) gives 





































Where 0HD  and 0SD are the enthalpy and entropy, respectively, of the transfer 
of the solute from the mobile phase to the stationary phase and e is the bed voidage.  






























, indicating that lnF is independent on 
the temperature. Additionally, the selectivity ( )12 / kk=a  is a parameter of the 
enantioselectivity, which has the following (Equation 6-4) relationship with 0GDD  
(difference of 0GD  for two enantiomers), 0HDD  and 0SDD , which is difference of 
























In this case, a plot of lna vs. the reciprocal of the absolute temperature (known 


















. This relationship demonstrates that the enantioselectivity is independent on 
changes within the inspected temperature range. 
 
6.3 Experimental 
Enantioseparations of 1-(3-hydroxylphenyl)ethanol, 1-(4-bromophenyl)ethanol 
and brompheniramine were carried out on SINU-PC, SINU-NC and ETHR-PC, 
respectively. The mobile phases comprised the mixtures of n-hexane and 2-propanol 
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(IPA) with the ratio of 90-10, 80-20, 70-30, 60-40 and 50-50 (v/v). Chromatographic 
data were collected in 5 °C increments within the temperature range of 2 to 38 °C. All 
data were repeated at least twice to determine their precision, accuracy and 
reproducibility. 
 
6.4 Results and discussions 
 
6.4.1 Thermodynamic studies on SINU-PC and SINU-NC. 
To illustrate the effects of temperature on the retention behavior and the 
enantioseparation, 1-(3-hydroxylphenyl)ethanol and brompheniramine were chosen as 
the test probes on SINU-PC and SINU-NC. The effects of temperature on the k’ of the 
enantiomers of these two samples are presented in Figures 6.1, 6.2 to 6.3.  
Chromatographic data indicate that an increase in the temperature causes a 
decrease in the retention, selectivity and resolution of enantiomers. For 1-(3-
hydroxylphenyl)ethanol, within the investigated temperature range of 2-38°C, a 





















Figure 6.1 Effect of temperature on k’ and a of 1-(3-hydroxyphenyl) ethanol.  
  Mobile phase: n-hexane: IPA = 60 : 40 (v/v) 
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Meanwhile, van’t Hoff plots for 1-(3-hydroxylphenyl)ethanol and 
brompheniramine are given in Table 6.2 and 6.3, respectively. As expected, good 
linearity is observed for 'ln k and aln  vs. 1/T within the whole temperature range 
tested. This trend remained unchanged when the different compositions of mobile 
phases were used. This result differs from that reported for cellulose derived CSPs, 
which exhibited a transition point instead of being linear. According to the equation 6-
4, 0HDD  and 0SDD  of these two samples can easily be eva luated from the slope and 
intercept of the van’t Hoff plots. From the slope, enthalpy of binding of the first 
component of 1-(3-hydroxyphenyl)ethanol and brompheniramine are –1.93 and –2.60 
kcal mol-1, respectively. This indicates that when the enantiomers of these two samples 
are removed from the mobile phase to SINU-PC, the relatively weak analyte-solvent 
interactions are replaced by strong solute-CD specific interactions through attractive 
H-bonding, van der Waals and dipole-dipole interactions between the rim of b-CD and 
the hydrophobic portion of the analyte, which results in the negative 0HDD  values. 
Consequently, it is energetically more favorable for the analytes to interact with the 
hydrophobic rim and their transfer from the mobile phase to the stationary phase are 
enthalpy-driven.  
On the other hand, from the intercept of van’t Hoff plots, entropy of binding to 
SINU-PC for 1-(3-hydroxylphenyl)ethanol and brompheniramine are –4.06 and –7.36 
cal mol-1K-1, respectively. The strong interactions between the hydrophobic rim of the 
b-CD and the enantiomers resulted in loss of freedom for the racemates at the 
interaction sites leading to negative 0SDD . These results further indicate that 


























Figure 6.2 Van’t Hoff curves for k’ and a of 1-(3-hydroxyphenyl)ethanol on SINU-PC.  






























Figure 6.3 Van’t Hoff plots for k’ and a of brompheniramine on SINU-NC.  
  Mobile phase: n-hexane : IPA= 80 : 20, v/v. 
 
In order to examine the relationship between the concentrations of polar 
organic modifier (IPA) and the thermodynamic parameters during the 
enantioseparation process, a plot of 0HDD  vs. 0SDD  under five conditions with 
different compositions of n-hexane and IPA showed that a good linearity with r2 of 
0.9997 was observed. (Figure 6.4) Their data are summarized in Table 6.1.  
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Figure 6.4 Enthalpy-entropy compensation for brompheniramine on SINU-NC with 
n-hexane/IPA as the mobile phase. 
Table 6.1 Influence of the mobile phase concentration on 




0HDD  (kcal/mol) 0SDD  (cal.mol-1 K-1) 
90/10 -2.37 -6.75 
80/20 -2.60 -7.36 
70/30 -2.66 -7.55 
60/40 -2.78 -7.88 
50/50 -2.94 -8.33 
Sample: brompheniramine. CSP: SINU-NC 
We may be able to observe the phenomenon known as “enthalpy-entropy 
compensation”, which is illustrated graphically by a linear relationship between 0HDD  
and 0SDD  under different IPA concentrations. In details, from Table 6.1 we may know 
that 0SDD  decreased from -6.86 to -8.33 cal mol-1K-1 with increasing concentration of 
IPA from 10 to 50%. However, with the increasing ratio of IPA in the mobile phase, 
the rate of decrease of 0HDD is much greater than that of 0SDD . According to equation 
6-4, the change of 0GDD  is the result of combination of changes in 0HDD and 0SDD . 
Therefore, the greater increasing rate of 0HDD  will compensate the loss of 0SDD . The 
resulting effect is the limitation of smaller change in 0GDD . 
 139
 
6.4.2 Thermodynamic studies on ETHR-PC. 
Using similar procedure, 1-(4-bromophenyl)ethanol was used as the test probe 























Figure 6.5 Effect of temperature on k’ and a of 1-(4-bromophenyl)ethanol on ETHR-PC.  




























Figure 6.6 Van’t Hoff curves for k’ and a of 1-(4-bromophenyl)ethanol on ETHR-PC.  
  Mobile phase: hexane: IPA = 70: 30, v/v. 
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Table 6.2 Influence of the mobile phase concentration on 0HDD  and 0SDD   
Solvent composition 
(hexane/IPA) 
0HDD  (kcal / mol) 0SDD  (cal mol-1 K-1) 
80/20 -2.93 -3.58 
70/30 -4.34 -8.02 
60/40 -4.65 -9.45 
50/50 -6.96 -18.66 
Sample: 1-(4-bromophenyl)ethanol, CSP: ETHR-PC 























Figure 6.7 Enthalpy-entropy compensation for 1-(4-bromophenyl)ethanol on ETHR-
PC with n-hexane/IPA as the mobile phase. 
Results of Figure 6.5 and 6.6 revealed that a similar trend is observed on 
ETHR-PC as in SINU-PC and SINU-NC in its thermodynamic behavior. These results 
demonstrated that changes of temperature have the similar effects on enantioseparation 




Chromatographic Properties of Chiral Stationary 





As discussed in Chapter 2 to 5, three series of novel chiral stationary phases 
(CSPs) were synthesized in both analytical and preparative scales depicting good 
enantioseparation abilities. Meanwhile, they also exhibited unique chromatographic 
properties, which are dependent on their special structures, such as the substituents at 
the b-cyclodextrin (b-CD) and different immobilizations onto the divergent surfaces of 
silica gel. Additionally, the enantioseparations may also be affected by the 
manipulation of solvent systems, buffers, and ionic strength of additives, etc.  
In this chapter, chromatographic properties of these CSPs and the influence of 
these factors are discussed in details.   
 
7.2 Interactions between CSPs and analytes 
Although it is difficult to determine the exact model or mechanism for 
enantioseparations of racemates on CSPs by HPLC, researchers are still trying to 
depict the possible explanations on the basis of experimental data. Nowadays, it is 
agreeable that the enantioseparations are results of multi- interactions occurring 
between the CSPs and analytes in different media. 
There is a general concurrence that the mechanisms for enantioseparations are 
different for normal phase (NP) and reversed-phase (RP) HPLC.  
In the NP mode, the cavity of the cyclodextrin is most likely occupied by the 
hydrophobic mobile phase, so that the hydrophobic interaction between the solute and 
CSPs is very weak. Consequently, the chiral recognition may be the result of 
hydrogen-bonding (H-bonding), p-p  interaction and steric hindrance provided by the 
aromatic and carbonyl substituents atop the CD cavity like a "lid" rather than inclusion 
complex.  
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However, for most RP-HPLC, the formation of an inclusion complex between 
the hydrophobic moiety of the analyte and the relatively non-polar CD cavity seems to 
be an essential step.  
There are several requirements for chiral recognition by CD-bonded CSPs in 
RP HPLC.  
1) The sizes for both CD cavity and enantiomer are of critical importance. 
Obviously, if the diameter of a molecule is significantly larger than the mouth of the 
CD cavity, no inclusion complex can be formed. If a molecule is much smaller than 
the cavity of the CD, inclusion complex can be formed but the binding constant (Kf, 
Equation 1-2) is often lower than that for "tighter- fitting" molecules. The formation of 
a relatively tight complex seems to improve chiral recognition on CD-CSPs because it 
may help prevent extensive rotation of the chiral molecule in the CD cavity and 
disallow it to adopt the minimum existing energy. This may cause increases in energy 
differences between [(R-solute)-CSP] and [(S-solute)-CSP] complexes thus improving 
the enantioseparation.  
For example, a-CD will only be able to include single phenyl or naphthyl 
group’s end-on. b-CD will accept naphthyl group and heavily substituted phenyl 
group. Possessing the largest cavity, g-CD is useful for bulky steroid-type molecules. 
However, to have a "tight- fitting" in CD cavity, the entire molecule does not 
need to fit inside the CD cavity for an effective separation but at least a portion of the 
molecule must be tightly complexed.  
It must be emphasized that inclusion complex alone is not sufficient for chiral 
recognition. Thus, other interactions such as H-bonding and/or steric interactions 
external to the CD cavity should be present. It can be demonstrated by the fact that 
higher selectivities usually were obtained using the aryl isocyanate-derivatized phases 
 144
rather than analogous ester- linked moieties. This is thought to be the result of 
additional sites for H-bonding and stronger dipole-dipole interactions with the 
carbamate linkages relative to the ester linkages. 
2) To achieve an enantioseparation, it is beneficial for the analyte to have 
a "chiral center" or other substituents from the "chiral center" that is near and can 
interact with the mouth of the CD cavity, and there must be an aromatic group for 
inclusion in the cavity. Meanwhile, the 2- and 3-hydroxyl groups and/or their 
substituents located at the mouth of the CD cavity appear to be particularly important 
in the chiral recognition.  
If an analyte has a chiral center between two aromatics or between a carbonyl 
and an aromatic group, it will almost certainly be separable by a CD-CSP. Aromatic 
groups will be preferentially attracted into the CD cavity if they have a substituent as 
following:  
a) The strength of inclusion into CD cavity has been found to follow the 
order of: 
I > Br > Cl > F > NO3 > SO3 > OH 
b) The preferred order of H-bonding with CD hydroxyls is: 
Carboxyls > carbonyls > amines.  
Separation will be better if the H-bonding groups in the analyte are brought into 
close proximity to the surface hydroxyls.   
Herein we use SINU-NC as an example, to explain the interaction sites 
provided by our CSP. (Figure 7.1) 
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Figure 7.1 Interaction sites in  mono-(6-azido-6-deoxy)-pernaphthylcarbamoylated-b-CD  
By forming the above structure, this CSP may play three functions, that are 1) 
chiral recognition ability mainly provided by the CD cone; 2) multi- interaction sites 
such as H-bonding, hydrophobic interactions derived from the naphthyl clusters at the 
mouth of the CD cavity; and 3) significantly improved stability on account of the 
stable urea linkages with the silica gel, especially in RP with high aqueous content. 
The aromatic rings at the mouths of CD cavity provide the p-basic and p-p interaction 
sides in NP with mixtures of hexane/IPA as mobile phase. The carbamido groups 
between aromatic rings and b-CDs provide H-bonding and donor/acceptor sites for 
chiral complex that will be favorable in polar organic phases. The CD cavity lends 
itself to form the inclusion complex that is most likely effective in RP. The urea 
linkages between the CDs and silica gel provide strong interaction sites for H-bonding 
and donor/acceptor sites that will be effective in polar organic phases. The amino 
groups on the surface of silica gel provide H-bonding sites. However, it plays a 
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negative role to enantioseparation because it may compete with the other interaction 
sites to reduce the enantioseparation.  
The detailed explanations of these interactions are as follows.  
 
1 H-bonding.  
The important role that H-bonding in enantioseparation was demonstrated on 
SINU-PC by the separations of a series of (1-aryl)ethanols (shown in Table 2.5), 2-
phenyl butane and 2-phenyl hexane using hexane-IPA (90/10) as the mobile phase. It is 
obvious that the latter two samples do not have interaction sites for H-bonding. It is 
interesting to see that all the (1-aryl)ethanols were easily separated with their 
selectivities (a) ranging from 1.1 to 2.2. On the contrary, 2-phenyl butane and 2-
phenyl hexane did not afford separation at all. Additionally, H-bonding also affects the 
retention times of analytes, which can be proved by k1-(p-methoxyphenyl)ethanol> k1-(p-
methylphenyl)ethanol. This clearly indicates that the H-bonding is essential for 
enantioseparation on this CSP.  
When the chiral carbon is at the b-position of the aromatic ring, such as 1-
benzyl ethanol, no enantioseparation could be achieved under the same condition with 
the other analytes, which indicates that higher rigidity of the chiral carbon is beneficial 
to the enantioseparation. Furthermore, comparing the separation results achieved on 
the analytes where the substituted group is at the para, ortho or meso position of the 
aromatic ring, the best enantioseparation was achieved by para-position substitution. 
For example, a1-(p-bromophenyl)ethanol> a1-(o-bromophenyl)ethanol, a1-(p-methoxyphenyl)ethanol> a1-(m-
methoxyphenyl)ethanol. Obviously the least steric hindrance at the para-substituted position is 
more favorable to the H-bonding interaction, thus leading to better enantioseparation. 
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H-bonding also largely affects the retention times which can be easily proved by k1-(p-
methoxyphenyl)ethanol> k1-(p-methylphenyl)ethanol. 
 
2 p-p Interaction.      
p-p  Interaction plays an important role in the chromatographic process 
particularly when the stationary phases have substituents as phenyl / naphthyl 
carbamates. This can be demonstrated by the retentions of a series of aromatic 
compounds using hexane/IPA= 90/10 as the mobile phase on SINU-NC. (Figure 7.2) 
Their retention times follow the order of: ttoluene< tbenzene< tnaphthalene< tacenaphthene< 
tacenaphthylene< tphenanthrene< tpyrene< tanthracene. It is obvious that with the sequence of 
benzene, naphthalene, acenaphthylene, acenaphthylene to pyrene, the conjugated 
system becomes bigger, where their p-p  interactions with SINU-NC become stronger 
which increase their retention times with the same sequence. Of which, anthracene 
eluted slower than pyrene, which may be caused by the bulk steric hindrance of the 
pyrene molecule. Comparing toluene with benzene or acenaphthylene with 
acenaphthene, the compound with bigger conjugated system (benzene and 
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1: toluene;  
2: benzene;  
3: naphtha lene;  
4: acenaphthene;  
5: acenaphthylene;  
6: phenanthrene;  
7: pyrene;  
8: anthracene 
Figure 7.2 Retentions of aromatic compounds on SINU-NC.  
 Mobile phase: Hexane/ IPA =90/10, Flow rate: 1.0  ml min-1; Detection: 254nm;  
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Furthermore, the influence of p-p  interaction of the enantioseparation can be 
demonstrated by the enantioseparations of (1-aryl)ethanols that the selectivities (a) 
increased with the sequence of a1-(p-methoxyphenyl)ethanol < a1-(p-methylphenyl)ethanol < a1-
phenylethanol < a1-(p-chlorophenyl)ethanol < a1-(p-bromophenyl)ethanol on SINU-PC. This clearly 
indicates that with the increasing electron-withdrawing ability of the substituted groups 
on the analytes, the enantioseparations increase. In particular for racemates with 
halogen (Br, Cl) substituted groups, enantioseparations with a of 2.0 and Rs of 6.55 
were easily achieved.  
Similar trend can also be observed in RP-HPLC by the enantioseparation of 
substituted pheniramines.  
The above experiments clearly show that p-p interaction is crucial to affect the 
retentions and enantioseparations of analytes in both NP and RP.  
  
7.2.1 Substituents of the b-CD-based CSPs 
Substituted groups at the b-CD rims of the CSPs also have different effects on 
the enantioseparation. In general, to our CSPs, those with naphthyl groups 
demonstrated better enantioselectivity under RPs than in NP, while those with phenyl 
groups were found to be effective under both two phases. The CSP with methyl group 
did not show good enantioseparation ability under both NP and RP. Therefore, the 
enantioseparation abilities of the CSPs are following the sequence of : 
In RP: 
· Naphthyl » Phenyl > Methyl 
While in NP: 
· Phenyl > Naphthyl > Methyl  
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Generally, CSPs with phenyl and naphthyl substituents are suitable for 
compounds such as amines, b-blockers or tropines, while methylated CSPs exhibits 
fair enantioseparation ability towards some weak acids such as benzoin and 
dihydrobenzoin. The reason may be explained by the carbamido groups presented in 
phenyl-/ naphthylcarbamoylated-CSPs to form excessively strong interactions with 
acids and retain them in column, thus limiting their enantioseparation abilities.  
SINU-PC and SINU-NC were prepared by attaching the b-CD derivatives to 
silica gel via stable urea linkages, that are hydrolytically stable177 in solvents. The 
introduction of phenyl/naphthyl groups brings into hydrophobic clusters, as well as 
somewhat extending the CD cavity and thus making it more flexible and hydrophobic.  
On the other hand, these aromatic rings also provide sites for steric repulsion at 
the mouth of the CD. These interactions can significantly alter the enantioselectivity of 
the CD. Steric repulsion between the analyte and the CD-CSPs can affect the strength 
of an inclusion complex but in a negative manner.  
To SINU-ME, since the substituted methyl group is such a group that the steric 
hindrance and interaction with analytes are very weak, it can neither extend the cavity 
nor introduce H-bonding/ hydrophobic interaction effectively. Therefore, the methyl 
groups did not show great influence to the enantioseparation ability thus making this 
CSP less effective.  
 
7.2.2 Immobilization methods 
As described above, three series of functionalized b-CD derivatives were 
immobilized onto silica gel in different manners, thus resulting in different chemical 
structures of CSPs. Therefore, in order to inspect the influence of the immobilization 
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methods on enantioseparation abilities of these CSPs, a comparison study between 
these CSPs was accomplished and results showed that: 
In NP mode, for most racemic aromatic alcohols, SINU-CSPs and ETHR-CSPs 
showed excellent enantioseparation abilities. 
In RP mode, although the three series of CSPs exhibited excellent chiral 
recognition abilities to most analytes, SINU-CSPs afforded the best results in terms of 
highest selectivities, resolutions and widest varieties of separated racemates.  
For those racemates with more than one optical center, ETHR-CSPs showed 
exceptional chiral resolution ability. 
On the other hand, the preparations of SINU-CSPs and HEPT-CSPs involved 
the aminized silica gel whose surfaces are slightly basic, thus make the resulting CSPs 
unsuitable for separating weak acids. However, the crosslinking in HEPT-CSPs 
showed improved anti-eluting ability in aqueous phase than the other two series of 
CSPs. 
 
7.2.3 Enantioseparated racemates 
On account of the complicated structures of the racemates, the 
enantioseparation mechanisms are usually hard to elucidate. As we discussed in 
Chapter 1, the hydrogen bonding, p-p interaction, dipole-dipole interaction, complex 
ability and the steric hindrance of analytes can contribute to the enantioseparations of 
racemates thus making them difficult to be predicted.  
In summary, our CSPs are good in the enantioseparations of racemates 




Table 7.1 Enantiomers resolved on our CSPs. 







































5. Asymmetric intermediates 
Chiral phenyl 







Nadolol, labetalol etc   ETHR-PC,  
ETHR-NC 
 
Generally, the racemic (1-aryl)ethanols and some of the b-blockers such as 
propranolol and metoprolol afforded enantioseparations on PC-CSPs in NP. While in 
RP, most analytes could be enantioseparated on all the CSPs. SINU-ME was effective 
to non-protolytic and weak acids in RP, while ETHR-CSPs exhibited unique 
enantioseparation abilities to chiral phenyl dihydrotrazines and racemates with more 
than one chiral centre such as nadolol and labetalol.  
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7.3 Optimization of enantioseparation conditions 
 
7.3.1 Mobile phase effects 
7.3.1.1 Polar modifiers 
Since inclusion complex may be formed easily in aqueous and polar organic 
phases, CD-based chiral HPLC columns have been used predominantly in the RP 
mode.243 Inclusion constants usually have higher values in water and tend to decrease 
upon addition of sufficient quantities of organic modifier, and bind ing strengths of 
substrates to CD are reduced in organic-aqueous systems compared with those in water 
alone. Therefore, in RP, retention can be increased by increasing the proportion of 
water/aqueous in the mobile phase. 
MeOH and CH3CN have been used as the most common organic modifiers. 
Since CH3CN has a much greater affinity for the CD cavity than MeOH, it has 
approximately four times the eluting power than MeOH. The selectivity can sometimes 
differ with these two organic modifiers. Currently, it is difficult to predict which 
modifier will produce the better separation in any given case. However, many of the 
published separations have been achieved using MeOH/water mixture and the choice is 
usually to try MeOH first. 
In this thesis, the sample 4,6-diamino-1-(3-nitro-phenyl)-1,2-dihydro-2,2-
dimethyl-s-triazine hydrochloride (M-NT) was used to demonstrate the difference of its 
enantioseparation behaviors in CH3CN and MeOH on ETHR-NC. (Figure 7.3) Results 
show that the enantioseparation in CH3CN was better than that in MeOH in terms of 
selectivities and resolutions. Furthermore, CH3CN gave better enantioseparations for 
M-NT in terms of better peak asymmetry and shorter retention times than MeOH did.  
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MeOH (or CH3CN)/TEAA (0.2%, pH: 6.0)= 45/55 (v/v) 
MeOH 
a= 1.04, Rs=1.05 
 
CH3CN 
a= 1.44, Rs= 1.75 
 
Figure 7.3 Enantioseparations of M-NT in MeOH (or CH3CN)/ buffer on ETHR-NC  
For the NP mode, the mixture of hexane and 2-propanol (IPA) is generally used 
as mobile phase.244-247  
In this thesis, propranolol was chosen on SINU-PC to study the effects of 
varying proportions of alcohol modifiers on the retention factors (k’) and selectivity 
(a). Under both NP and RP, where hexane/IPA and CH3CN/water were applied as 
mobile phases, respectively, the proportion of IPA in NP and CH3CN in RP were 
varied from 5-40%. (Figure 7.4)  
The results in Fig 7.4a show that in NP, the increasing IPA content resulted in a 
significant decrease of k’ for each propranolol enantiomer. A similar phenomenon was 
observed under RP with increasing content of CH3CN in Fig 7.4c. This can be 
explained by the weaken H-bonding and dipole-dipole interaction with increasing IPA 
or CH3CN contents. 
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Figure 7.4a-b)  Influence of the IPA proportion on k’ and a for each enantiomer on SINU-PC. 
   Mobile phase, hexane/IPA, Detection, 230 nm. Flow rate: 1.0  ml  min-1 
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Figure 7.4c-d)  Influence of CH3CN proportion in RP on k’ and a  for each enantiomer on 
SINU-PC.  
 Mobile phase: water/CH3CN; Detection: 230 nm. Flow rate: 1.0 ml min-1 
 
Interestingly, regardless of whether enantioseparations were effected in NP or 
RP conditions, the enantioselectivities (a) were essentially unchanged within the entire 
range of modifier contents. (Fig 7.4b and 7.4d). This suggests that, at a constant 
temperature, the [enantiomer-CSP] association is not affected by the modifier 
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concentration. It is mostly possible that enantioseparation is a result of multi-model 
modes, that is, there should be a leading interaction such as H-bonding or hydrophobic 
interaction that determines the retentions of enantiomers and at least one another type 
of interaction, such as p-p interaction, dipole-dipole interaction, that is independent on 
solvent polarity and responsible for enantiomeric selectivity. If under RP, the complex 
ability of cyclodextrin is another important contribution.  
Another interesting phenomenon is that the elution order of the R and S 
components of enantioseparated analytes followed a similar sequence under both NP 
and RP. Thus, on SINU-PC, with propranolol as an example, the elution order was 
always S before R. Furthermore, (+)-1-(4-bromophenyl)ethanol and (+)-1-(4-
chlorophenyl)ethanol were always eluted out before their respective (-) enantiomers. 
These results indicate that despite the great chromatographic difference between the 
NP and RP, the determining factors for enantioseparation are similar. 
 
7.3.1.2 Solvents 
The solvents also plays an important role in affecting enantioseparations, which 
is reflected by changing the retention times, selectivities and resolutions of racemates. 
Mostly it affects the efficiency of the active adsorption sites on CSPs, interactions 
between analytes and CSPs, and even the size and shape of the chiral cavities.248-249 
In this thesis, the mixtures of hexane and several alcohols were applied as 
mobile phases in NP, as well as the mixtures of MeOH (or CH3CN) and water (or 
buffer) were applied under RP conditions. Results indicate that the mixtures of 
hexane/IPA and MeOH/buffer (or MeOH/water) were the most suitable solvent 
systems for the best enantioseparations.  
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With 1-(4-bromophenyl)ethanol as a typical example, it gave excellent 
enantioseparation results with a 2.0 and Rs 6.55 on SINU-PC using hexane/IPA 
mixtures 90/10 (v/v). (Table 2.5) However, its enantioseparation tend to decrease in 
the mixture of hexane/1-propanol mixture, and the CSP failed to achieve 
enantioseparations in mixtures of hexane/acetone, hexane/1-butanol, hexane/THF and 
hexane/CHCl3.   
 
7.3.1.3 Compositions of mobile phase 
Composition of the mobile phases is expected to be an essential factor to 
enantioseparation. When increasing proportion of solvents with high polarity or strong 
eluting ability in the mobile phase, the analytes will not have sufficient time to interact 
with the chiral selector, which may decrease the resolution. However, a decrease in the 
organic content in the mobile phase may cause excessively long retention time that 
may not be beneficial to the enantioseparation by the long-tailing and broaden peaks, 
which is also regarded less valuable in HPLC. Therefore, the optimal composition and 
its effect on the enantioseparation are worth investigating.  
Using metoprolol, 1-(4-bromophenyl)ethanol in NP and bendroflumethiazide, 
M-NT in RP, the influences of the composition of the mobile phases represented by 
retention factors (k¢), selectivities (a) and resolution (Rs) were studied on the SINU-
PC. Under NP, the mobile phases employed herein were mixtures of hexane/ IPA with 
the percentage of IPA varied from 0.5 to 20.0%. Meanwhile, under RP, the mobile 
phases applied were mixtures of CH3CN/ water (or 0.75% TEAA buffer, pH: 5.0) with 
the CH3CN content varied from 30-45% for bendroflumethiazide and 25-75% for M-
NT, respectively. The results are showed in Figure 7.5. 
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Figure 7.5a) Effects of2-propanol content on k¢, a and Rs for metoprolol in NP. 
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Figure 7.5b) Effects of IPA content on k ¢, a and Rs for 1-(4-bromophenyl)ethanol in NP 
From Fig 7.5a-b, we may know that both metoprolol and (1-4-
bromophenyl)ethanol achieved good enantioseparations within this mobile phase 
compositions ranges. The a for metoprolol changed from 1.41 to 2.17, with Rs from 
1.97 to 2.57, respectively, and that for 1-(4-bromophenyl)ethanol fell in ranges of 1.82 
to 2.5 and 4.0 to 6.21, respectively. All these values afforded the base- line resolutions 
for the accuracy of the experiments.  
As expected, the capacity factors decreased with an increase in concentration of 
IPA. However, it decreased greatly at the beginning when the concentration of IPA 
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was changed from 1% to 5%. For IPA content above 5%, the decreasing rates for k’ 
became slower and the retention factors kept unchanged after the IPA content reached 
15%.  
However, a and Rs showed different trends with k’. For a, it increased with the 
increasing IPA content and became stable in the value after the IPA content reached at 
15% by giving the highest values of 2.17 and 2.5 for metoprolol and 1-(4-
bromophenyl)ethanol, respectively and kept unchanged after that. On the other hand, 
Rs increased with the increasing IPA content and afforded the highest values of 2.57 
for metoprolol and 6.18 for 1-(4-bromophenyl)ethanol, respectively, when the IPA 
content was 10%. However, Rs decreased with the increasing IPA content after this 
point. The above results indicate that on the same CSPs, these two samples achieved 
the similar optimal conditions, that is, when using hexane/IPA=90/10. (v/v) 
Under RPs, (Figure 7.5c-d) bendroflumethiazide and M-NT also depicted 
similar trends. The k’ for both samples decreased greatly with increasing CH3CN 
content, as well as that for Rs, which decreased from 1.47 to 0.75 for 
bendroflumethiazide and 2.55 to 0.88 for M-NT. However, within the inspecting range 
of CH3CN content, a for both samples kept unchanged, which demonstrate that a is 
independent on the organic content. Therefore, the optimal condition for both samples 
should be CH3CN / water = 30/70 and CH3CN / TEAA = 20/80 (v/v), respectively.  
It should be noted that in RP, we started our experiments at a 20% CH3CN 
content for M-NT. (Figure 7.5c-d) That is due to the reason that low content of CH3CN 
may give excessively long retention time and broad peaks with long tailing, which is 
less valuable for enantioseparations for HPLC, as described previously.  
By the similar reason, we stopped the experiments at IPA content of 20% in NP 
and CH3CN content of 45 and 75% for bendroflumethiazide and M-NT in RP.  
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Figure 7.5c) Effects of CH3CN content on k¢, a and Rs for bendroflumethiazide in RP 
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Figure 7.5d) Effects of CH3CN content on k¢, a and Rs for M-NT in RP 
It has to be emphasized that on the same CSP, different samples may afford 
different optimal conditions or divergent trends for k, a and Rs versus the polar 
organic content. It is reasonable because the mechanism for enantioseparation is the 
results of combination of multi- interactions. Different analytes may have divergent 
interactions sites with CSPs which result in specific properties.  
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7.3.2 Effects of pH value and salt under RP mode  
Buffer is also important in enantioseparation process. Adding a small amount of 
salt to the mobile phase usually has a significant effect on both the retention and the 
resolution. We believe that adding the buffer produce three effects to improve the 
chiral resolution.  
1) It controls the ionization of analytes that have weak acidic or basic functional 
groups thus makes it act as H-bond acceptors or donors. Whether the chiral 
solute is neutral or in an ionized state has a lot influence on its retention and 
selectivity on the column. The separation of b-blocker gave a very good 
example on this aspect. When no buffer is introduced, the drugs gave very 
poor separations excluding propranolol. After introducing the buffer, most 
drugs obtained baseline separations.  
2) pH control can eliminate or increase the interaction of a functional group with 
the CD or change its H-bonding ability.  
3) The buffer may sometimes enhance column efficiency by masking excessive 
adsorption sites on the surface of CSPs. As a result, the surface of CSPs will 
be smoother, which gives higher efficiency and better enantioseparation 
abilities. 
On the other hand, even if there is no ionization of the analyte, addition of 
buffer may still affect separation. It tends to decrease retention in effect acting like 
additional organic modifier. As the result, with the addition of salts, retention and 
resolution can be improved markedly due to a narrowing peak width. In particular, pH 
shows the greatest effect when it is close to the pKa of the compound.  
It has to be emphasized that all salts seem to produce beneficial results, some 
are better than other. Buffers that can be used with CD-CSPs are trifluoroacetic acid, 
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triethylammonium acetate (TEAA) and phosphate buffers. TEAA is often 
recommended as a salt additive because it is relatively non-corrosive and can be used 
to adjust the pH. In some cases, enantiomeric resolution can be obtained at one pH but 
not another.  
In our study, TEAA and triethylamine phosphate (TEAP) were applied to 
compare their difference in affecting enantioseparation. They make for interactions 
with the amino groups present in the spacer and also with those of the solute structure. 
Acetic acid can also give H-bonding interactions with the carbonyl groups of the 
carbamate moiety, which introduces a steric hindrance at the entrance of the CD 
cavity.  
 
7.3.2.1 Buffer types 
In this thesis, M-NT was tested on ETHR-NC using CH3CN/Buffer (0.2%, pH: 
5.0) mixtures as mobile phases, where the buffers applied herein were TEAA and 
TEAP. (Figure 7.6) Results indicate that TEAA gave better enantioseparation than 
TEAP in terms of higher a and Rs. In addition, TEAA also proved effective to most 
analytes while TEAP was only effective to some analytes.  
M-NT 
In triethylammonium acetate  
a=1.44,         Rs=1.75 
In triethylammonium phosphate 
a=1.58,        Rs= 1.56 
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Figure 7.6 Effects of buffer using M-NT as analyte.  
  Mobile Phase: CH3CN / buffer (0.2%, pH=5.0) = 45/55 (v/v) 
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7.3.2.2 pH values of buffer 
In general, pH ranges in 3.0 to 8.0 are used for CD-bonded CSPs, because at 
pH lower than 3.0 it is possible to cleave the cyclodextrin groups while at pH higher 
than 8.0, the silica gel surface may be destroyed.  
In this thesis, the influence of pH value on the enantioseparation was firstly 
investigated on ETHR-NC using M-NT and O-Br (4,6-diamino-1-(2-bromo-phenyl)-
1,2-dihydro-2,2-dimethyl-s-triazine hydrochoride) under different conditions, 
respectively, with the pH range of 3.8 to 6.5.  
In the mobile phases using CH3CN / TEAA (or TEAP) = 45/55 (v/v), O-Br and 
M-NT demonstrated the effects of ionic strength on the enantioseparation. (Figure 7.7) 



































Figure 7.7a) Effect of pH on k’, a and Rs for O-Br. 
In mobile phases comprising TEAA buffer, retention times / retention factors of 
analytes increased with increasing pH value. However, selectivities did not show 
obvious changes and Rs reached the highest value at pH 5.5 and slightly dropped when 
the pH were 6.0 and 6.5 for O-Br. (Figure 7.7a) 
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Figure 7.7b) Effect of pH on k’, a and Rs for M-NT. 
 
The similar trend was also observed for M-NT in mobile phase employing 
TEAP buffer. (Figure 7.7b) However, it was difficult to obtain the best condition for 
enantioseparation in terms of Rs.  
The above results demonstrate that variation in pH values plays an important 
effect on the enantioseparation in RP conditions. In addition, TEAA and TEAP proved 
to be suitable buffers for cyclodextrin columns.  
 
7.3.2.3 Concentrations of buffer 
The influence of buffer concentration on enantioseparation was also studied 
using P-OM (4,6-diamino-1-(4-methoxy-phenyl)-1,2-dihydro-2,2-dimethyl-s-triazine 
hydrochoride) on HEPT-NC. The composition of the mobile phase was TEAA / 
CH3CN = 60/40, with the pH value at 5.0. The buffer concentrations varied from 0.25-
2.0%, because the HPLC column lost the enantioseparation ability when buffer 
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Figure 7.8 Effect of concentration of TEAA on k', a and Rs of P-OM.  
The concentration of TEAP was also tested and the results show that the CSP 
exhibited good resolution when the concentration fell in the range of 0.1 to 0.25%, and 
the CSP lost the enantioseparation ability after the concentration above 0.3%. 
Results also demonstrate that the retention factors and resolution decreased 
with the increasing buffer concentration. However, selectivity did not show obvious 
change throughout the whole experimental conditions.  
 
7.3.3 Effect of the flow rates of mobile phases.  
Both in NP and RP, the chromatography efficiency and flow rate are related. 
However, flow rate is rarely considered as a means of optimizing a separation, since 
short analysis times are usually a higher priority. Most enantioseparations are carried 
out at 0.5-2.0 ml min-1 for CD-bonded CSPs. 
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In this thesis, flow rate in RP was inspected upon the requirement of the 
optimization condition for collection of optical-pure enantiomers. In general, a suitable 
speed of analysis with baseline resolution is highly valuable on account of the reduced 
cost and time-consume for semi-preparative HPLC analysis.  
In this work, O-Br was chosen as the example in the mobile phase of CH3CN/ 
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Figure 7.9 Influence of flow rate on retentions, selectivity and resolutions of O-Br 
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Results show that the retention times decreased with increasing flow rate. 
However, the retention factors (k’) reached the highest value when flow rate was 0.5 
ml min-1, and there was a marked decrease in resolution in going from 0.1 to 1.0 ml 
min-1, while selectivity did not show obvious changes in this flow rate range.  
According to the results, although resolution reached the highest value when 
flow rate was 0.1 ml min-1, we may not choose this condition because of excessively 
long retention time for each injection and collection of the enantiomers. Therefore, 0.5 
ml min-1 is a good choice for this purpose.   
 
 
7.3.4 Influence of the silica gel. 
As a support material for CSPs, silica gel can also play a crucial role in 
enantioseparation that its effects are worth inspecting. Generally, it may affect the 
enantioseparation abilities of resulting CSPs in column efficiency, surface properties, 
interaction sites, and so on. Therefore, in order to inspect the effects in detail, a wide 
variety of silica gels with different surface properties, particle size and shapes were 
applied and their chromatographic properties were compared.  
In this thesis, 5 different types of silica gels: Ggel, Hypersil, Hypersil-BDS5, 
Hypersil-BDS3 and Kieselgel 100 were employed to afford different CSPs derived 
from mono-(6-azido-6-deoxy)-perphenylcarbamoylated-b-CD. The surface areas, 
particle and pore sizes, surface properties of silica gels and column efficiencies for 
resulting CSPs are summarized in Table 7.2, while their carbon contents are listed in 
Table 7.3. 
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Table 7.2 Comparison of  CSPs on divergent silica gels.  





















































Irregular 15-35 100 400 12,000 
 
When the surface areas, particle and pore sizes of silica gels are fixed with 
similar surface properties, their shapes will obviously become the sole influencing 
factor that leads to the different  properties that related to their enantioseparation 
abilities. That is mainly because spherical (round-shaped) silica gel with uniform or 
narrow diffusion of particle size will lead to high column efficiency. Figure 7.10a and 
b gave the SEM of two species of silica gel (Ggel and Hypersil ) with different shapes.  
Table 7.3 Elemental analyses of the amino-functionalized silica gel and corresponding CSPs. 
Materials C% H% N% 
 Ggel 5.30 1.16 1.59 
2.5a Hypersil (spherical) 3.42 0.95 1.11 
2.5b Hypersil-BDS5 2.85 1.03 1.03 
2.5c Hypersil-BDS3 2.85 0.81 1.04 
Amino-
functionalized 
silica gels  
 Kieselgel 100 3.25 0.90 1.08 
 Ggel 14.23 1.84 2.63 
2.6a SINU-PC (spherical) 17.42 2.15 2.56 
2.6g SINU-PC-BDS5 9.03 1.32 1.74 
2.6h SINU-PC-BDS3 9.01 1.42 1.86 
Resulting CSPs  
5.1 PREP-SINU-PC 7.55 1.27 1.64 
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a)    Ggel silica gel with Irregular shape 
 
Beam: 10.0Kv, Magnitude: 4176x. 
 
Beam: 10.0Kv, Magnitude: 312x 
Figure 7.10a) SEMs for Ggel silica gel with irregular shapes. (Particle size is 5mm.)  
b)    Hypersil silica gel with spherical shape 
 
Beam: 10.0Kv, Magnitude: 5209x. 
 
Beam: 10.0Kv, Magnitude: 2083x 
Figure 7.10b) SEMs for Hypersil silica gel with spherical shapes. (Particle size is 5mm.) 
Compared with other bonded silica gel stationary phases, multiple-model CSPs 
exhibited characteristically high efficiency. This is one of the principal advantages for 
this class of chiral phases. Although there is little systematic documentation in the 
literature, these phases are clearly superior in this respect to most other types of CSPs.  
In general, the CD-bonded CSPs give the number of theoretical plates N 
varying over a range of 12,000-40,000 plate m-1 (3000-10,000 plates for the 25 cm 
columns most commonly available and utilized). However, each column may give 
variation in this figure because of the variable factors such as nature of CSP, 
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characteristics of the silica support, as well as the choice of mobile phases and from the 
number and type of polar functional groups present in the enantiomers when the 
analyte is adopt as the test probe in column efficiency.  
From Table 7.2 we may also know that the CSPs derived from Ggel (SINU-
PC1) and Hypersil-BDS5 (SINU-PC-BDS5) gave the column efficiencies as 18,000 
and 38,000 plates per meter, respectively. In comparison to the other published 
columns, our CSPs exhibited high column efficiencies.  
Although column efficiency is not the sole factor determining the 
enantioseparation ability for CSPs, it is essential to a good enantioseparation. For 
example, above 80% of racemates within the inspecting ranges obtained 
enantioseparations on SINU-PC, while only 10% of them were separated with 
relatively lower resolutions on SINU-PC1.  
Particle size is another key factor to affect the enantioseparation. For example, 
PREP-SINU-PC with the particle size range of 15-35mm exhibited lower efficiency 
compared to that on the analytical scale silica gel. Similarly, Hypersil-BDS3, with the 
particle size of 3mm, obtained an efficiency of 60,000 plates per meter that is much 
higher than tha t of Hypersil-BDS5, which has the particle size of 5mm. Thus, SINU-
PC-BDS3 obtained the best enantioseparations compared to SINU-PC1 and PREP-
SINU-PC by affording the highest Rs and a to the same samples at an optimal 
condition, while PREP-SINU-PC showed the poorest enantioseparation ability.  
However, smaller particles also incurs problems in the enantioseparation 
process. For example, small particle will produce a high flow resistance which is 
responsible for a poor chromatographic mass transfer. Thus, it may lead to higher pre-
column pressure which may greatly limit the choices for mobile phases and applicable 
conditions for the resulting column. According to the data in Table 2.7, SINU-PC-
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BDS3 did not show obvious advantages over SINU-PC-BDS5 for analytical 
enantioseparations.  
On the other hand, surface properties of silica gel also have much influence on 
the enantioseparations for CSPs. In this study, Ggel and Hypersil-BDS5, which have 
an untreated surface and based-deactivated surface, respectively, were applied for the 
enantioseparation for the study of effect on surface properties.  
Table 7.3 shows the difference in the carbon amounts for these two species of 
silica gel. In order to minimize the deviations during the synthetic procedure, the 
experiments have been repeated for three times and an average value was applied 
herein.   
To Ggel, the easy occurrence of aminization onto the untreated surface was 
demonstrated by the highest carbon and nitrogen contents of 5.30 and 1.59%, 
respectively. However, to Hypersil-BDS5, the carbon and nitrogen contents are much 
lower than that of the former, which is probably due to the less active hydroxyl groups 
on the surface.  
The difference in the carbon and nitrogen contents for the resulting CSPs 
further proved the influence mentioned above. SINU-PC obtained the highest carbon 
content of 17.42%, while SINU-PC-BDS3 and SINU-PC-BDS5 obtained relatively 
lower carbon amounts of only 9.01 and 9.03%, respectively.  
However, despite having the highest carbon content, SINU-PC did not show 
superior enantioseparation results over BDS-CSPs. This indicates that the higher 
content of loaded chiral selector is not responsible for the better enantioseparation 
abilities of CSPs.  
 






8.1 Chemicals, materials and apparatus 
Triphenylphosphine, phenyl isocyanate, naphthyl isocyanate were purchased 
from Sigma Chemical Co. (St Louis, Missouri). Pyridine (Merck) and N,N-
dimethylformamide (DMF) (Merck) were dried after refluxing with calcium hydride 
(Fluka) for 6 hrs and distilled. Tetrahedrofuran (THF) and benzene were from Merck 
and dried after refluxing with sodium (Merck) and distillation. Iodomethane and 
benzyl bromide were purchased from Merck. Nitrogen and carbon dioxide (99.9% 
pure) were purchased from National Oxygen Pte. Ltd, (Singapore). Sodium dihydrogen 
phosphate dihydrate, disodium hydrogen phosphate anhydrous, b-cyclodextrin (b-CD) 
(purified by recrystallization from water), 3-aminopropyltriethoxysilane were 
purchased from Fluka (Buchs, Switzerland).   
 
8.2 Instrumentation for structural analysis and 
characterization 
 
Mass spectra and Nuclear Magnetic Resonance Spectroscopy (NMR): 1H NMR 
and 13C NMR spectra were recorded on a Bruker ACF300 FT-NMR spectrometer 
using tetramethylsilane as an internal reference at room temperature. (23°C). Mass 
spectra were obtained using a Micromass 7034E Mass Spectrometer under electron 
impact.  
 
Fourier Transformation Infrared Spectroscopy (FT-IR) All the samples including 
b-CD derivatives, amino-functionalized silica gel and chiral stationary phases (CSPs) 
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were pressed into KBr pellets and recorded on Bio-Rad TFS165 spectrometer at room 
temperature (23°C).  
 
Elemental Analysis (EA) Elemental analyses of b-CD derivatives, amino-
functionalized silica gel and CSPs were performed on a Perkin Elmer 240C elemental 
analyzer for C, H, N and S determinations.  
 
Scanning Electron Microscope. (SEM)  SEM of the silica gels and CSPs were 
obtained on a Jeol JSM-5200 (Japan).  
 
8.3 HPLC part 
Carbon tetrachloride (Aldrich), dioxane (Aldrich), glacial acetic acid (Fluka), 
triethylamine (Merck), phosphoric acid and the solvents such as hexane, acetone, 
CH3CN, isopropanol, MeOH (Sigma) are of AR grade. Water was purified using 
Nanopure water system.  
The racemic (1-aryl)ethanols were prepared from the reduction of their 
respective ketones using lithium aluminum hydride. All the racemic drugs were 
purchased from Sigma and Aldrich Company. The pyrimidine series were kindly 
supplied by Dr. Chui Wai Keong of Department of Pharmacy, National University of 
Singapore. The 2-(1-phenylaminoethyl) cyclopentanone, 2-(phenylamino-pyridin-3-yl-
methyl) cyclopentanone were kindly supplied by A/P Loh T. P. of Department of 
Chemistry of National University of Singapore. Atropine sulfate, homatropine 
hydrobromide and (-)-scopolamine hydrobromide were supplied by Sigma (St. Louis, 
MO, USA). Eight synthetic drugs, namely tropinyl cyclohexylphenylacetate (TCPA), 
tropinyl cyclohexylphenylglycolate (TCPG), tropinyl cyclohexylphenylpropionate 
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(TCPP), tropinyl 2-phenylpropionate (TPP), N-methyl-1-4-piperidinyl 
cyclohexylphenylacetate (NCPA), N-methyl-1-4-piperidinyl 
cyclohexylphenylpropionate (NCPP), N-methyl-1-4-piperidinyl 2-phenylpropionate 
(NPP), were kindly provided by A/P Go M. L. of Department of Pharmacy, National 
University of Singapore. 
The silica gels used were HypersilÒ (5mm, pore size 100 Å; surface area 170 
m2/g), Hypersil-BDS5 (base-deactivated surface, 5mm, pore size 100Å; surface area 
170 m2/g) and Hypersil-BDS3 (base-deactivated surface, 3 mm, pore size 100 Å; 
surface area 170 m2/g) which were purchased from Hichrom Limited for use in the 
HPLC columns. For preparative scale, Kieselgel 100 silica gel, (particle size falls in 
range of 15-35, pore size: 100 Å, surface area: 400 m2/g) was purchased from Fluka. 
The stainless steel columns for analytical scale (250 mm ´ 4.6 mm I.D.) and for 
preparative scale (250 ´ 10 mm I.D.) were purchased from Phenomenex®. The 
standard slurry packer was Alltech® from Alltech Associates, Inc., USA.  
 
8.3.1 HPLC system 
The employed HPLC system comprised of a Perkin Elmer series 200 LC pump, 
Perkin Elmer 785A UV/Vis detector, connected to a computer via Perkin Elmer 
Nelson 900 series interface and 600 series link. Another set of HPLC comprised 
Perkin-Elmer Binary LC pump model 250, a Perkin-Elmer Bip UV-Vis 
Spectrophotometric detector model LC 290 (Foster city, CA, USA), and a CR-6A 
integrator (Shimadzu Corp., Kyoto, Japan). 
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8.3.2 HPLC conditions 
For analytical column, the flow rate of the eluent was 1.0 and 0.5 ml min-1 for 
normal (NP) and reversed-phase (RP), respectively. For preparative column, the flow 
rate is 2.0 and 1.0 ml min-1 for NP and RP.  
The concentration of samples was 1000 ppm (1.0 mg ml-1) using the mobile 
phase as solvent.  
The dead time (t0) was determined with hexane and MeOH as non-retained 
compounds under NP and RP, respectively. 
All the experiments except thermodynamic properties were carried out at room 
temperature (about 25 °C). 
The UV-Vis detection was effected at 254, 245, 230, 225 or 210 nm.  
The optical rotation was performed on Perkin Elmer 241 polarimeter. 
The adjustment of pH was performed on the Metrohm®pH meter (Swiss) with 
the calibration using 3-point method using standard buffer. 
The sonicator is Elma Transsonic 460.  
 
8.3.3 Packing Procedure for HPLC column 
1) Analytical scale column 
CSP (3.2 g) was suspended in a mixture of dioxane (10 ml) and 
tetrachloromethane (20 ml), and sonicated for 20-30 min. It was then packed into a 
stainless steel column (250 mm ´ 4.6 mm I.D.) with a Alltech air compressor where 
hexane was used as the solvent using a slurry method. The pressure using compressed 
air was increased stepwise to 7500 psi and keep for 20 mins, followed by stepwise 
release of the pressure.  
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2) Preparative scale column 
Preparative CSP (17.0 g) was suspended in a mixture of dioxane (20 ml) and 
tetrachloromethane (40 ml), and sonicated for 20-30 mins. It was then slurry-packed 
into a stainless steel column (250 mm ´ 10 mm I.D.) using a Alltech air compressor. 
The packing solvent, acetone was pushed through the column at packing pressure of 
3000 psi, and kept for 30 mins, followed by the stepwise release of the pressure.  
 
8.3.4 Preparation of mobile phases 
The solvents, including the triethylammonium acetate (TEAA) buffer, 
triethylammonium phosphate (TEAP) and phosphate buffer, were freshly prepared, 
filtered through 0.45 mm frit using a Millipore system, and degassed under vacuum 
using a DEGASY S DG-2410 degasser before use. Subsequently, the mobile phases, 
were mixed at different ratios in volume / volume composition.  
 
8.3.5 Preparation of buffer solutions 
TEAA / TEAP were prepared by addition of glacial acetic acid/ phosphoric acid 
into aqueous triethylamine to the desired pH value. 50 mM phosphate pH 7.36 was 
obtained by adjusting with phosphoric acid.   
 
8.3.6 Optical rotation 
For b-CD derivatives prior to functionalization, optical rotation was obtained 
on a Perkin Elmer 241 polarimeter under 20 or 25 °C with the volume as 1ml. For 
functionalization b-CD derivatives, optical rotation was obtained under the same 
condition with the concentration of 1% in CHCl3 or DMSO. 
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8.3.7 Calculation methods of chromatographic parameters and 
equations  
1) Column efficiency and theoretical height of plates 
A chromatographic column may be characterized by its efficiency, which is a 
measure of its ability to transport a compound with little peak broadening. It is very 
important to determine whether the column is packed well or bad. It is measured by the 
number of theoretical plates, N. This parameter is defined as:  










N R  8-1 
Column efficiency is also expressed as height equivalent to one theoretical 




H =  8-2 
Where, tR is the retention time, w the baseline peak width and L the column 
length. 
 
Figure 8.1 An example of a chromatogram. 
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2) Retention factors, k1’ and k2’ 
The retention factors, k1’ and k2’, describe the migration rates of solutes on 












k R  8-4 
Where 0t  is the retention time of the unretained (or solvent) peak. Normally, k 
should fall in range of 1-5. It often can be manipulated to give better separation by 
varying the composition of the mobile phase or temperature. 
 
3) Selectivity a 
The selectivity a for 2 analytes (or two components for one pair of 
enantiomers) provides a measure of how well they can be separated on a column. It is 
defined as: 

















=a  8-6  
It is obvious that the 2 peaks can only be resolved when a¹ 1. 
Normally, the 2 analytes / enantiomers can be considered as fully separated 
when a is above 1.05.  
 
4) Resolution (Rs) 
The resolution, Rs, of a column is very important to provides a quantitative 










=  8-7 
where tR1 and tR2 are retention times for the first and second eluent-out 
components, W1 and W2 are the widths for first and second peaks.  
 
5) Surface concentration  
The calculations of coverage were based on the unit of functionalized-b-CD 










S  8-8 
Where S is surface concentration of CSP in terms of carbon content. C% is 
elemental analyses of carbon, Nc is number of carbon atoms in the molecule of chiral 
selector and Ssilica is the surface area of silica gel. The unit of S is mmol m-1.  
This equation is only for the CSPs with well-defined structures. Therefore, only 
CSPs prepared in Chapter 2 are suitable to use this equation.  
 
8.4 Syntheses of b-CD derivatives 
8.4.1 Mono-(6-azido-6-deoxy)-b-CD derivatives 
8.4.1.1 Mono-(6-(p-tosylsulphonyl)-6-deoxy)-b-CD (OTS-CD) 
b-CD (39.40 g, 35.0 mmol, dried overnight in 0.1 mmHg vacuum at 95 °C) was 
dissolved in anhydrous pyridine (420 ml). 4-Methylbenzene sulfonyl chloride (6.62 g, 
34.6 mmol) was dissolved in anhydrous pyridine and added drop wise into the b-CD 
solution within a period of 1.5 hours. Stirring was continued for another 22 hrs at 
ambient temperature (ca. 25 °C). The reaction mixture was then concentrated and the 
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residual was added drop wise into acetone (200 ml). The solid formed was separated 
by filtration and recrystallized four times from water to give the mono-6-(p-
tosylsulphonyl)-b-CD 2.1.  Yield = 10.37 g (23.2%); mp decomposes on heating at 
159°C; (Lit,169 mp 159-162 °C) 25][ Da  +120 (c 0.0007, H2O); IR (cm
-1): 3389 (0-H); 
1644, 1462 (C=C arom str); 1157 (S(=O)2 str); 1028(C-O str); 752 (C-H arom op 
bend); 1H NMR (DMSO, TMS) d (ppm): 2.43 (s, 3H); 3.26-5.78 (m, 69H); 7.43 (d, 
2H, J=8Hz); 7.75 (d, 2H, J=8Hz). Calcd for C49H76O37S: C, 45.65; H, 5.94; S, 2.49%. 
Found: C, 45.63; H, 6.20; S, 2.80%. 
 
8.4.1.2 Mono-(6-azido-6-deoxy)-b-CD derivatives 
8.4.1.2.1 Mono-(6-azido-6-deoxy)-b-CD 2.2 (AZIDOCD): 
DMF (500 ml, 27.8 mol) was added to 2.1 (5.0 g, 3.91 mmol) and sodium azide 
(5.0 g, 77.0 mmol). The reaction mixture was heated for 4 hrs over a boiling water 
bath. The resolution was filtered and then evaporated to a low volume (ca. 40 ml) and 
1,1,2,2-tetrachloroethane (5 ml) was added and the reaction mixture was stirred for 
another 0.5 hour. The tetrachloromethane complex formed was separated from the 
aqueous solution by centrifugation. The mono-(6-azido-6-deoxy)-b-CD complex was 
obtained by heating the complex in boiling water. Evaporation of the aqueous solution 
yielded the product 2.2. Yield = 4.42 g (98.2 %) mp decomposes on heating at 220oC; 
(Lit,169 mp 217 °C dec) 25][ Da  +109 (c 0.01, H2O); IR (cm
-1): 3381 (0-H); 2107 (N3 str); 
1028 (C-O str) 1H NMR (DMSO, TMS) d (ppm): 3.22-3.32 (overlap with HOD); 3.42-
3.62 (m, 28H); 4.42-4.48 (m, 6H); 4.46-4.88 (m, 7H); 5.42-5.70 (m, 14H), Calcd for 
C42H63N21O28 : C, 43.49; H, 5.95; N, 3.62%. Found: C, 42.99; H, 5.50; N, 4.09%. 
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8.4.1.2.2 Mono-(6-azido-6-deoxy)-perfunctionalized-b-CD derivatives 2.3 
Mono-(6-azido-6-deoxy)-perphenylcarbamoylated-b-CD (AZIDOPHCD) 2.3a: 
2.2 (2.0 g, 1.73 mmol) was dissolved in anhydrous pyridine (30 ml). Phenyl isocyanate 
(10.0 ml, 84.0 mmol) was then added into the above solution and was allowed to stir 
for 12 hrs. Ethyl acetate (ca. 300 ml) was added to extract the product formed. Water 
(ca. 200 ml) was added into the ethyl acetate layer with stirring to remove the pyridine 
complex that was formed in the course of the reaction. The organic layer was then 
isolated and dried over anhydrous magnesium sulfate. The mixture was filtered and 
concentrated under reduced pressure and dried under vacuum. It was then subjected to 
flash chromatography over silica gel using hexane-chloroform (1:1, v/v) as eluent, 
yielding 2.3a (3.40 g). M. p.: 220-227°C; 25][ Da : +33.4 (c 0.01, CHCl3); IR (cm
-1): 
3393, 3313 (N-H str); 2102 (N3 str); 1732 (C=O str); 1604,1537,1443 (arom C=C ring 
str); 1221 (asym C-O-C str); 1053 (sym C-O-C str); 750 (C-H arom op bend); 1H NMR 
(CDCl3, TMS) d (ppm): 7.48-6.55 (m,  120H); 5.65-5.50 (m, 7H), 5.32-5.08 (m, 14H), 
4.82-4.25 (m, 21H), 4.05-3.90 (m, 7H), Calcd for C182H169N23O54: C, 59.29; H, 5.06; 
N, 8.73%. Found: C, 59.59; H, 5.34; N, 8.48%. 
 
Mono-(6-azido-6-deoxy)-pernaphthylcarbamoylated-b-CD (AZIDONACD) 2.3b:  A 
similar procedure as described for 2.3a was used for synthesis of 2.3b.(5.97 g). M. p: 
192-199oC; 25][ Da  +89.5 (c 0.01, CHCl3); IR (cm
-1): 3401, 3308 (N-H str); 2110 
(N=N+=N- str); 1738 (C=O str); 1549, 1505,(arom C=C ring str); 1215 (asym C-O-C 
str); 1043 (sym C-O-C str); 772 (C-H arom op bend); 1H NMR (CDCl3, TMS) d 
(ppm): 6.20-8.40 (m, 160H), 2.50-5.75 (m, 49H), Calcd for C262H209N23O54 : C, 68.17; 
H, 4.74; N, 6.98%. Found: C, 68.45, H, 4.93; N, 6.62%. 
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Mono-(6-azido-6-deoxy)-peracetylated-b-CD (2.3c) (AZIDOACECD): Mono-(6-azido-6-
deoxy)-peracetylated-b-cyclodextrin 2.3c was prepared by acetylation of 2.2 with 
acetic anhydride in pyridine according to the above procedure. Yield = 82%. mp 133-
135°C; (Lit,250 mp 155-157 °C) 25][ Da  +120.92 (c1.0, CHCl3); IR (cm
-1): 2966(C-H str), 
2111 (-N3 str); 1750 (C=O str); 1052 (C-O str); 1H NMR (CDCl3, TMS) d (ppm): 5.33-
5.26 (m, 7H), 5.13-5.01 (m, 7H), 4.85-4.77 (m, 7H), 4.58-4.54 (d, J= 12.3Hz, 7H), 
4.32-4.18 (m, 7H), 4.15-4.10 (m, 7H), 3.80-3.66 (m, 7H), 2.16-2.02 (multi s, 60H); 
Calcd for C82H109O54N3: C, 49.23; H, 5.49; N, 2.10%. Found: C, 49.14; H, 5.64; N, 
1.95%. 
 
Mono-(6-azido-6-deoxy)-permethylated-b-CD 2.3d (AZIDOMECD): 2.2 (2.12 g, 1.83 
mmol) was dissolved in DMF (ca. 35 ml). Sodium hydride (6.46 g, 27.0 mmol, 55-
60% in paraffin) was washed with hexane to remove paraffin. The b-CD solution was 
then added to the reaction mixture, with a vigorous stirring. After the bubbling ceased, 
the reaction mixture was cooled using an ice bath for 30 mins, followed by drop wise 
addition of methyl iodide (4.0 ml, 28.2 mmol). The reaction mixture was allowed to 
stir for another 12 hours at room temperature (ca. 25°C). MeOH (2 ml) was added into 
the reaction mixture to destroy the excess sodium hydride. Thereafter, after 
concentration and filtration of the reaction mixture, ethyl acetate (200 ml) was added to 
extract the product formed. The organic layer was then washed with brine (3 ´ 50 ml) 
to remove the sodium iodide formed in the course of the reaction, followed by 
separated and dried over anhydrous magnesium sulfate. The solution was filtered and 
concentrated under reduced pressure and dried under vacuum. It was then subjected to 
flash chromatography over silica gel using acetate-acetone (1:1, v/v) as eluent, yielding 
2.3d (2.0 g). M. p: 95-99oC; 25][ Da  +157 (c1.0, CHCl3); IR (cm
-1): 2929 (C-H); 2103 
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(N3 str); 1034 (C-O str) 1H NMR (CDCl3, TMS) d (ppm): 5.18-5.08 (m, 7H); 3.95-3.38 
(m, 7H), 3.23-3.15 (m, 7H); Calcd for C62H109N3O34: C, 51.70; H, 7.57; N, 2.92%. 
Found: C, 49.83; H, 7.0; N, 2.76%.  
 
Mono-(6-azido-6-deoxy)-perbenzoylated-b-CD 2.3e (AZIDOBENCD): Benzoyl chloride 
(30 ml, 21.0 mmol) was dissolved in anhydrous pyridine (20 ml). 2.2 (2.31 g, 1.99 
mmol) was then added into the above solution and was allowed to stir for 12 hours. 
The reaction mixture was then poured into 300 ml of cold water to destroy the excess 
benzoyl chloride. Ethyl acetate (ca. 300 ml) was added to extract the product formed 
and was then isolated using separating funnel, followed by washed with excess sodium 
bicarbonate solution to remove the benzoic acid formed and isolated. After dried over 
anhydrous magnesium sulfate, the solution was filtered and concentrated under 
reduced pressure and dried under vacuum. It was then subjected to flash 
chromatography over silica gel using hexane-chloroform (5:2, v/v) as eluent, yielding a 
clear solid 2.3e (4.16 g). M. p: 96-99oC;  25][ Da  +24.65 (c1.0, CHCl3); IR (cm
-1): 3071 
(arom C-H str); 2105 (N3 str); 1729 (C=O str); 1603, 1449 (C=C arom ring str); 1273 
(asym C-O-C str); 1097 (sym C-O-C str); 704 (C-H arom op bend); 1H NMR (CDCl3, 
TMS) d (ppm): 8.24-8.12 (m, 12H), 7.75-7.24 (m, 46H), 7.23-7.13 (m, 14H), 7.09-6.80 
(m, 28H), 6.10-5.88 (m, 7H), 5.75-5.42 (m, 7H), 5.20-4.50 (m, 28H), 4.24-3.95 (m, 
7H), Calcd for C182H149N3O54: C, 67.46; H, 4.60; N, 1.30%. Found: C, 66.91; H, 4.51; 
N, 1.25%. 
 
Mono-(6-azido-6-deoxy)-perbenzylated-b-CD 2.3f (AZIDOBYLCD): 2.2 (2.12 g, 1.83 
mmol) was dissolved in DMF (ca. 35 ml). Sodium hydride (6.46 g, 27.0 mmol, 55-
60% in paraffin) was washed with hexane to remove paraffin. The b-CD solution was 
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then added to the reaction mixture, with a vigorous stirring. After the bubbling ceased, 
the reaction mixture was cooled using an ice bath for 30 mins, followed by drop wise 
addition of benzyl bromide (17.4 ml, 146 mmol) and the reaction mixture was allowed 
to stirred for another 12 hours at 30 °C. The reaction mixture was then poured into 300 
ml of cold water to destroy the excess benzoyl bromide. Ethyl acetate (ca. 200 ml) was 
added to extract the product formed and was then isolated using separating funnel, 
followed by washed with brine (3 ´ 50 ml) to remove the sodium bromide formed and 
isolated. After dried over anhydrous magnesium sulfate, the solution was filtered and 
concentrated under reduced pressure and dried under vacuum. It was then subjected to 
flash chromatography over silica gel using ethyl acetate-hexane (10:1, v/v) as eluent, 
yielding light yellow solid 2.3f (3.33 g). M. p: 39-42°C; 25][ Da  +45.2 (c1.0, CHCl3); IR 
(cm-1): 3071(arom C-H str); 2105 (N3 str); 1729(C=O str); 1603, 1449 (C=C arom ring 
str); 1273 (asym C-O-C str); 1097 (sym C-O-C str); 704 (C-H arom op bend); 1H NMR 
(CDCl3, TMS) d (ppm): 7.40-6.90 (m, 100H), 5.40-3.30 (m, 89H); 3.92-6.08 (m, 49H); 
6.85-8.15 (m, 100H), Calcd for C138H127O29N3: C, 72.33; H, 5.54; N, 1.83%. Found: C, 
72.08; H, 5.34; N, 1.81%. 
 
8.4.1.2.3 Mono-(6-10’-undecenylcarbamido-6-deoxy)- and Mono-(6-
decanylcarbamido-6-deoxy)-perfunctionalised-b-CD (2.4a-f) 
Mono-(6-10’-undecenylcarbamido-6-deoxy)-perphenylcarbamoylated-b-CD 2.4a 
(C=CPHCD): A solution of w-undecenylamine (0.086 g, 0.50 mmol) and mono-(6-
azido-6-deoxy)-perphenylcarbamoylated-b-CD 2.3a (1.59 g, 0.45 mmol) was stirred in 
anhydrous THF (5 ml) through which a continuous stream of CO2 gas was passed. 
After 2 minutes, a solution of PPh3 (0.12 g, 0.45 mmol) in anhydrous THF (5 ml) was 
added. The reaction mixture was  allowed to react until TLC revealed that the starting 
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material 2.3a had been consumed. After evaporation of solvent, the product was 
purified by column chromatography using CHCl3-ethyl acetate (4:1, v/v) as eluent, 
yielding a white powder 2.4a (1.61 g). Mp: 198-200 °C ; [a]D +8.5 °C (c1.0, CHCl3); 
IR (cm-1): 3401, 3315 (N-H str); 3145, 3059 (arom C=C ring str); 2930, 2862 (C-H 
str); 1733 (C=O, str); 1598, 1533, 1447 (arom C=C ring str); 1227, 1049 (C-O-C str); 
749 (C-H arom op bend);  1H NMR (CDCl3) d (ppm): 7.38-6.56 (m, 120H,), 5.90-5.80 
(m, 1H), 5.56-3.60 (m, 55H), 1.30-1.20 (m, 16H); 13C NMR (CDCl3, 25°C) d (ppm): 
153.7-152.7, 137.0-136.8, 128.7-128.4, 123.6, 119.7-118.8, 114.0, 98.8, 78.8, 73.5, 
69.7, 67.8, 62.0, 60.3, 33.7-20.9; Calcd for C194H192N22O55: C, 62.78; H, 5.21; N, 
8.31%. Found: C, 61.94; H, 5.38; N, 7.89%. 
 
Mono-(6-decenylcarbamido-6-deoxy)-perphenyl-carbamoylated-b-CD 2.4b (CH3PHCD): 
2.4b (1.60 g) was obtained according to the procedure applied for the synthesis of 
compound 2.4a using mono-(6-azido-6-deoxy)-perphenylcarbamoylated b-CD 2.3a 
(1.59 g, 0.45 mmol). Mp: 206-209 °C; [a]D +5.6 °  (c1.0, CHCl3); IR (cm-1): 3400, 
3319 (N-H str); 3145, 3064 (arom C=C ring str); 2936, 2862 (C-H str); 1732 (C=O, 
str); 1604, 1537, 1443 (arom C=C ring str); 1227, 1053 (C-O-C str); 750 (C-H arom op 
bend); 1H NMR (CDCl3, TMS) d (ppm): 7.70-6.60 (m, 120H,), 5.65-3.00 (m, 53H), 
1.25-1.15 (m, 16H), 0.9 (t, 3H); 13C NMR (CDCl3, 25°C) d (ppm): 153.9-152.7, 137.6-
136.9, 128.7-128.4, 123.4, 119.8-118.9, 98.8, 78.8, 73.5, 69.7, 67.8, 62.0, 60.3, 31.8, 
29.5-29.3, 25.5, 22.6, 20.9, 14.1; Calcd for C193H192N22O55: C, 62.66; H, 5.23; N, 
8.33%. Found C, 61.94; H, 5.38; N, 7.89%. 
 
Mono-(6-(10’-undecenylcarbamido)-6-deoxy)-peracetylated-b-CD 2.4c (C=CACECD): 2.4c 
(0.95 g) was obtained according to the procedure applied for the synthesis of 
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compound 2.4a by treating mono-(6-azido-6-deoxy)-peracetylated-b-CD 2.3b (0.90 g, 
0.45 mmol) with w-undecenylamine (0.086 g, 0.50 mmol). Mp:115-117 °C; [a]D 
+106.1° (c1.0, CHCl3); IR (cm-1): 3427 (N-H str), 2937, 2859 (C-H str), 1744, 1663 
(C=O str), 1227, 1042 (C-O-C str); 1H NMR (CDCl3, TMS) d (ppm): 5.85-5.76 (m, 
1H, C=CHR), 5.38-5.21 (m, 7H, (H3)), 5.16-5.05 (m, 7H, (H1)), 5.02-4.94 (m, 4H, 
(C=CH2 and NH)), 4.84-4.68 (m, 7H, (H2)), 4.58-4.50 (d, 6H, J=12Hz, (Hb6)), 4.35-
4.26 (d, 6H, J=12.7Hz, (Hb6’)), 4.24-4.05 (m, 7H, (Ha5)), 3.78-3.64 (m,7H, (H4)), 
3.57-3.51 (m, 1H, (Ha6)), 3.49-3.35 (m, 1H, (Ha6’)), 3.30-3.18 (m, 1H, NCH2R), 3.11-
3.00 (m, 1H, NCH2’R), 2.18-2.00 (several s, 60H, CH3CO), 1.46-1.19 (m, 16H, 
(CH2)8); 13C NMR (CDCl3, 25 °C) d (ppm): 170.6-169.3 (CH3CO), 158.0 (NH-CO-
NH), 139.1 (CH2=CR), 113.9  (CH2=CR), 96.6-96.4 (C1), 77.4-76.5 (C4), 70.7-69.5 
(C2, C3, C4), 62.4 (Cb6), 41.2 (Ca6), 40.3 (NHCH2R), 33.7-26.8 ((CH2)8), 20.62 
(CH3CO); Calcd for C94H132N2O55: C, 52.01; H, 6.13; N, 1.29%. Found C, 51.72; H, 
6.30; N, 1.20%. 
 
Mono-(6-decanylcarbamido-6-deoxy)-peracetylated-b-CD 2.4d (CH3ACECD):  2.4d (0.95 
g) was obtained according to the procedure applied for the synthesis of compound 2.4a 
by treating mono-(6-azido-6-deoxy)-peracetylated-b-CD 2.3b (0.90 g, 0.45 mmol) 
with n-decenylamine (0.08 g, 0.50 mmol). Mp:127-129 °C; 25][ Da  +107.7 (c1.0, 
CHCl3); IR (cm-1): 3431 (N-H str), 2937, 2856 (C-H str), 1752 (C=O str, acetyl), 1663 
(C=O str, urea), 1235, 1045 (C-O-C str); 1H NMR (CDCl3, TMS) d (ppm): 5.33-5.27 
(m, 7H, H3), 5.15-5.06 (m, 7H, H1), 5.02-4.79 (m, 2H, NH), 4.82-4.79 (m, 7H, H2), 
4.55-4.51 (d, 6H, J=10.8Hz, Hb6), 4.35-4.26 (m, 6H, J=12.6 Hz, Hb6’), 4.20-4.05 (m, 
7H, H5), 3.75-3.70 (m, 7H, H4), 3.57-3.51 (m, 1H, Ha6), 3.49-3.32 (m, 1H, Ha6’), 
3.30-3.16 (m, 1H, NCH2 R), 3.11-3.00 (m, 1H, NCH2’R), 2.18-2.00 (several s, 60H, 
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CH3CO),1.46-1.26 (m,16H, (CH2)7), 0.88 (t, 3H, J=6.6Hz, CH3-); 13C NMR (CDCl3, 
25°C) d (ppm): 171.2-169.2 (CH3CO), 158.0 (NH-CO-NH), 97.1-96.4 (C1), 78.3-75.9 
(C4), 70.7-69.5 (C2, C3, C4), 62.4 (Cb6), 41.3 (Ca6), 40.2 (-NHCH2R) , 31.7-22.4 
((CH2)8), 20.5 (CH3CO), 13.9 (-RCH3); Calcd for C93H132N2O55: C, 51.76; H, 6.12; N, 
1.30%. Found: C, 51.22; H, 6.10; N, 1.30%. 
 
Mono-(6-(10’-undecenylcarbamido)-6-deoxy)-permethylated-b-CD 2.4e (C=CMECD): 2.4e 
(0.69 g) was obtained according to the procedure applied for the synthesis of 
compound 2.4a by treating mono-(6-azido-6-deoxy)-permethylated-b-CD 2.3c (0.65 g, 
0.45 mmol) with w-undecenylamine (0.086 g, 0.50 mmol). Mp 72-74 °C; [a]D +132.94 
°C  (c1.0, CHCl3); IR (cm-1): 3406 (N-H str), 3084 (C=C- str), 2976, 2922, 2855 (C-H 
str), 1651 (C=O, urea), 1160,1032 (C-O-C, str); 1H NMR (CDCl3, TMS) d (ppm): 
5.82-5.76 (m, 1H), 5.14-5.01 (m, 11H), 3.85-3.15 (m, 104H), 1.28-1.24 (m, 16H); 13C 
NMR (CDCl3, 25 °C) d (ppm): 159.0, 139.0,114.0, 99.2- 98.8, 81.9- 79.8, 71.4- 70.85, 
61.4- 61.2, 59.1-58.3, 42.1, 42.0, 40.4, 33.6-26.9; Calcd for C74H132N2O35: C, 55.22; H, 
8.26; N, 1.74%. Found: C, 55.15; H, 8.26; N, 1.66%. 
 
Mono-(6 -decanylcarbamido-6-deoxy)-permethylated-b-CD 2.4f (CH3MECD): 2.4f (0.69 g) 
was obtained according to the procedure applied for the synthesis of compound 2.4a by 
treating mono-(6-azido-6-deoxy)-permethylated-b-CD 2.3c (0.65 g, 0.45 mmol) with 
w-undecenylamine (0.086 g, 0.50 mmol). Mp: 78-80 °C; 25][ Da  +126.0 
 (c1.0, CHCl3); 
IR (cm-1): 3400 (N-H str), 2928 (C-H str), 1651 (C=O str, urea), 1038 (C-O-C str); 1H 
NMR (CDCl3, TMS) d (ppm): 5.13-5.03 (m, 9H), 3.95-3.05 (m, 104H), 1.50-1.20 (m, 
16H), 0.92 (t, 3H); 13C NMR (CDCl3, 25°C) d (ppm): 158.5, 98.6, 81.6, 80.8, 70.6, 
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63.0, 61.2, 58.9, 58.4, 41.4, 40.4, 31.0, 30.5, 29.6, 28.0, 22.2, 14.0; Calcd for 
C73H132N2O35: C, 54.89; H, 8.33; N, 1.75%. Found C, 54.91; H, 8.21; N, 1.69%. 
 
8.4.2 Heptakis-(6-azido-6-deoxy)-b-CD derivatives 
Heptakis-(6-iodo-6-deoxy)-b-CD 3.1 (7IODOCD): Iodine (48.1 g, 0.19 mol) and 
triphenylphosphine (50.0 g, 0.19 mol) were mixed in anhydrous DMF (ca. 300 ml) and 
stirred for 5 mins, followed by adding the solution of vacuumly dried b-CD (8.84 g, 
7.79 mmol) in anhydrous DMF (ca 80 ml). The reaction mixture was stirred for 20 
hours at 90-95 °C under nitrogen atmosphere and was concentrated under reduced 
pressure later. Then the reaction flask was cooled with an ice-bath and 3.5 M sodium 
methanoate (100 ml) was added to the mixture to adjust the pH of the reaction mixture 
at 9-10. After filtration, the brown orange precipitate was washed with a large amount 
of acetone, yielding light brown solid. Yield=12.6 g (84 %), mp >205.7°C, 
decomposed; (Lit,251 mp uncorrected) 25][ Da  +180 (c 0.05, DMSO); IR (cm
-1): 3366 (O-
H str), 2914, (C-H str), 1038 (C-O-C str); 1H NMR (DMSO, TMS) d (ppm): 6.2-5.6 
(m, 14H), 5.1-4.9 (m, 7H), 4.0-3.5 (m, 42H), Calcd for C42H63O28I7: C, 26.46; H, 
3.31%. Found: C, 27.11; H, 2.96% 
 
Heptakis-(6-azido-6-deoxy)-b-CD 3.2 (7AZIDOCD): 7IODOCD 3.1 (13.0 g, 6.82 
mmol) was dissolved in anhydrous DMF (200 ml) followed by adding sodium azide 
(15.52 g, 0.28 mol, 5 equiv. per iodide atom) and stirred at 95 °C overnight under 
nitrogen atmosphere. The reaction mixture was concentration under reduced pressure 
and washed with ultra pure water. After filtration, the residue was washed with water, 
yielding light brown solid 3.2. (7.35 g, 82%). Mp: >220.4°C, decomposed; 25][ Da +240 
 
(c 0.05, DMSO); IR (cm-1): 3366 (O-H str), 2925, (C-H str), 2106 (N3 str), 1053 (C-O-
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C str); 1H NMR (DMSO, TMS) d (ppm): 5.9-5.7 (m, 14H), 4.0-3.5 (m, 42H), Calcd for 
C42H63O28N21: C, 38.47; H, 4.81; N, 22.44%. Found: C, 37.90; H, 4.85; N, 22.11%. 
 
Heptakis-(6-azido-6-deoxy-2,3-di-O-perphenyl-carbamoylated)-b-CD 3.3a. (7PPHCD): 
Vacuumly dried 3.2 (2.0 g, 1.50 mol) dissolved in anhydrous pyridine (30 ml) and 
phenyl isocyanate (10 ml) was added. The reaction mixture was stirred for 15 hours at 
90 °C under a nitrogen atmosphere. After removal of pyridine and unreacted phenyl 
isocyanate under reduced pressure, the residue was dissolved in anhydrous ethyl 
acetate (100 ml). The solution was washed with water (3´50 ml). The organic layer 
was combined and dried with anhydrous magnesium sulphate. The solution was 
filtered, concentrated and the resulting yellowish residue was purified by column 
chromatography over silica gel using n-hexane-chloroform (1:4) as eluent, yielding 
light yellow powder, 3.3a. (3.06 g) Mp: 202-204.8 °C, 25][ Da  +150 (c 0.05, CHCl3); IR 
(cm-1): 3393, 3309 (N-H str), 3053 (arom C-H str), 2106 (N3 str), 1738(C=O str), 1542, 
1497 (arom C=C ring str), 1041 (sym C-O-C str), 767 (C-H arom op bend); 1H NMR 
(CDCl3, TMS) d (ppm): 7.60-6.70 (m, 84H), 4.5-3.5 (m, 49H); Calcd for 
C140H133O42N35: C, 56.45; H, 4.50; N, 16.46 %. Found: C, 56.65; H, 4.47; N, 16.84 %. 
 
Heptakis(6-azido-6-deoxy-2,3-di-O-naphthyl-carbamoylated)-b-CD 3.3b (7PNACD):  
Heptakis(6-azido-6-deoxy-2,3-di-O-naphthylcarbamoylated b-CD 3.3b was prepared 
using 1-naphthyl isocyanate instead of phenyl isocyanate according to the above 
procedure. (3.022g) Mp: >202-204.8°C, 25][ Da  +155 
 (c 0.05, CHCl3); IR (cm-1): 3393, 
3309 (N-H str), 3053 (arom C-H str), 2106 (N3 str), 1738(C=O str), 1542, 1497 (arom 
C=C ring str), 1041 (sym C-O-C str), 767 (C-H arom op bend); 1H NMR (CDCl3, 
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TMS) d (ppm): 7.60-6.70 (m, 112H), 4.5-3.5 (m, 49H), Calcd for C196H161O42N35: C, 
64.0; H, 4.38; N, 13.33%. Found: C, 64.55; H, 4.47; N, 12.99%.  
 
8.4.3 Partial-6-(5-pent-1-enylated)-b-CD derivatives 
8.4.3.1 Partial-6-(5-pent-1-enylated)-b-CD 4.1 (C=C(CH2)3CD): 211  
Sodium hydride (5.06 g, 21.1 mmol, 50-60 % in paraffin) was washed with 
hexane to remove the paraffin. Vacuum dried b-CD (20.0 g, 17.6 mmol, dried 
overnight in 0.1 mmHg vacuum at 95 °C ) was dissolved in anhydrous DMF (400 ml) 
before bromo-1-pentene (3.96 g, 26.41 mmol) and sodium hydride were added in. This 
mixture was constantly stirred at 40  C for 24 hrs. After DMF was removed under 
vacuum, the residue was recrystalized four times from water. Partial-6-(5-pent-1-
enylated) b-CD 4.1 was obtained. Yield= 26%, mp > 320 °C, 25][ Da  +107.20 
 (c 0.8, 
CH2Cl2); IR (cm-1) 1600, 1421 (C=C str); 1H NMR (CDCl3, TMS) d 5.78 (m, olefinic 
CH-group), 5.10 (d, anomeric H), 4.97 and 4.92, (m, olefinic CH2-group), 2.13 (CH2 in 
allylic position). Microanalysis: found: C, 52.19; H, 3.56; O, 44.25%. 
 
8.4.3.2 Partial-6-(5-pent-1-enylated)-perfunctionalized-b-CDs  
Partial-6-(5-pent-1-enylated) perphenylcarbamoylated 4.2a (C=C(CH2)3PhCD): 4.1 
(2.0 g, 1.76 mmol) was dissolved in anhydrous pyridine (ca. 60 ml) before phenyl 
isocyanate (10 ml) was added in. The mixture was allowed to stir for 15 hours at 90 oC. 
after filtered to remove the residue, the pyridine and unreacted phenyl isocyanate were 
removed under vacuum as more as possible and the resultant the residue was dissolved 
in ethyl acetate (100 ml) and washed with water (3 ´  100 ml). The organic layers were 
combined and dried over anhydrous magnesium sulfate. After filtration and 
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concentration, the residue was subject to flash chromatography over silica gel by using 
hexane-ethyl acetate (1:4, v/v) as eluent to afford 4.2a. Yield= 85%, mp 190-200 oC; 
[a]D= + 8.56 o (c 0.01, CHCl3); IR (cm-1) 3393, 3313, (N-H str), 1732 (C=O str), 1604, 
1537, 1443 (arom C=C ring str), 1221 (asym C-O-C str), 1053 (sym C-O-C str); 1H 
NMR (CDCl3, TMS) d 7.50-6.50 (m, aromatic H), 5.80- 3.75 (m, CD ring H). 
Microanalysis: found: C, 62.34; H, 3.36; O, 34.30%. 
 
Partial-6-(5-pent-1-enylated)-pernaphthylcarbamoylated-b-CD 4.2b (C=C(CH2)3NaCD):    A 
similar procedure as the one used for the synthesis of compound 4.2a using naphthyl 
isocyanate to afforded 4.2b. Yield= 76%, mp: >230-250°C, 25][ Da  +77.50 (c 0.05, 
DMSO); IR (cm-1) 3401, 3308 (N-H str), 1738 (C=O str), 1549, 1505 (arom C=C ring 
str), 1221 (asym C-O-C str), 1043 (sym C-O-C str); 1H NMR (CDCl3, TMS) d 7.95-
6.40 (m, aromatic H), 6.10- 4.00 (m, CD ring H). Microanalysis: found C, 63.26; H, 
3.28; O, 33.46%. 
 
8.5 Preparation of chiral stationary phases (CSPs) 
8.5.1 Amino-functionalized silica gel 2.5a-c 
Silica gel (20 g, dried overnight in 0.1 mmHg vacuum at 180°C) was suspended 
in a mixture of benzene (250 ml) and anhydrous pyridine (3 ml) under a nitrogen 
atmosphere. 3-Aminopropyltriethoxysilane (5 ml, 0.023 mmol) was added to the 
suspension and the reaction mixture was refluxed for 15 hours. The resultant product, 
amino-functionalized silica gels 2.5a-c was purified by soxhlet exaction with acetone 
for 24 hours. Hypersil: C, 5.43; H, 1.82; N, 2.11%. Hypersil-BDS5: C, 2.85; H, 1.03; 
N, 1.03%. Hypersil-BDS3: C, 2.85; H, 0.81; N, 1.04%. 
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8.5.2 Immobilization of b-CD derivatives onto silica gel 
8.5.2.1 Immobilization of mono-(6-azido-6-deoxy)-functionalized-b-CDs 
onto amino-functionalized silica gel 2.6a-f 
SINU-PC-CSP (perphenylcarbamoylated-b-CD-CSP)(2.6a): Amino-functionalized 
silica gel 2.5a (4.0 g) was stirred in anhydrous THF (30 ml) through which a 
continuous stream of carbon dioxide gas was bubbled. After 20 minutes, a solution of 
compounds 2.3a-f in anhydrous THF (10 ml) was added. Stirring was continued for 
another 5 minutes, followed by addition of a solution of triphenyl phosphine (0.4 g) in 
THF (20 ml). The mixture was stirred for 21 hours with constant bubbling of CO2 at 
ambient temperatures (ca. 25 °C), followed by the soxhlet extraction with acetone for 
24 hours. After removal of the solvent, the derived SINU-PC-CSPs 2.6a was obtained. 
C, 17.42; H, 2.15; N, 2.56%. 
 
SINU-NC-CSP (pernaphthylcarbamoylated-b-CD-CSP)(2.6b):   A similar procedure 
as described for SINU-PC-CSP was used for synthesis of SINU-NC-CSP. C, 16.17; H, 
2.07; N, 2.45%. 
 
SINU-ME-CSP (permethylated-b-CD-CSP)(2.6c): A similar procedure as described 
for SINU-PC-CSP was used for synthesis of SINU-ME-CSP. C, 15.49; H, 3.07; N, 
1.52%. 
 
SINU-AC-CSP (peracetylated-b-CD-CSP)(2.6f): A similar procedure as described 
for SINU-PC-CSP was used for synthesis of SINU-AC-CSP. C, 16.70; H, 2.98; N, 
1.56%. 
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SINU-BN-CSP (perbenzylated-b-CD-CSP)(2.6d): A similar procedure as described 
for SINU-PC-CSP was used for synthesis of SINU-BN-CSP. C, 4.95; H, 0.97; N, 
0.94%. 
 
SINU-BL-CSP (perbenzoylated-b-CD-CSP)(2.6e): A similar procedure as described 
for SINU-PC-CSP was used for synthesis of SINU-BL-CSP. C, 17.25; H, 2.40; N, 
1.43%. 
 
SINU-PC-BDS5-CSP (perphenylcarbamoylated-b-CD-CSP)(2.6g): A similar procedure 
as described for SINU-PC-CSP was used for synthesis of SINU-PC-BDS5-CSP. C, 
9.03; H, 1.32; N, 1.74%. 
 
SINU-PC-BDS3-CSP (perphenylcarbamoylated-b-CD-CSP)(2.6g): A similar procedure 
as described for SINU-PC-CSP was used for synthesis of SINU-PC-BDS3-CSP. C, 
9.01; H, 1.42; N, 1.86%. 
 
8.5.2.2 Immobilization of heptakis-(6-azido-6-deoxy-2,3-di-O-phenyl/ 
naphthyl carbamoylated)-b-CD derivatives onto amino-
functionalized silica gels 
HEPT-PC-CSP (perphenylcarbamoyla ted-b-CD-CSP):  Amino-functionalized 
silica gel (4.0 g, prepared according to the method described in chapter 2 ) was stirred 
in anhydrous THF (30 ml) through which a continuous stream of CO2 gas was passed. 
After 20 minutes, 7PPHCD (1.2 g) or 7PNACD (1.2 g) in anhydrous THF (10 ml) was 
added. Stirring was continued for another 5 minutes, whenupon triphenylphosphine 
(2.0 g) in anhydrous THF (20 ml) was added. The mixture was stirred for 3 hours with 
constant bubbling of CO2 at ambient temperature (ca. 25°C). The reaction mixture was 
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then extracted with acetone for 24 hrs. After removal of acetone, HEPT-PC-CSP was 
obtained. C, 13.78; H, 2.02; N, 2.38%. 
 
HEPT-NC-CSP (pernaphthylcarbamoylated-b-CD-CSP): A similar procedure as 
described for HEPT-PC-CSP was used for synthesis of HEPT-NC-CSP. C, 8.35; H, 
0.48; N, 1.75%. 
 
8.5.2.3 Immobilization of partial-6-(5-pent-1-enylated)-perphenyl/ 
pernaphthylcarbamoylated-b-CDs 4.3a-b onto silica gel 4.4a-b 
(ETHR-PC and ETHR-NC)  
Hydrosilylation of partial-6-(5-pent-1-enylated)-b-CD 4.3a-b (HydroETHR-PC and 
HydroETHR-NC): Partial-6-(5-pent-1-enylated)-b-CD 4.2a-b (1.5g), 
triethoxysilane (ca. 10 ml) and tetrakis (triphenylphosphine) platinum(0) (20 mg) were 
mixed together in a 50 ml round bottom flask. After stirring for 72 hrs, the mixture was 
poured into a Bucher funnel packed with 2 cm of silica gel layer and was eluted with 
100 ml of diethyl ether. After removal of the volatile under reduced pressure, the 
yellow viscous oil 4.3a or 4.3b were obtained (ca. 1.6 g). 
 
ETHR-PC-CSP (perphenylcarbamoylated-b-CD-CSP):  HydroETHR-PC was 
dissolved into anhydrous toluene (50 ml) followed by the addition of silica gel (3.5 g, 
dried over 180 oC/ 0.5 mmHg for 5 hrs). The mixture was refluxed with stirring for 10 
hrs. After addition of water (1 ml), the mixture was continued to stir for another 5 hrs. 
The reaction mixture was filtered, and the obtained silica gel was heated under N2 gas 
for 4 hrs at 160 oC before it was transferred to soxhlet extraction apparatus and 
extracted with acetone for 24 hrs. The perphenylcarbamoylated- and 
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pernaphthylcarbamoylated-b-CD immobilized silica gel 4.4a namely ETHR-PC was 
obtained after removal of the acetone. C, 7.6; H, 0.94; N, 0.80%. 
 
ETHR-NC-CSP (pernaphthylcarbamoylated-b-CD-CSP): A similar procedure as 
described for ETHR-PC-CSP was used for synthesis of ETHR-NC-CSP. C, 8.13; H, 
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9.1 Conclusions 
In conclusion, three series of novel b-cyclodextrin(CD)-based chiral stationary 
phases (CSPs) were prepared which exhibited enantioseparation abilities. Of which, 
mono-(6-azido-6-deoxy)-perfunctionalized b-CD-CSPs have well-defined structures 
and could be applied in both normal (NP) and reversed phases (RP). Heptakis-(6-
azido-6-deoxy-2,3-di-O-perfunctionalized)-b-CD-CSPs only showed 
enantioseparations in RP with the highest stability in high aqueous phases within the 
widest application ranges. Partially (5-pent-1-enylated)-perfunctionalized-b-CD-CSPs 
proved to be the most suitable for racemates with more than one optical center, other 
than pyrimidine compounds.  
Of all the substituents at the b-CD rims including phenyl-, naphthyl 
carbamates, methyl, benzyl, acetyl and benzoyl, phenyl carbamate substitution makes 
the corresponding CSPs mostly effective in both NP and RP. Meanwhile, naphthyl 
carbamoylated-CSPs are much effective in RP than in NP. Methyl did not show as 
good results as the former two substituents but is more effective towards weak acids in 
RP. On the other hand, CSPs with acetyl, benzyl and benzoyl groups did not show 
good enantioseparation abilities.   
In summary, the above three series of CSPs proved to be effective chiral 
stationary phases towards a wide variety of racemates with excellent enantioseparation 
abilities and wide application ranges. 
 
9.2 Suggestions for future work 
Based on the work accomplished in this dissertation, future work with 
advantages should be concentrated on the following areas: 
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1) Mechanism of enantioseparation: The mechanism should be further 
studied in the enantioseparations of b-CD-based CSPs. Although it is difficult to 
predict the precise separation mechanism, molecular modeling should be a choice for 
this purpose compared with other methods.  
2) Application areas: The applications of these b-CD-CSPs can be 
extended to NMR, GC, SFC, CEC etc. For example, partial-(5-pent-1-enylated)-
perfunctionalized-b-CDs can be hydrosilylated and further reacted with the silicon 
groups of the internal wall of capillary to form the chiral GC columns. Methylated-b-
CD may be applied as a chiral reagents in the chiral recognization using NMR 
techniques. Particularly, the resulting HPLC columns  
3) Substitution at b-CD rims: The substituents at b-CD rims can be further 
extended to other substituted phenyl isocyanate, such as 2-methoxyl phenyl isocyanate, 
3,5-dimethyl phenyl isocyanate, 2- or 3- or 4- chloro phenyl isocyanate, etc. The 
comparative studies on the different substituents on enantioseparations should be 
inspected in detail. 
4) Scale up procedure and preparative scale separations: Since this work 
mainly focuses on analytical enantioseparations, only one semi-preparative scale 
column was reported. The scale up synthesis and enantioseparations of these CSPs 





1. C&EN Northeast News Bureau, Special Report,1998, p. 83. 
2. Giacomini, K. M.; Nelson, W. L.; Pershe, R. A.; Valdinieso, L.; Truner-
Tamiyasu, K., and Blaschke, T. F., J. Pharmacokin. Biopharm., 1986. 14: 335. 
3. Balschke, G.; Kraft, H. P., and and Markgraf, H., Chem. Ber., 1980. 113: 2318. 
4. Tucker, G. T. and Lennard, M. S., Pharmacol. Therapeut., 1990. 45(3): 309-329. 
5. Blaschke, G.; Kraft, H. P.; Fickentscher, K., and Koehler, F., Arznein-Forsch, 
1979. 29: 1640. 
6. Souter, R. W., Title Chromatographic separations of stereoisomers. 1985: 
Imprint Boca Raton, Fla. CRC Press. 
7. Ahuja, S., Chromatography and separation chemistry. 1986. 
8. Pasteur, L., Ann. Chim. Phys., 1848. 24: 442. 
9. Schlenk, W., Experientia, 1952. 8: 337. 
10. Dickey, F. H., Proc. Natl. Acad. Sci., 1949. 35: 227. 
11. Henderson, G. M. and Rule, H. G., J. Chem. Soc. Perkin, 1939: 1568. 
12. Kotake, M.; Sakan, T.; Nakamura, N., and Senon, S., J. Am. Chem. Soc., 1951. 
73: 2973. 
13. Closs, K. and Hang, C. K., Chem. Lett., 1953: 103. 
14. Rhuland, L. E.; Work, E.; Denman, R. E., and Hoare, D. S., J. Am. Chem. Soc., 
1955. 77: 4844. 
15. Dalgliesh, C. E., J. Chem. Soc. Perkin, 1952: 3940. 
16. Gil-Av, E.; Feibush, B., and Charles-Sigler, R., Tetrahedron Lett., 1966. 7(10): 
1009-1015. 
17. Feibush, B., Resolution of Enantiomers on Optically Active Stationary Phases by 
Gas  Chromatography. 1967, The Weizmann Institute Of Science: Rehovot, 
Israel. 
18. Gil-Av, E.; Feibush, B., and Charles-Sigler, R., Gas Chromatography, ed. 
Littlewood, A. B. 1966, London: Institute Of Petroleum. p. 227. 
19. Brinkman, U. A. T. and Kamminga, D., J. Chromatogr. A, 1985. 330: 375-378. 
20. Davankov, V. A. and Rogozhin, S. V., J. Chromatogr., 1971. 60(2): 280-283. 
 200
21. Davankov, V. A. and Rogozhin, S. V., J. Chromatogr. A, 1971. 60: 284-312. 
22. Wulff, G. and Sarhan, A., Angew. Chem., 1972. 11: 341. 
23. Hesse, G. and Hagel, R., Chromatographia, 1973. 6: 277. 
24. Stewart, K. K. and Doherty, R. F., Proc. Natl. Acad. Sci., 1973. 70: 2850. 
25. Balschke, G., Chem. Ber., 1974. 107: 237. 
26. Okamoto, Y.; Suzuki, K.; Ohta, K.; Hatada, K., and Yuki, H., J. Am. Chem. Soc., 
1979. 101: 4763. 
27. Pirkle, W. H.; Finn, J. M.; Schreiner, J. L., and Hamper, B. C., J. Am. Chem. 
Soc., 1981. 103: 3964. 
28. Uekama, K.; Imai, T.; Hirayama, F.; Otagiri, M.; Hibi, T., and Yamasaki, M., 
Chem. Lett., 1985: 61. 
29. Greatbanks, D. and Pickford, R., Magn. Reson. Chem., 1987. 25: 208. 
30. Casy, A. and Mercer, A., Magn. Reson. Chem., 1988. 26: 765. 
31. Botsi, A.; Yannakopoulou, K.; Hadjoudis, E., and Perly, B., J. Chem. Soc.-Chem. 
Commun., 1993(13): 1085-1086. 
32. Botsi, A.; Perly, B., and Hadjoudis, E., J. Chem. Soc.-Perkin Trans. 2, 1997(1): 
89-94. 
33. Cimecioglu, A. L.; Ball, D. H.; Huang, S. H., and Kaplan, D. L., 
Macromolecules, 1997. 30(1): 155-156. 
34. Tseng, H.; Furuhata, K., and Sakamoto, M., Carbohydr. Res., 1995. 270(2): 149-
161. 
35. Sakamoto, M.; Tseng, H., and Furuhata, K.-I., Carbohydr. Res., 1994. 265(2): 
271-280. 
36. Furuhata, K.; Chang, H. S.; Aoki, N., and Sakamoto, M., Carbohydr. Res., 1992. 
230(1): 151-164. 
37. Kawashima, K.; Levy, A., and Spector, S., J. Pharmacol. Exp. Ther., 1976. 
196(2): 517-523. 
38. Allenmark, S. G., Chromatographic enantioseparation methods and application. 
1988, NewYork: Ellis Horwood. 
39. Welch, C. J., J. Chromatogr. A, 1994. 666(1-2): 3-26. 
40. Zief, M. and Crane, L., Chromatographic enantioseparation. 1988, NewYork: 
Marcel Dekker. 
41. Pirkle, W. H. and Pochapsky, T. C., Chem. Rev., 1989. 89(2): 347-362. 
 201
42. Wainer, I. W., TrAC-Trend. Anal. Chem., 1987. 6(5): 125-134. 
43. Armstrong, D. W., Anal. Chem., 1987. 59(2): 84A-91A. 
44. Pirkle, W. H. and Pochapsky, T. C., Adv. Chromatogr., 1987. 27: 73-127. 
45. Wainer, I. W. and Doyle, T. D., HPLC, 1988. 2: 88. 
46. Pirkle, W. H. and House, D. W., J. Org. Chem., 1979. 44: 1957. 
47. Pirkle, W. H. and Finn, J. M., J. Org. Chem., 1982. 47: 4037. 
48. Pirkle, W. H. and Welch, C. J., J. Org. Chem., 1984. 49: 148. 
49. Pirkle, W. H. and Burke, J. A., J. Chromatogr., 1991. 557(1-2): 173-185. 
50. Okamoto, Y.; Kawashima, M., and Hatada, K., J. Chromatogr. A, 1986. 363(2): 
173-186. 
51. Okamoto, Y.; Aburatani, R., and Hatada, K., J. Chromatogr., 1988. 448(3): 454-
455. 
52. Okamoto, Y.; Aburatani, R.; Kaida, Y., and Hatada, K., Chem. Lett., 1988(7): 
1125-1128. 
53. Hakli, H.; Mintas, M., and Mannschreck, A., Chem. Ber., 1979. 12: 2028. 
54. Rimbock, K.-H.; Kastner, F., and Mannschreck, A., J. Chromatogr. A, 1986. 
351: 346-350. 
55. Armstrong, D. W. 1985: US. Patent.4539399. 
56. Armstrong, D. W.; Ward, T. J.; Armstrong, R. D., and Beesley, T. E., Science, 
1986. 232(4754): 1132-1135. 
57. Hinze, W. L.; Riehl, T. E.; Armstrong, D. W.; DeMond, W.; Alak, A., and Ward, 
T., Anal. Chem., 1985. 57(1): 237-242. 
58. Ichida, A.; Shabata, T.; Okamoto, I.; Yuki, Y.; Namikashin, N., and Toga, Y., 
Chromatographia, 1984. 19: 280. 
59. Lindner, K. R. and Mannschreck, A., J. Chromatogr. A, 1980. 193(2): 308-310. 
60. Dappen, R.; Arm, H., and Meyer, V. R., J. Chromatogr. A, 1986. 373: 1-20. 
61. Sousa, L. R.; Sogah, G. D. Y.; Hoffman, D. H., and Cram, D. J., J. Am. Chem. 
Soc., 1978. 100: 4569. 
62. Davankov, V. A., Adv. Chromatogr., 1980. 18: 139. 
63. Gubitz, G.; Jellenz, W., and Santi, W., J. Chromatogr. A, 1981. 203(1): 377-384. 
64. Gübitz, G., J. Liq. Chromatogr., 1980. 9: 519. 
 202
65. Hermansson, J. and Ericksson, M., J. Liq. Chromatogr., 1986. 9: 62. 
66. Hermansson, J., J. Chromatogr., 1983. 269: 71. 
67. Hermansson, J., J. Chromatogr. A, 1985. 325: 379-384. 
68. Domenici, E.; Bertucci, C.; Salvadori, P.; Motellier, S., and Wainer, I. W., 
Chirality, 1990. 2(4): 263-268. 
69. Zhang, Q.; Zou, H.; Chen, X.; Wang, H.; Luo, Q., and Ni, J., Chirality, 2000. 
12(10): 714-719. 
70. Andrisano, V.; Gotti, R.; Recanatini, M.; Cavalli, A.; Varoli, L., and Bertucci, C., 
J. Chromatogr. B, 2002. 768(1): 137-145. 
71. Domenici, E.; Bertucci, C.; Salvadori, P.; Motellier, S., and Wainer, I. W., 
Chirality, 1990. 2(4): 263-268. 
72. Domenici, E.; Bertucci, C.; Salvadori, P., and Wainer, I. W., J. Pharm. Sci., 
1991. 80(2): 164-166. 
73. Haginaka, J., J. Chromatogr. A, 2001. 906(1-2): 253-273. 
74. Millot, M. C.; Taleb, N. L., and Sebille, B., J. Chromatogr. B, 2002. 768(1): 157-
166. 
75. Noctor, T. A. G.; Wainer, I. W., and Hage, D. S., J. Chromatogr. B, 1992. 
577(2): 305-315. 
76. Vigh, G.; Quintero, G., and Farkas, G., J. Chromatogr., 1989. 484: 237-250. 
77. Allenmark, S.; Bomgren, B., and Boren, H., J. Chromatogr. A, 1983. 264: 63-68. 
78. Allenmark, S.; Bomgren, B., and Boren, H., J. Chromatogr., 1984. 316: 617-624. 
79. Miwa, T.; Miyakawa, T.; Kayano, M., and Miyake, Y., J. Chromatogr., 1987. 
408: 316-322. 
80. Armstrong, D. W.; Tang, Y. B.; Chen, S. S.; Zhou, Y. W.; Bagwill, C., and 
Chen, J. R., Anal. Chem., 1994. 66(9): 1473-1484. 
81. LePage, J. N.; Lindner, W.; Davies, G.; Seitz, D. E., and Karger, B. L., Anal. 
Chem., 1979. 51: 433-435. 
82. Hare, P. E. and Gil-Av, E., Science, 1979. 204(4398): 1226-1228. 
83. Pettersson, C. and Josefsson, M., Chromatographia, 1986. 6: 21. 
84. Pettersson, C. and Schill, G., Chromatographia, 1982. 16: 192. 
85. Pettersson, C., J. Chromatogr. A, 1984. 316: 553-567. 
86. Villiers, A., Compt. Rend., 1891. 112: 536. 
 203
87. Schardinger, F. and Z., U., Nahr. U. Genussm., 1903. 6: 865. 
88. Schardinger, F., Wien. Klin. Wochenschr., 1904. 17: 207. 
89. Freudenberg, K. and Meyer-Delius, M., Ber. Dtsch. Chem. Ges., 1938. 71: 1596. 
90. Freudenberg, K. and Cramer, F., Z. Naturforsch., 1948. B3: 464. 
91. French, D.; Levine, M. L.; Pazur, J. H., and Norberg, E., J. Am. Chem. Soc., 
1949. 71: 353. 
92. Scriven, E. F. V. and Turnbull, K., Chem. Rev., 1988. 88(2): 297-368. 
93. Gololobov, Yuri G. and Kasukhin, L. F., Tetrahedron, 1992. 48(8): 1353-1406. 
94. Messmer, A.; Pinter, I., and Szego, F., Angew. Chem., 1964. 76: 227. 
95. Lau, O.-W. and Mok, C.-S., J. Chromatogr. A, 1997. 766(1-2): 270-276. 
96. Ikeda, H.; Nakamura, M.; Ise, N.; Toda, F., and Ueno, A., J. Org. Chem., 1997. 
62(5): 1411-1418. 
97. Szejtli, J., Cyclodextrins and their inclusion complexes. 1982, Budapest: 
Akademia Kiado. 
98. Ward, T. J. and Armstrong, D. W., Cyclodextrin-bonded phases in 
chromatographic chiral separation, Zief, M., Editor. 1987, Marcel Dekker: New 
York. 
99. Hinze, W. L., Sep. Purif. Methods, 1981. 10(2): 159-237. 
100. Bender, M. L. and Komiyama, M., Cyclodextrin Chemistry. 1978, Berlin: 
Springer-Verlag. p. 1-24. 
101. Ward, T. J. and Armstrong, D. W., J. Liq. Chromatogr., 1986. 9: 407. 
102. Szejtli, J., in Comprehensive Supramolecular Chemistry, Osa, T., Editor. 1996, 
Pergamon Elsevier: Oxford. 
103. Casu, B.; Reggiani, M.; Gallo, G. G., and Vigevani, A., Tetrahedron, 1966. 
22(9): 3061-3083. 
104. Casu, B.; Reggiani, M.; Gallo, G. G., and Vigevani, A., Tetrahedron, 1968. 
24(2): 803-821. 
105. Saenger, W. R.; Jacob, J.; Gessler, K.; Steiner, T.; Hoffmann, D.; Sanbe, H.; 
Koizumi, K.; Smith, S. M., and Takaha, T., Chem. Rev., 1998. 98(5): 1787-1802. 
106. Schneider, H. J.; Hacket, F.; Rudiger, V., and Ikeda, H., Chem. Rev., 1998. 98(5): 
1755-1785. 
107. Solms, J. and Egli, R. H., Helv. Chim. Acta., 1965. 48: 1225. 
 204
108. Zsadon, B.; Szilasi, M.; Otta, K. H.; Tudos, F.; Fenyvesi, E., and Szejtli, J., Acta 
Chim. Acad. Sci. Hung., 1979. 199: 265. 
109. Mizobuchi, Y.; Tanaka, M., and Shono, T., J. Chromatogr. A, 1981. 208(1): 35-
40. 
110. Zsadon, B.; Szilasi, M.; Tudos, F., and Szejtli, J., J. Chromatogr. A, 1981. 
208(1): 109-112. 
111. Harada, A.; Furue, M., and Nozakura, S.- i., J. Polym. Sci. Polym. Chem., 1978. 
16(1): 189-196. 
112. Zsadon, B.; Szilasi, M.; Decsei, L.; Ujhazy, A., and Szejtli, J., J. Chromatogr. A, 
1986. 356: 428-432. 
113. Zsadon, B.; Szilasi, M.; Tudos, F.; Fenyvesi, E., and Szejtli, J., Stark, 1979. 31: 
11. 
114. Zsadon, B.; Decsei, L.; Szilasi, M.; Tudos, F., and Szejtli, J., J. Chromatogr. A, 
1983. 270: 127-134. 
115. Armstrong, D. W.; DeMond, W.; Alak, A.; Hinze, W. L.; Riehl, T. E., and Bui, 
K. H., Anal. Chem., 1985. 57(1): 234-237. 
116. Fujimura, K.; Ueda, T., and Ando, T., Anal. Chem., 1983. 55(3): 446-450. 
117. Kawaguchi, Y.; Tanaka, M.; Nakae, M.; Funazo, K., and Shono, T., Anal. Chem., 
1983. 55(12): 1852-1857. 
118. Tanaka, M.; Kawaguchi, Y.; Shono, T.; Uebori, M., and Kuge, Y., J. 
Chromatogr. A, 1984. 301: 345-353. 
119. Fujimura, K.; M., K.; Takayanagi, H., and Ando, T., J. Liq. Chromatogr., 1986. 
9: 607. 
120. Feitsma, K. G.; Bosman, J.; Drenth, B. F. H., and de Zeeuw, R. A., J. 
Chromatogr. A, 1985. 333: 59-68. 
121. Armstrong, D. W.; Chang, C. D., and Lee, S. H., J. Chromatogr., 1991. 539(1): 
83-90. 
122. Stalcup, A. M.; Chang, S. C.; Armstrong, D. W., and Pitha, J., J. Chromatogr., 
1990. 513: 181-194. 
123. Pawlowska, M., J. Liq. Chromatogr., 1991. 14(12): 2273-2286. 
124. Armstrong, D. W. and DeMond, W., J. Chromatogr. Sci., 1984. 22: 441. 
125. Armstrong, D. W.; Stalcup, A. M.; Hilton, M. L.; Duncan, J. D.; Faulkner, J. R., 
and Chang, S. C., Anal. Chem., 1990. 62(15): 1610-1615. 
126. Berthod, A.; Chang, S. C., and Armstrong, D. W., Anal. Chem., 1992. 64(4): 
395-404. 
 205
127. Armstrong, D. W., Bonded Phase Material For Chromatographic Separation. 
1985. 
128. Fisher, C. M., Chromatogr. Int., 1984. 5: 10. 
129. Kvstulovic, A. M., Enantioseparation By HPLC. 1989: Ellis Horwood Ltd. 
130. Armstrong, D. W. and Jin, H. L., Chirality, 1989. 1(1): 27-37. 
131. Cachau, C.; Thienpont, A.; Soulard, M. H., and Felix, G., Chromatographia, 
1997. 44(7-8): 411-416. 
132. Li, S. and Purdy, W. C., Anal. Chem., 1992. 64(13): 1405-1412. 
133. Hargitai, T.; Kaida, Y., and Okamoto, Y., J. Chromatogr., 1993. 628(1): 11-22. 
134. Hargitai, T. and Okamoto, Y., J. Liq. Chromatogr., 1993. 16(4): 843-858. 
135. Stalcup, A. M. and Gahm, K. H., Anal. Chem., 1996. 68(8): 1369-1374. 
136. Armstrong, D. W., J. Liq. Chromatogr., 1990. 13: 18. 
137. Stalcup, A. M.; Jin, H. L.; Armstrong, D. W.; Mazur, P.; Derguini, F., and 
Nakanishi, K., J. Chromatogr., 1990. 499: 627-635. 
138. Armstrong, D. W.; Hilton, M., and Coffin, L., LC GC-Mag. Sep. Sci., 1991. 9(9): 
646-&. 
139. Gahm, K. H. and Stalcup, A. M., Anal. Chem., 1995. 67(1): 19-25. 
140. Nakamura, K.; Fujima, H.; Kitagawa, H.; Wada, H., and Makino, K., J. 
Chromatogr. A, 1995. 694(1): 111-118. 
141. Gahm, K. H.; Yoshida, W.; Niemczura, W. P., and Stalcup, A. M., Carbohydr. 
Res., 1993. 248: 119-128. 
142. Baczuk, R. J.; Landram, G. K.; Dubois, R. J., and Dehm, H. C., J. Chromatogr., 
1971. 60(3): 351-361. 
143. Schill, G.; W., W. I., and Barkan, S. A., J. Liq. Chromatogr., 1984. 9: 641-666. 
144. Souter, R. W., Chromatographic Separation Of Stereoisomers. 1985, Vleveland, 
OH: CRC Press. 
145. Pirkle, W. H. and Finn, J. M., in Asymmetric Synthesis, Analytical Methods, 
Morrison, J. D., Editor. 1983, Academic Press, NY: New York. p. Ch. 6. 
146. Pochapsky, T. C., Biochromatography, 1987. 2: 28-35. 
147. Felix, G. and Zhang, T., J. Chromatogr., 1993. 639(2): 141-149. 
148. Stalcup, A. M.; Chang, S. C., and Armstrong, D. W., J. Chromatogr., 1991. 
540(1-2): 113-128. 
 206
149. Maguire, J. H., J. Chromatogr., 1987. 387: 453-458. 
150. Kuroda, Y.; Kato, T., and Ogoshi, H., Bull. Chem. Soc. Jpn., 1993. 66(4): 1116-
1120. 
151. Armstrong, D. W.; Chen, S.; Chang, C., and Chang, S., J. Liq. Chromatogr., 
1992. 15(3): 545-556. 
152. Hilton, M. L.; Chang, S. C.; Gasper, M. P.; Pawlowska, M.; Armstrong, D. W., 
and Stalcup, A. M., J. Liq. Chromatogr., 1993. 16(1): 127-147. 
153. Zhang, L. F.; Wong, Y. C.; Chen, L.; Ching, C. B., and Ng, S. C., Tetrahedron 
Lett., 1999. 40(9): 1815-1818. 
154. Zhang, L. F.; Chen, L.; Lee, T. C., and Ng, S. C., Tetrahedron-Asymmetr., 1999. 
10(21): 4107-4113. 
155. Ng, S. C.; Ching, C. B., and Zhang, L. F. 2000: SG. Patent.69210. 
156. Ng, S. C.; Ching, C. B., and Zhang, L. F. 2001: US. Patent.6,296,768. 
157. Staudinger, H. and Hauser, E., Helv. Chim. Acta, 1921. 4: 861-886. 
158. Pinter, I.; Kovacs, J., and Toth, G., Carbohydr. Res., 1995. 273(1): 99-108. 
159. Kovacs, J.; Pinter, I.; Messmer, A., and Toth, G., Carbohydr. Res., 1985. 141(1): 
57-65. 
160. Matsui, Y. and Okamoto, A., Bull. Chem. Soc. Jpn., 1978. 51: 3030. 
161. Zhong, N.; Byun, H.-S., and Bittman, R., Tetrahedron Lett., 1998. 39(19): 2919-
2920. 
162. Petter, R. C.; Salek, J. S.; Sikorski, C. T.; Kumaravel, G., and Lin, F. T., J. Am. 
Chem. Soc., 1990. 112: 3860. 
163. Gibson, A. R.; Melton, L. D., and Slessor, K. N., Can. J. Chem., 1974. 52: 3905. 
164. Parrot-Lopez, Helene; Galons, H.; Coleman, A. W.; Mahuteau, J., and Miocque, 
M., Tetrahedron Lett., 1992. 33(2): 209-212. 
165. Takahashi, K.; Hattori, K., and Toda, F., Tetrahedron Lett., 1984. 25(31): 3331-
3334. 
166. Bonomo, R. P.; Cucinotta, V.; Dalessandro, F.; Impellizzeri, G.; Maccarrone, G.; 
Vecchio, G., and Rizzarelli, E., Inorg. Chem., 1991. 30(13): 2708-2713. 
167. Liu, Y.; Zhang, Y. M.; Qi, A. D.; Chen, R. T.; Yamamoto, K.; Wada, T., and 
Inoue, Y., J. Org. Chem., 1997. 62(6): 1826-1830. 
168. Uekama, K.; Minami, K., and Hirayama, F., J. Med. Chem., 1997. 40(17): 2755-
2761. 
 207
169. Melton, L. D. and Slessor, K. N., Carbohydr. Res., 1971. 18(1): 29-37. 
170. Bradshaw, J. S.; Chen, Z.; Yi, G. L.; Rossiter, B. E.; Malik, A.; Pyo, D.; Yun, H.; 
Black, D. R.; Zimmerman, S. S.; Lee, M. L.; Tong, W. D., and Dsouza, V. T., 
Anal. Chem., 1995. 67(23): 4437-4439. 
171. Malik, A.; Yun, H.; Yi, G. L.; Bradshaw, J. S.; Rossiter, B. E.; Markides, K. E., 
and Lee, M. L., J. Microcolumn Sep., 1995. 7(2): 91-105. 
172. Jung, M. and Schurig, V., J. Microcolumn Sep., 1993. 5(1): 11-22. 
173. Ciucanu, I. and Konig, W. A., J. Chromatogr. A, 1994. 685(1): 166-171. 
174. Tanaka, M.; Yoshinaga, M.; Ito, M., and Ueda, H., Anal. Sci., 1995. 11(2): 227-
231. 
175. Okamoto, M. and Kishimoto, H., J. Chromatogr. A, 1981. 212(3): 251-260. 
176. Okamoto, M., J. Chromatogr. A, 1980. 202(1): 55-61. 
177. Cabrera, K.; Schwinn, G., and Lubda, D. 1992: US. Patent.5104547. 
178. Gololobov, Yu. G.; Zhmurova, I. N., and Kasukhin, L. F., Tetrahedron, 1981. 
37(3): 437-472. 
179. Leffler, J. E. and Temple, R. D., J. Am. Chem. Soc., 1967. 89: 5235 - 5246. 
180. Horner, L. and Winkler, H., Tetrahedron Lett., 1964. 5(3): 175-179. 
181. Bock, H. and Schnoller, M., Angew. Chem., 1968. 80: 667. 
182. Katritzky, A. R.; Jiang, J. L., and Urogdi, L., Synthesis, 1990(7): 565-567. 
183. Molina, P.; Alajarin, M., and Vidal, A., J. Chem. Soc.-Chem. Commun., 
1990(18): 1277-1279. 
184. Barluenga, J.; Ferrero, M., and Palacios, F., J. Chem. Soc.-Perkin Trans. 1, 
1990(8): 2193-2197. 
185. Tsuge, O.; Kanemasa, S., and Matsuda, K., J. Org. Chem., 1984. 49(15): 2688-
2691. 
186. Barluenga, J.; Ferrero, M., and Palacios, F., Tetrahedron Lett., 1988. 29(38): 
4863-4864. 
187. Meyers, F. H.; Jawetz, E., and Goldfien, A., Review of medical pharmacology, in 
7th Ed. Lange Mecidal publications. 1980: Los Altos. p. 95, 104. 
188. Ram, C. V. and Kaplan, N. M., Current Problems in Cardiology, 1979. 3(10): 1-
53. 
189. Okamoto, Y.; Kawashima, M.; Aburatani, R.; Hatada, K.; Nishiyama, T., and 
Masuda, M., Chem. Lett., 1986: 1237. 
 208
190. Tazerouti, F.; Badjah-Hadj-Ahmed, A. Y.; Meklati, B. Y.; Franco, P., and 
Minguillon, C., Chirality, 2002. 14(1): 59-66. 
191. Armstrong, D. W.; Chen, S.; Chang, C., and Chang, S., J. Liq. Chromatogr., 
1992. 15(3): 545-556. 
192. Perkins, S. L.; Tattrie, B.; Johnson, P. M., and Rabin, E. Z., Ther. Drug Monit., 
1988. 10(4): 480-485. 
193. Berthault, F.; Kintz, P., and Mangin, P., Ann. Pharm. Franc., 1997. 55(1): 12-19. 
194. Ching, C. B.; Lim, B. G.; Lee, E. J., and Ng, S. C., Chirality, 1992. 4(3): 174-
177. 
195. Krause, K.; Girod, M.; Chankvetadze, B., and Blaschke, G., J. Chromatogr. A, 
1999. 837(1-2): 51-63. 
196. Arnold, E. N.; Lillie, T. E., and Beesky, T. E., J. Liq. Chromatogr., 1989. 12: 
337. 
197. Mothes, K.; Schutte, H. R., and Luckner, M., Biochemistry of Alkaloids. 1985: 
VCH Publishers, USA. 
198. Cordell, G. A., Introduction to Alkaloids. 1986: John Wiley & Sons, USA. 
199. Cherkaoui, S.; Mateus, L.; Christen, P., and Veuthey, J. L., J. Chromatogr. B, 
1997. 696(2): 283-290. 
200. Armstrong, D. W.; Han, S. M., and Han, Y. I., Anal. Biochem., 1987. 167(2): 
261-264. 
201. Arvidsson, E.; Jansson, S. O., and Schill, G., J. Chromatogr., 1990. 506: 579-
591. 
202. Tang, Y., Chirality, 1996. 8(1): 136-142. 
203. Bhushan, R. and Ali, I., Chromatographia, 1993. 35(9-12): 679-680. 
204. Chen, L.; Zhang, L.-F.; Ching, C.-B., and Ng, S.-C., J. Chromatogr. A, 2002. 
950(1-2): 65-74. 
205. Gadelle, A. and Defaye, J., Angew. Chem., 1991: 78. 
206. Gorin, B. I.; Riopelle, R. J., and Thatcher, G. R. J., Tetrahedron Lett., 1996. 
37(27): 4647-4650. 
207. Boger, R. J.; Corcoran, R. J., and Lehn, J. M., Helv. Chim. Acta, 1978. 61: 2190. 
208. Hepburn, D. R. and Hudson, J. R., J. Chem. Soc. Perkin, 1976. 1: 754. 
209. Sallas, F.; Kovacs, J.; Pinter, I.; Jicsinszky, L., and Marsura, A., Tetrahedron 
Lett., 1996. 37(23): 4011-4014. 
 209
210. Felix, G.; Cachau, C.; Thienpont, A., and Soulard, M. H., Chromatographia, 
1996. 42(9-10): 583-590. 
211. Schurig, V.; Schmalzing, D.; Muhleck, U.; Jung, M.; Schleimer, M.; Mussche, 
P.; Duvekot, C., and Buyten, J. C., HRC-J. High Resolut. Chromatogr., 1990. 
13(10): 713-717. 
212. Lu, X. R.; Zhang, L. F.; Wang, Z. X.; Liu, X. F., and Chen, Y. Y., Chem. Res. 
Chin. Univ., 1994. 10(2): 126. 
213. Matthews, D. A.; Bolin, J. T.; Burridge, J. M.; Filman, D. J.; Volz, K. W., and 
Kraut, J., J. Biol. Chem., 1985. 260(1): 392-399. 
214. Rosowsky, A.; Chen, K. K.; Amand, R. S., and Modest, E. J., J. Pharm. Sci., 
1973. 62(3): 477-479. 
215. Hutchison, D. J. and Schmid, F. A., Folate Antagonists as Therapeutic Agents, 
ed. Montgomery, J. A. Vol. 2. 1984: Eds.; Academic Press, Inc. p. 1-21. 
216. Berman, E. M. and Werbel, L. M., J. Med. Chem., 1991. 34(2): 479-485. 
217. Rosenblatt, J. E., Mayo Clin. Proc., 1992. 67(3): 276-287. 
218. Schweitzer, B. I.; Dicker, A. P., and Bertino, J. R., FASEB, 1990. 4(8): 2441-
2452. 
219. Tsitsa, P.; Antoniadou-Vyza, E.; Hamodrakas, S. J.; Eliopoulos, E. E.; Tsantili-
Kakoulidou, A.; Lada-Hytiroglou, E.; Roussakis, C.; Chinou, I.; Hempel, A., and 
et, a., Euro. J. Med. Chem., 1993. 28(2): 149-158. 
220. Modest, E.; Farber, S., and Foley, G. E., Proc. Am. Ass. Cancer Res., 1954. 1: 
33. 
221. Roth, B., Federation Proc., 1986. 45(12): 2765-2772. 
222. Lee, H. K. and Chui, W. K., Bioorg. Med. Chem., 1999. 7(6): 1255-1262. 
223. Lecoq, H., Bull. Soc. R. Sci. Liege, 1943. 12: 136. 
224. Prelog, V. and Wieland, P., Helv. Chim. Acta, 1994. 27: 1127. 
225. Mayer, W. and Merger, F., Liebigs Ann. Chem., 1961. 644: 65. 
226. Legg, J. I. and Douglas, B. E., Inorg. Chem., 1968. 7: 1452. 
227. Falk, H. and Schlögl, K., Tetrahedron, 1966. 22: 3047. 
228. Hesse, G. and Hagel, R., Liebigs Ann. Chem., 1976: 996. 
229. Lautsch, W. and Heinicke, D., Kolloid Z., 1957. 154: 1. 
230. Steckelberg, W.; Bloch, M., and Musso, H., Chem. Ber., 1968. 101: 1519. 
 210
231. Hess, H.; Burger, G., and Musso, H., Angew. Chem., 1978. 90: 645. 
232. Schwanghart, A.-D.; Backmann, W., and Blaschke, G., Chem. Ber., 1977. 110: 
778. 
233. Satinger, A., Chiral separations: application and technology. 1996, Washington 
DC: ACS. 
234. Isaksson, R.; Erlandsson, P.; Hansson, L.; Holmberg, A., and Berner, S., J. 
Chromatogr., 1990. 498(2): 257-280. 
235. Miller, L. and Bergeron, R., J. Chromatogr., 1993. 648(2): 381-388. 
236. Lee, S. H.; Berthod, A., and Armstrong, D. W., J. Chromatogr., 1992. 603(1-2): 
83-93. 
237. Li, S. and Purdy, W. C., J. Chromatogr., 1992. 625(2): 109-120. 
238. Armstrong, D. W. and Li, W., Chromatographia, 1987. 2: 43. 
239. Maissa, P.; Seurin, M. J., and Sixou, P., Polym. Bull. (Berlin), 1986. 15(3): 257-
263. 
240. Klarman, A. F.; Galanti, A. V., and Sperling, L. H., J. Polym. Sci. Part A-2, 
1969. 7(9): 1513-1523. 
241. Ogura, K.; Miyachi, Y.; Sobue, H., and Nakamura, S., Makromol. Chem., 1975. 
176: 1173. 
242. Ringo, M. C. and Evans, C. E., Anal. Chem., 1997. 69(4): 643-649. 
243. Street, K. W. J., J. Liq. Chromatogr., 1987. 10(4): 655-662. 
244. Chang, C. A. and Wu, Q., J. Liq. Chromatogr., 1987. 10: 1359. 
245. Chang, C. A. and Wu, Q., Anal. Chim. Acta, 1986. 189: 293. 
246. Chang, C. A.; Wu, Q., and Eastman, M. P., J. Chromatogr., 1986. 371: 269-282. 
247. Chang, C. A.; Wu, Q. H., and Tan, L., J. Chromatogr., 1986. 361: 199-207. 
248. Rizzi, A. M., J. Chromatogr. A, 1989. 478: 71-86. 
249. Francotte, E. and Wolf, R., Chirality, 1990. 2: 16. 
250. Sallas, F.; Marsura, A.; Petot, V.; Pinter, I.; Kovacs, J., and Jicsinszky, L., Helv. 
Chim. Acta, 1998. 81(4): 632-645. 




List of Patents and Publications:  
 
Papers: 
1. “A facile immobilization approach for perfunctionalised cyclodextrin onto 
silica via the Staudinger reaction”, L. F. Zhang, Y. C. Wong, L. Chen, C. B. 
Ching, S. C. Ng, Tetrahedron Lett., 1999, 40: (9), 1815 
2. “A facile route into 6A-mono-omega-alkenylcarbamido-6A-deoxy-
perfunctionalised cyclodextrin: key intermediate for further reactive 
functionalisations”, L. F. Zhang, L. Chen, T. C. Lee, S. C. Ng, Tetrahedron-
Asymmetry, 1999, 10: (21), 4107 
3. “Facile Preparative HPLC Enantioseparation Of Racemic Drugs Using Chiral 
Stationary Phases Based On Mono-6A-Azido-6A-Deoxy-
Perphenylcarbamoylated b-Cyclodextrin Immobilized On Silica Gel”, S. C. Ng, 
L. Chen, L. F. Zhang, C. B. Ching, Tetrahedron Lett.,2000, 43 (4), 677  
4. “Synthesis and chromatographic properties of a novel chiral stationary phase 
derived from heptakis(6-azido-6-deoxy-2,3-di-O-phenylcarbamoyla ted)-b-
cyclodextrin immobilized onto amino-functionalized silica gel via multiple urea 
linkages”, L. Chen, L. F. Zhang, C. B. Ching and S. C. Ng, J. Chromatogr. A, 
2002, 950(1), 65 
 
Patents: 
1. “Materials Comprising Saccharide Cross-Linked And Chemically Bonded to a 
Support Via Urea Linkages Useful For Chromatography and Electrophoresis 
 212
Applications”, S. C. Ng, C. B. Ching, L. F. Zhang and L. Chen, PCT, Appl. No. 
PCT/SG01/00130. Filing date: 22 Jun 2001.  
2. “Materials Comprising Saccharide Cross-Linked And Chemically Bonded to a 
Support Via Urea Linkages Useful For Chromatography and Electrophoresis 
Applications”, S. C. Ng, C. B. Ching, L. F. Zhang and L. Chen, Singapore 
Patent,  Appl. No: 20004213-5. Filing Date: 23 Jun 2001.  
3. “Materials Comprising Saccharide Cross-Linked And Chemically Bonded to a 
Support Via Urea Linkages Useful For Chromatography and Electrophoresis 
Applications”, S. C. Ng, C. B. Ching, L. F. Zhang and L. Chen, US Patent, 
Appl. No: 09/888,088. Filing Date: 22 Jun 2001.  
4. “Materials Comprising Polymers or Oligomers of Saccharides Chemically 
Bonded to a Support Useful for Chromatography and Electrophoresis 
Applications”, S. C. Ng, C. B. Ching, L. F. Zhang and L. Chen, US Patent, 
Appl. No. 10/054,162. Filing Date: 18 Jan 2002. 
 
Papers in preparations for publications: 
1. “Preparation And Chromatographic Properties Of Perphenyl Carbamoylated  
And Pernaphthyl Carbamoylated b-Cyclodextrin Immobilised Silica Gel Via 
Single Urea Linkage” L. F. Zhang, L. Chen, C. B. Ching and S. C. Ng. (will be 
submitted to Analytical Chemistry) 
2. “Novel Chiral Stationary Phases For HPLC Comprising 
Perphenylcarbamoylated Or Pernaphthylcarbamoylated b-Cyclodextrin 
Chemically Bonded To Silica Gel Via An Ether Covalent Bond Via 
 213
Hydrosilylation” L. F. Zhang, L. Chen, A. F. Yeng, C. B. Ching and S. C. Ng. 
(will be submitted to Journal of Chromatography A) 
3. “Preparation And Chromatographic Properties Of A Novel Chiral Stationary 
Phase Derived From Heptakis(6-azido-6-deoxy) Perphenyl Carbamoylated b-
Cyclodextrin Cross-Linked and Immobilized Silica Gel Via Multiple Urethane 
Linkages” L. F. Zhang, L. Chen and S. C. Ng (will be submitted to Journal of 
Chromatography A) 
4. “Preparation And Chromatographic Properties Of Mono-6A-Azide-6A-Deoxy-
Perphenylcarbamoylated b-Cyclodextrin With Single Alkyl Side Chain Via 
Ureathe Linkages Onto The Surface Of Silica On HPLC In Preparative Scale”, 
L. Chen, L. F. Zhang, S. C. Ng and C. B. Ching. (will be submitted to 
Tetrahydron: Assymetry).  
5. “Enantioseparations of 1-(substituted-phenyl)-6-phenyl-1, 6-dihydro-
pyrimidine-2, 4-diamine and its analogues on Novel Chiral Stationary Phases 
Comprising Perphenylcarbamoylated Or 2-methoxyphenylcarbamoylated b-
Cyclodextrin Chemically Bonded To Silica Gel Via An Ether Covalent Bond 
Via Hydrosilylation by HPLC.” L. Chen, H. K. Lee, S. C. Ng and W. K. Chui. 




Appendix I.  Structures of Commercial Drugs 
 
1, 1’-binaphthol 
OH OH
 
5-(4-methylphenyl)-hydantoin 
HN
N
HO
O
 
 
 
Acebutolol 
N
H
O O
OH H
N
O  
 
 
Alprenolol 
O
OH H
N
 
. 
 
Ancymidol 
O OH
N N
 
 
 
Atenolol 
O
OH H
N
H2N
O
 
 
 
Atropine  
N
O
O
OH
 
 
 
Bendroflumethiazide  
N
H
NH
S
OO
F
F
F
S
H2N
O
O
 
  
 
Benzoin 
OH
O  
 
Bromopheniramine  
N
Br
N  
  
 
 
 
 
 215
Bupivacaine  
N
O
NH
 
Chloropheniramine  
N
Cl
N  
 
 
Dihydrobenzoin 
OH
HO  
 
 
Ibuprofen 
O
OH
 
 
 
Indapamide  
N
H
N
O
Cl
S
NH2
OO
 
 
 
Isoproterenol 
NH
OH
HO
HO
 
 
 
Ketamine  
Cl
O
H
N CH3
 
 
 
Labetalol 
H
N
OH
HO
H2N O
*
*
 
 
 
Metoprolol 
O
O
OH H
N
 
 
 
Nadolol 
O N
OH
HO
HO
*
*
*
 
 
 
N-(1-methyl-allyl)-N-phenyl-formamide 
O
N
 
 
 
Oxprenolol 
H
N
OH
O
O  
  
 216
Pheniramine  
N
N  
Pindolol 
OH
O
H
NHN
 
 
 
Praziquantel 
O
N
N
O  
 
 
Proglumide  
N
O
HO
O
HN
O
 
  
 
Promethazine  
S
N
N
 
 
 
Propranolol 
OH
HN
O
 
  
 
Suprofen 
O
S
O
OH
 
 
Tetrahydrozoline  
N
H
N
 
  
 
Tolperisone  
N
O
 
 
 
  
